rearrangement	amino_acid	frame_type	rearrangement_type	templates	reads	frequency	productive_frequency	cdr3_length	v_family	v_gene	v_allele	d_family	d_gene	d_allele	j_family	j_gene	j_allele	v_deletions	d5_deletions	d3_deletions	j_deletions	n2_insertions	n1_insertions	v_index	n1_index	n2_index	d_index	j_index	v_family_ties	v_gene_ties	v_allele_ties	d_family_ties	d_gene_ties	d_allele_ties	j_family_ties	j_gene_ties	j_allele_ties	sequence_tags	v_shm_count	v_shm_indexes	antibody	bio_identity	v_resolved	d_resolved	j_resolved	sample_name	species	locus	product_subtype	kit_pool	sku	test_name	sample_catalog_tags	sample_rich_tags	sample_rich_tags_json	kit_control	total_templates	productive_templates	outofframe_templates	stop_templates	dj_templates	total_rearrangements	productive_rearrangements	outofframe_rearrangements	stop_rearrangements	dj_rearrangements	total_reads	total_productive_reads	total_outofframe_reads	total_stop_reads	total_dj_reads	productive_clonality	productive_entropy	sample_clonality	sample_entropy	sample_amount_ng	sample_cells_mass_estimate	fraction_productive_of_cells_mass_estimate	sample_cells	fraction_productive_of_cells	max_productive_frequency	max_frequency	counting_method	primer_set	sequence_result_status	release_date	upload_date	sample_tags	fraction_productive	order_name	kit_id	total_t_cells	total_templates_agg
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCCTCTGGGGCGCCGGGACGTCCGGGGAGCTGTTTTTTGGAGAA	CASLWGAGTSGELFF	In	VDJ	1	28	3.6574055932181253E-4	4.6190138405450437E-4	45	TCRBV09	TCRBV09-01					TCRBJ02	TCRBJ02-02	01	7	0	7	6	12	2	23	32	49	44	51			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 1	CASLWGAGTSGELFF+TCRBV09-01+TCRBJ02-02	TCRBV09-01		TCRBJ02-02*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCCCCACGGAGGGGTTTAGCACAGATACGCAGTATTTTGGCCCA	CASSPTEGFSTDTQYF	In	VDJ	1	41	5.355486761497969E-4	6.7635559807981E-4	48	TCRBV09	TCRBV09-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	4	10	0	0	5	4	23	35	46	40	50			01,02										Vb 1	CASSPTEGFSTDTQYF+TCRBV09-01+TCRBJ02-03	TCRBV09-01	TCRBD02-01*02	TCRBJ02-03*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGCTTGGGGTAGCACCGGGGAGCTGTTTTTTGGAGAA	CASSAWGSTGELFF	In	VDJ	1	41	5.355486761497969E-4	6.7635559807981E-4	42	TCRBV09	TCRBV09-01					TCRBJ02	TCRBJ02-02	01	3	6	2	4	3	3	23	36	43	39	46			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 1	CASSAWGSTGELFF+TCRBV09-01+TCRBJ02-02	TCRBV09-01		TCRBJ02-02*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGACCGGGACAGAAGAATGAAAAACTGTTTTTTGGCAGT	CASRPGQKNEKLFF	In	VDJ	1	42	5.486108389827187E-4	6.928520760817565E-4	42	TCRBV09	TCRBV09-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	5	0	5	5	3	3	23	34	44	37	47			01,02										Vb 1	CASRPGQKNEKLFF+TCRBV09-01+TCRBJ01-04	TCRBV09-01	TCRBD01-01*01	TCRBJ01-04*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCCCCCGGGTGGGGGGGCCCTACGAGCAGTACTTCGGGCCG	CASSPRVGGPYEQYF	In	VDJ	1	47	6.139216531473281E-4	7.753344660914894E-4	45	TCRBV09	TCRBV09-01		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	4	9	0	2	8	1	23	35	50	43	51			01,02										Vb 1	CASSPRVGGPYEQYF+TCRBV09-01+TCRBJ02-07	TCRBV09-01	TCRBD02-01*01	TCRBJ02-07*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCTACGCCGAGGATGAGCGAGCAGTACTTCGGGCCG		Out	VDJ	1	49	6.400459788131719E-4		37	TCRBV09	TCRBV09-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	7	11	1	6	6	5	23	32	42	38	47			01,02										Vb 1	X+TCRBV09-01+TCRBJ02-07	TCRBV09-01	TCRBD02-01*02	TCRBJ02-07*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCGGGGAAAGGACAGCTTCAACCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	50	6.531081416460937E-4		44	TCRBV09	TCRBV09-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	7	1	5	7	7	7	23	32	45	39	52			01,02										Vb 1	X+TCRBV09-01+TCRBJ01-05	TCRBV09-01	TCRBD01-01*01	TCRBJ01-05*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAATTGGACAGGGGCTATGGCTACACCTTCGGTTCG	CASSQLDRGYGYTF	In	VDJ	1	22	2.8736758232428126E-4	3.6292251604282485E-4	42	TCRBV14	TCRBV14-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	2	1	2	4	2	0	29	44	-1	46	55													Vb 16	CASSQLDRGYGYTF+TCRBV14-01+TCRBJ01-02	TCRBV14-01*01	TCRBD01-01*01	TCRBJ01-02*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAAGGGAGACAGGATCCCTGACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	24	3.13491907990125E-4		49	TCRBV14	TCRBV14-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	1	2	4	5	3	7	29	45	54	48	61													Vb 16	X+TCRBV14-01+TCRBJ02-01	TCRBV14-01*01	TCRBD01-01*01	TCRBJ02-01*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAAGAATCCGGATTCTTCACAGATACGCAGTATTTTGGCCCA	CASSQESGFFTDTQYF	In	VDJ	1	38	4.963621876510313E-4	6.268661640739702E-4	48	TCRBV14	TCRBV14-01	01				TCRBJ02	TCRBJ02-03	01	0	1	8	2	4	5	29	46	53	50	58				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 16	CASSQESGFFTDTQYF+TCRBV14-01+TCRBJ02-03	TCRBV14-01*01		TCRBJ02-03*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAAGATCGGGGGAAAGAGACCCAGTACTTCGGGCCA	CASSQDRGKETQYF	In	VDJ	1	41	5.355486761497969E-4	6.7635559807981E-4	42	TCRBV14	TCRBV14-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	0	8	2	3	1	1	29	46	53	47	54													Vb 16	CASSQDRGKETQYF+TCRBV14-01+TCRBJ02-05	TCRBV14-01*01	TCRBD02-01*01	TCRBJ02-05*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAAGACCGGAGCGCTGAAGCTTTCTTTGGACAA	CASSQDRSAEAFF	In	VDJ	1	55	7.184189558107031E-4	9.073062901070622E-4	39	TCRBV14	TCRBV14-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	0	6	6	6	4	0	29	46	-1	50	54						01,02							Vb 16	CASSQDRSAEAFF+TCRBV14-01+TCRBJ01-01	TCRBV14-01*01	TCRBD02-01	TCRBJ01-01*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCGGGGACAGGAGCACCCTTGATTCCTACGAGCAGTACTTCGGGCCG	CASSGDRSTLDSYEQYF	In	VDJ	1	64	8.35978421307E-4	0.0010557745921245813	51	TCRBV14	TCRBV14-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	0	4	1	1	12	29	41	50	42	62													Vb 16	CASSGDRSTLDSYEQYF+TCRBV14-01+TCRBJ02-07	TCRBV14-01*01	TCRBD01-01*01	TCRBJ02-07*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAAGGAGGGGACGCTCTGGGGCCAACGTCCTGACTTTCGGGGCC		Out	VDJ	1	67	8.751649098057657E-4		50	TCRBV14	TCRBV14-01	01				TCRBJ02	TCRBJ02-06	01	1	0	7	0	3	1	29	45	53	48	54				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 16	X+TCRBV14-01+TCRBJ02-06	TCRBV14-01*01		TCRBJ02-06*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAAAGACGGACAAACGGGGAGCTGTTTTTTGGAGAA	CASSQRRTNGELFF	In	VDJ	1	69	9.012892354716094E-4	0.0011382569821343142	42	TCRBV14	TCRBV14-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	2	1	6	7	4	2	29	44	53	48	55													Vb 16	CASSQRRTNGELFF+TCRBV14-01+TCRBJ02-02	TCRBV14-01*01	TCRBD01-01*01	TCRBJ02-02*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCGGCGTTGCGACTAGCGATTACAATGAGCAGTTCTTCGGGCCA	CASSGVATSDYNEQFF	In	VDJ	1	102	0.0013323406089580314	0.0016826407561985517	48	TCRBV14	TCRBV14-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	5	2	6	4	8	2	29	41	57	49	59						01,02							Vb 16	CASSGVATSDYNEQFF+TCRBV14-01+TCRBJ02-01	TCRBV14-01*01	TCRBD02-01	TCRBJ02-01*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCCTCTTTTGGACAACTACGAGCAGTACTTCGGGCCG	CASSPLLDNYEQYF	In	VDJ	2	137	0.001789516308110297	0.002260017486266682	42	TCRBV14	TCRBV14-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	4	1	6	3	7	1	29	42	54	49	55													Vb 16	CASSPLLDNYEQYF+TCRBV14-01+TCRBJ02-07	TCRBV14-01*01	TCRBD01-01*01	TCRBJ02-07*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
CTGGAGTTTATTTCTGTGCCAGCAGCCAATCAAACCGGGACTAGCGGGAGGAGAGAACGAGACCCAGTACTTCGGGCCA		Out	VDJ	2	186	0.0024295622869234686		59	TCRBV14	TCRBV14-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	2	0	1	5	7	7	14	29	51	36	58													Vb 16	X+TCRBV14-01+TCRBJ02-05	TCRBV14-01*01	TCRBD02-01*02	TCRBJ02-05*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCTTTCCGGGACATCCGACGAGCAGTACTTCGGGCCG	CASSLSGTSDEQYF	In	VDJ	3	229	0.0029912352887391095	0.003777693462445768	42	TCRBV14	TCRBV14-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	4	0	6	5	5	4	29	42	53	47	57													Vb 16	CASSLSGTSDEQYF+TCRBV14-01+TCRBJ02-07	TCRBV14-01*01	TCRBD01-01*01	TCRBJ02-07*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCCCCGGACTAGCGGATTCCAAGAGACCCAGTACTTCGGGCCA	CASSPRTSGFQETQYF	In	VDJ	3	252	0.0032916650338963124	0.004157112456490539	48	TCRBV14	TCRBV14-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	4	1	5	1	3	3	29	42	55	45	58						01,02							Vb 16	CASSPRTSGFQETQYF+TCRBV14-01+TCRBJ02-05	TCRBV14-01*01	TCRBD02-01	TCRBJ02-05*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCGTAGGGGGCGGGATGGCCTACAATGAGCAGTTCTTCGGGCCA	CASSVGGGMAYNEQFF	In	VDJ	1	27	3.5267839648889064E-4	4.454049060525578E-4	48	TCRBV21	TCRBV21-or09_02	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	5	5	0	2	2	7	24	36	45	38	52														CASSVGGGMAYNEQFF+TCRBV21-or09_02+TCRBJ02-01	TCRBV21-or09_02*01	TCRBD01-01*01	TCRBJ02-01*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCGGGGAAGGGGCGCTTAAGGAGACCCAGTACTTCGGGCCA	CASGEGALKETQYF	In	VDJ	1	30	3.9186488498765625E-4	4.948943400583975E-4	42	TCRBV21	TCRBV21-or09_02	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	10	7	3	5	0	14	24	-1	37	31	51														CASGEGALKETQYF+TCRBV21-or09_02+TCRBJ02-05	TCRBV21-or09_02*01	TCRBD02-01*01	TCRBJ02-05*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGTAGCAAACACCACGGACAGGCCCGACACCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	1	32	4.179892106535E-4		52	TCRBV21	TCRBV21-or09_02	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	2	1	4	3	6	4	24	39	52	45	56														X+TCRBV21-or09_02+TCRBJ02-02	TCRBV21-or09_02*01	TCRBD01-01*01	TCRBJ02-02*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCGTAGGGGACGGCGGGGAGCTGTTTTTTGGAGAA	CASSVGDGGELFF	In	VDJ	1	36	4.702378619851875E-4	5.938732080700771E-4	39	TCRBV21	TCRBV21-or09_02	01				TCRBJ02	TCRBJ02-02	01	5	0	7	7	4	2	24	36	45	40	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSVGDGGELFF+TCRBV21-or09_02+TCRBJ02-02	TCRBV21-or09_02*01		TCRBJ02-02*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGTGACAGTCGAGGGCCCGAGCAGTACTTCGGGCCG	CASSDSRGPEQYF	In	VDJ	1	36	4.702378619851875E-4	5.938732080700771E-4	39	TCRBV21	TCRBV21-or09_02	01				TCRBJ02	TCRBJ02-07	01	6	2	5	6	1	9	24	35	41	36	50				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSDSRGPEQYF+TCRBV21-or09_02+TCRBJ02-07	TCRBV21-or09_02*01		TCRBJ02-07*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAAGATGTGGGGGGGATCGCAAGAGACCCAGTACTTCGGGCCA	CASKMWGGSQETQYF	In	VDJ	1	39	5.094243504839531E-4	6.433626420759168E-4	45	TCRBV21	TCRBV21-or09_02	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	10	9	0	2	9	4	24	31	47	40	51														CASKMWGGSQETQYF+TCRBV21-or09_02+TCRBJ02-05	TCRBV21-or09_02*01	TCRBD02-01*01	TCRBJ02-05*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGTCCGATGAAAGACCTATGGCTACACCTTCGGTTCG		Out	VDJ	1	39	5.094243504839531E-4		40	TCRBV21	TCRBV21-or09_02	01				TCRBJ01	TCRBJ01-02	01	6	2	7	4	10	0	24	35	-1	45	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV21-or09_02+TCRBJ01-02	TCRBV21-or09_02*01		TCRBJ01-02*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGGAGAGAAAATAGCAATCAGCCCCAGCATTTTGGTGAT	CASRRENSNQPQHF	In	VDJ	1	40	5.22486513316875E-4	6.598591200778634E-4	42	TCRBV21	TCRBV21-or09_02	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-05	01	6	11	2	0	0	6	24	-1	38	35	44														CASRRENSNQPQHF+TCRBV21-or09_02+TCRBJ01-05	TCRBV21-or09_02*01	TCRBD02-01*02	TCRBJ01-05*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGTTGGTCACATGACGCGTGAGTGAAAGACCTATGGCACACCTCGGTTCG		Out	VDJ	1	46	6.008594903144063E-4		53	TCRBV21	TCRBV21-or09_02	01				TCRBJ01	TCRBJ01-02	01	6	2	7	18	10	27	24	35	48	45	75				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV21-or09_02+TCRBJ01-02	TCRBV21-or09_02*01		TCRBJ01-02*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCGTAGAACGGCCAGGCCAATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	47	6.139216531473281E-4		46	TCRBV21	TCRBV21-or09_02	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	5	4	4	3	10	1	24	36	50	46	51														X+TCRBV21-or09_02+TCRBJ01-05	TCRBV21-or09_02*01	TCRBD01-01*01	TCRBJ01-05*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCGTAGTAGGGACATATAACAATGAGCAGTTCTTCGGGCCA	CASSVVGTYNNEQFF	In	VDJ	1	54	7.053567929777813E-4	8.908098121051156E-4	45	TCRBV21	TCRBV21-or09_02	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	5	0	6	5	6	4	24	36	48	42	52														CASSVVGTYNNEQFF+TCRBV21-or09_02+TCRBJ02-01	TCRBV21-or09_02*01	TCRBD01-01*01	TCRBJ02-01*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCACACTGGGGGCGGAGACACGAAAATTTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	55	7.184189558107031E-4		53	TCRBV21	TCRBV21-or09_02	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	4	6	0	4	4	15	24	37	47	41	62														X+TCRBV21-or09_02+TCRBJ02-07	TCRBV21-or09_02*01	TCRBD01-01*01	TCRBJ02-07*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCGCGACGGCGGGGCTCGAAGCTTTCTTTGGACAA	CASSATAGLEAFF	In	VDJ	1	61	7.967919328082343E-4	0.0010062851581187416	39	TCRBV21	TCRBV21-or09_02	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	5	7	3	8	6	3	24	36	48	42	51														CASSATAGLEAFF+TCRBV21-or09_02+TCRBJ01-01	TCRBV21-or09_02*01	TCRBD02-01*01	TCRBJ01-01*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGTCTGTCAATGCAGGGACTGGGCCGCATGGAGAGCTGTTTTTTGGAGAA		Out	VDJ	1	61	7.967919328082343E-4		50	TCRBV21	TCRBV21-or09_02	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	10	0	10	11	13	12	24	31	50	44	62						01,02								X+TCRBV21-or09_02+TCRBJ02-02	TCRBV21-or09_02*01	TCRBD02-01	TCRBJ02-02*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGTCAAGGACTGCAGAAAACCCAGTACTTCGGGCCA	CASSQGLQKTQYF	In	VDJ	1	64	8.35978421307E-4	0.0010557745921245813	39	TCRBV21	TCRBV21-or09_02	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	6	1	10	8	4	7	24	35	44	39	51						01,02								CASSQGLQKTQYF+TCRBV21-or09_02+TCRBJ02-05	TCRBV21-or09_02*01	TCRBD02-01	TCRBJ02-05*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGTGATAGCGGGAGGACCCTTCCCGGGGAGCTGTTTTTTGGAGAA	CASSDSGRTLPGELFF	In	VDJ	1	74	9.666000496362187E-4	0.0012207393721440473	48	TCRBV21	TCRBV21-or09_02	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	6	5	1	6	3	7	24	35	48	38	55														CASSDSGRTLPGELFF+TCRBV21-or09_02+TCRBJ02-02	TCRBV21-or09_02*01	TCRBD02-01*02	TCRBJ02-02*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAAGGTCGGATCTTCGGGGGGGACCCAGTACTTCGGGCCA	CASKVGSSGGTQYF	In	VDJ	1	80	0.00104497302663375	0.0013197182401557268	42	TCRBV21	TCRBV21-or09_02	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	10	8	1	7	15	0	24	31	-1	46	53														CASKVGSSGGTQYF+TCRBV21-or09_02+TCRBJ02-05	TCRBV21-or09_02*01	TCRBD02-01*01	TCRBJ02-05*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCGTTGGGGGAGGCTAGCGGGAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	84	0.0010972216779654375		47	TCRBV21	TCRBV21-or09_02	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	5	4	4	5	11	0	24	36	-1	47	55						01,02								X+TCRBV21-or09_02+TCRBJ02-03	TCRBV21-or09_02*01	TCRBD02-01	TCRBJ02-03*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAAGAGGGAGCGAGATGGCTACACCTTCGGTTCG	CASKRERDGYTF	In	VDJ	2	143	0.0018678892851078282	0.0023589963542783618	36	TCRBV21	TCRBV21-or09_02	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	10	9	2	6	6	4	24	31	42	37	46														CASKRERDGYTF+TCRBV21-or09_02+TCRBJ01-02	TCRBV21-or09_02*01	TCRBD02-01*02	TCRBJ01-02*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCGCCGGACAGGGGGCTTGGTCCGGGGAGCTGTTTTTTGGAGAA	CASSAGQGAWSGELFF	In	VDJ	3	260	0.0033961623365596876	0.004289084280506112	48	TCRBV21	TCRBV21-or09_02	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	5	1	0	6	3	5	24	36	50	39	55														CASSAGQGAWSGELFF+TCRBV21-or09_02+TCRBJ02-02	TCRBV21-or09_02*01	TCRBD01-01*01	TCRBJ02-02*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCGTAACCGGGACAGGCAACTATGGCTACACCTTCGGTTCG	CASSVTGTGNYGYTF	In	VDJ	4	305	0.003983959664041172	0.0050314257905937085	45	TCRBV21	TCRBV21-or09_02	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	0	4	2	6	1	24	36	50	42	51														CASSVTGTGNYGYTF+TCRBV21-or09_02+TCRBJ01-02	TCRBV21-or09_02*01	TCRBD01-01*01	TCRBJ01-02*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCGTAGTCAATGCGGTGACTAGGTCTCAGATACGCAGTATTTTGGCCCA		Out	VDJ	5	385	0.005028932690674922		53	TCRBV21	TCRBV21-or09_02	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	5	2	8	4	14	4	24	36	56	50	60						01,02								X+TCRBV21-or09_02+TCRBJ02-03	TCRBV21-or09_02*01	TCRBD02-01	TCRBJ02-03*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
GACTCGGCCATGTATCGCTGTGCCAGCAGCCCCTCCGGGACAGGGGGCTGGGACCACGAGCAGTACTTCGGGCCG	CASSPSGTGGWDHEQYF	In	VDJ	1	34	4.4411353631934375E-4	5.608802520661838E-4	51	TCRBV07	TCRBV07-06	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	0	0	5	6	7	18	30	48	36	55														CASSPSGTGGWDHEQYF+TCRBV07-06+TCRBJ02-07	TCRBV07-06*01	TCRBD01-01*01	TCRBJ02-07*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
GACTCGGCCATGTATCGCTGTGCCAGCAGCTTAGTGTCTGGGGGCGAGGGCGAGCAGTACTTCGGGCCG	CASSLVSGGEGEQYF	In	VDJ	1	36	4.702378619851875E-4	5.938732080700771E-4	45	TCRBV07	TCRBV07-06	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	1	6	0	6	5	5	18	34	45	39	50														CASSLVSGGEGEQYF+TCRBV07-06+TCRBJ02-07	TCRBV07-06*01	TCRBD01-01*01	TCRBJ02-07*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
CGACTCGGCTGTGTATCTCTGTGCCAGCAGCTTAGTCCGACTGGCGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSLVRLANTGELFF	In	VDJ	1	26	3.3961623365596876E-4	4.289084280506112E-4	48	TCRBV07	TCRBV07-05	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	0	2	10	0	3	2	19	35	42	38	44						01,02								CASSLVRLANTGELFF+TCRBV07-05+TCRBJ02-02	TCRBV07-05*01	TCRBD02-01	TCRBJ02-02*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
CGACTCGGCTGTGTATCTCTGTGCCAGCAGCTTAATAGGCCAGGGGGCGACCCAGTACTTCGGGCCA	CASSLIGQGATQYF	In	VDJ	1	29	3.7880272215473436E-4	4.7839786205645094E-4	42	TCRBV07	TCRBV07-05	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	1	4	0	7	6	0	19	34	-1	40	48														CASSLIGQGATQYF+TCRBV07-05+TCRBJ02-05	TCRBV07-05*01	TCRBD01-01*01	TCRBJ02-05*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
CGACTCGGCTGTGTATCTCTGTGCCAGCAGCTCTCGATTGACAGGGGGAAACACTGAAGCTTTCTTTGGACAA	CASSSRLTGGNTEAFF	In	VDJ	1	71	9.274135611374531E-4	0.0011712499381382076	48	TCRBV07	TCRBV07-05	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	2	1	2	7	1	19	32	48	39	49														CASSSRLTGGNTEAFF+TCRBV07-05+TCRBJ01-01	TCRBV07-05*01	TCRBD01-01*01	TCRBJ01-01*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTGGGCAGGGCGGCGGCAGATACGCAGTATTTTGGCCCA	CASSLGRAAADTQYF	In	VDJ	1	23	3.0042974515720315E-4	3.7941899404477143E-4	45	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	0	4	3	4	1	6	19	35	41	36	47													Vb 5.1	CASSLGRAAADTQYF+TCRBV05-01+TCRBJ02-03	TCRBV05-01*01	TCRBD01-01*01	TCRBJ02-03*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTGGTTACCCCGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSLVTPNTGELFF	In	VDJ	1	23	3.0042974515720315E-4	3.7941899404477143E-4	45	TCRBV05	TCRBV05-01	01				TCRBJ02	TCRBJ02-02	01	0	3	7	0	2	2	19	35	39	37	41				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 5.1	CASSLVTPNTGELFF+TCRBV05-01+TCRBJ02-02	TCRBV05-01*01		TCRBJ02-02*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTGGGCTGGAGGGCYCAAGAGACCCAGTACTTCGGGCCA	CASSLGWRAQETQYF	In	VDJ	1	26	3.3961623365596876E-4	4.289084280506112E-4	45	TCRBV05	TCRBV05-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	0	10	0	2	3	2	19	35	44	38	46													Vb 5.1	CASSLGWRAQETQYF+TCRBV05-01+TCRBJ02-05	TCRBV05-01*01	TCRBD02-01*02	TCRBJ02-05*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCCCACAGGGGGGAGCTAACTATGGCTACACCTTCGGTTCG	CASSPQGGANYGYTF	In	VDJ	1	37	4.8330002481810936E-4	6.103696860720237E-4	45	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	4	3	1	0	2	3	19	31	41	33	44													Vb 5.1	CASSPQGGANYGYTF+TCRBV05-01+TCRBJ01-02	TCRBV05-01*01	TCRBD01-01*01	TCRBJ01-02*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
GGACTCGGCCCTTTATCTTTGCCAGCAGCCAATACGGGGAGGGAGGGCCCAGTGAGCAGTTCTTCGGGCCA		Out	VDJ	1	45	5.877973274814844E-4		46	TCRBV05	TCRBV05-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	13	9	0	9	14	9	19	22	43	36	52													Vb 5.1	X+TCRBV05-01+TCRBJ02-01	TCRBV05-01*01	TCRBD02-01*02	TCRBJ02-01*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCCAAGACAGGGCAGCACAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	45	5.877973274814844E-4		44	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	4	2	3	0	3	1	19	31	41	34	42													Vb 5.1	X+TCRBV05-01+TCRBJ02-03	TCRBV05-01*01	TCRBD01-01*01	TCRBJ02-03*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCGCGGCACTAGCGGGACAAAACATTCAGTACTTCGGCGCC	CASSAALAGQNIQYF	In	VDJ	1	46	6.008594903144063E-4	7.588379880895429E-4	45	TCRBV05	TCRBV05-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-04	01	4	3	3	5	5	1	19	31	46	36	47													Vb 5.1	CASSAALAGQNIQYF+TCRBV05-01+TCRBJ02-04	TCRBV05-01*01	TCRBD02-01*02	TCRBJ02-04*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTGGCCTCCGGGACAGGGCCGGGAGAGCAGTTCTTCGGGCCA	CASSLASGTGPGEQFF	In	VDJ	1	46	6.008594903144063E-4	7.588379880895429E-4	48	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	0	0	3	10	5	6	19	35	49	40	55													Vb 5.1	CASSLASGTGPGEQFF+TCRBV05-01+TCRBJ02-01	TCRBV05-01*01	TCRBD01-01*01	TCRBJ02-01*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTCGCAGGGCGGACGAGAGACCCAGTACTTCGGGCCA	CASSSQGGRETQYF	In	VDJ	1	53	6.922946301448593E-4	8.74313334103169E-4	42	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	3	4	3	4	2	6	19	32	39	34	45													Vb 5.1	CASSSQGGRETQYF+TCRBV05-01+TCRBJ02-05	TCRBV05-01*01	TCRBD01-01*01	TCRBJ02-05*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTTTCAGACTAGTCTTGTGGAGCAGTACTTCGGGCCG		Out	VDJ	9	693	0.009052078843214859		43	TCRBV05	TCRBV05-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	2	2	8	7	4	7	19	33	43	37	50						01,02							Vb 5.1	X+TCRBV05-01+TCRBJ02-07	TCRBV05-01*01	TCRBD02-01	TCRBJ02-07*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTCCTAGCTACCAAGAAGGCCCAGTACTTCGGGCCA	CASSFLATKKAQYF	In	VDJ	1	22	2.8736758232428126E-4	3.6292251604282485E-4	42	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	3	4	7	9	1	11	25	39	45	40	56						01,02							Vb 3	CASSFLATKKAQYF+TCRBV28-01+TCRBJ02-05	TCRBV28-01*01	TCRBD02-01	TCRBJ02-05*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGGTTAGGGGGCGGCATCTCCTACAATGAGCAGTTCTTCGGGCCA	CASRLGGGISYNEQFF	In	VDJ	1	25	3.2655407082304687E-4	4.1241195004866464E-4	48	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	2	6	0	0	0	5	25	-1	46	40	51													Vb 3	CASRLGGGISYNEQFF+TCRBV28-01+TCRBJ02-01	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-01*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTCCGGGTTGAAGAGACCCAGTACTTCGGGCCA	CASSFRVEETQYF	In	VDJ	1	25	3.2655407082304687E-4	4.1241195004866464E-4	39	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	3	8	4	3	1	3	25	39	44	40	47						01,02							Vb 3	CASSFRVEETQYF+TCRBV28-01+TCRBJ02-05	TCRBV28-01*01	TCRBD02-01	TCRBJ02-05*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTAGGATCTCTCTCAAGGGGGGGCTACACCTTCGGTTCG	CASSLGSLSRGGYTF	In	VDJ	1	28	3.6574055932181253E-4	4.6190138405450437E-4	45	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	2	5	1	8	12	0	25	40	-1	52	58													Vb 3	CASSLGSLSRGGYTF+TCRBV28-01+TCRBJ01-02	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-02*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTCCACTGGGGGGGGCACGGCAGCCCCAGCATTTTGGTGAT	CASSPLGGARQPQHF	In	VDJ	1	30	3.9186488498765625E-4	4.948943400583975E-4	45	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-05	01	5	9	0	7	5	6	25	37	49	42	55													Vb 3	CASSPLGGARQPQHF+TCRBV28-01+TCRBJ01-05	TCRBV28-01*01	TCRBD02-01*01	TCRBJ01-05*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTGCCCGGGACAGGGGGCTTAGAAATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	30	3.9186488498765625E-4		53	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	3	0	0	4	4	5	25	39	55	43	60													Vb 3	X+TCRBV28-01+TCRBJ01-05	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-05*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTGCGGACTAGCGGGAATAAGCAGTTCTTCGGGCCA		Out	VDJ	1	34	4.4411353631934375E-4		41	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	4	1	3	11	2	3	25	38	52	40	55													Vb 3	X+TCRBV28-01+TCRBJ02-01	TCRBV28-01*01	TCRBD02-01*02	TCRBJ02-01*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTCTCGGTTTGTCCGGAGAGCCCAAAAACATTCAGTACTTCGGCGCC	CASSLGLSGEPKNIQYF	In	VDJ	1	35	4.5717569915226564E-4	5.773767300681304E-4	51	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-04	01	5	10	2	2	12	3	25	37	53	49	56													Vb 3	CASSLGLSGEPKNIQYF+TCRBV28-01+TCRBJ02-04	TCRBV28-01*01	TCRBD02-01*02	TCRBJ02-04*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGACAAGGGATCGGGGGGGAGACCTACGAGCAGTACTTCGGGCCG	CASRQGIGGETYEQYF	In	VDJ	1	36	4.702378619851875E-4	5.938732080700771E-4	48	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	6	8	0	2	9	3	25	36	53	45	56													Vb 3	CASRQGIGGETYEQYF+TCRBV28-01+TCRBJ02-07	TCRBV28-01*01	TCRBD02-01*01	TCRBJ02-07*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTCTCCCCAGCGAACCGCTACAATGAGCAGTTCTTCGGGCCA	CASSFSPANRYNEQFF	In	VDJ	1	37	4.8330002481810936E-4	6.103696860720237E-4	48	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	3	6	6	3	6	5	25	39	49	45	54						01,02							Vb 3	CASSFSPANRYNEQFF+TCRBV28-01+TCRBJ02-01	TCRBV28-01*01	TCRBD02-01	TCRBJ02-01*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTACCCAGAGGCGAGCGGTGGCTACACCTTCGGTTCG	CASSYPEASGGYTF	In	VDJ	1	39	5.094243504839531E-4	6.433626420759168E-4	42	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	4	6	5	7	11	0	25	38	-1	49	54						01,02							Vb 3	CASSYPEASGGYTF+TCRBV28-01+TCRBJ01-02	TCRBV28-01*01	TCRBD02-01	TCRBJ01-02*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
TCTATGTACCTCTGTGCCAGCAGTTTCCTCAACGTTCCGGGACAGGGGAAATAGCAATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	39	5.094243504839531E-4		61	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	3	0	2	0	12	3	12	26	48	38	51													Vb 3	X+TCRBV28-01+TCRBJ01-05	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-05*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCATTCCAAGCGTAGGACAGGTAAGAGATCAGCCCCAGCATTTTGGTGAT	CASIPSVGQVRDQPQHF	In	VDJ	1	41	5.355486761497969E-4	6.7635559807981E-4	51	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	7	1	4	5	11	6	25	35	53	46	59													Vb 3	CASIPSVGQVRDQPQHF+TCRBV28-01+TCRBJ01-05	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-05*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGCCGAGACAGGGGCAACACCGGGGAGCTGTTTTTTGGAGAA	CASSRDRGNTGELFF	In	VDJ	1	42	5.486108389827187E-4	6.928520760817565E-4	45	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	6	2	2	2	4	1	25	36	48	40	49													Vb 3	CASSRDRGNTGELFF+TCRBV28-01+TCRBJ02-02	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-02*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTAGGGGCAGGGGTGGAGACCCAGTACTTCGGGCCA	CASSLGAGVETQYF	In	VDJ	1	42	5.486108389827187E-4	6.928520760817565E-4	42	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	2	4	2	5	4	2	25	40	50	44	52													Vb 3	CASSLGAGVETQYF+TCRBV28-01+TCRBJ02-05	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-05*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTCCGGACAAAGATCAGCCCCAGCATTTTGGTGAT	CASSPDKDQPQHF	In	VDJ	1	43	5.616730018156407E-4	7.093485540837031E-4	39	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	5	1	6	5	2	3	25	37	44	39	47													Vb 3	CASSPDKDQPQHF+TCRBV28-01+TCRBJ01-05	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-05*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAAGTGGGCAGATCCTAACTATGGCTACACCTTCGGTTCG	CASKWADPNYGYTF	In	VDJ	1	45	5.877973274814844E-4	7.423415100875963E-4	42	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	7	8	0	0	3	5	25	35	42	38	47													Vb 3	CASKWADPNYGYTF+TCRBV28-01+TCRBJ01-02	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-02*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTACTAGCGGGGGGCACAGATACGCAGTATTTTGGCCCA	CASSLLAGGTDTQYF	In	VDJ	1	54	7.053567929777813E-4	8.908098121051156E-4	45	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	2	4	2	1	0	0	25	-1	-1	40	50													Vb 3	CASSLLAGGTDTQYF+TCRBV28-01+TCRBJ02-03	TCRBV28-01*01	TCRBD02-01*01	TCRBJ02-03*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTATCACAGGACGCCGGGGAGCTGTTTTTTGGAGAA	CASSLSQDAGELFF	In	VDJ	1	66	8.621027469728437E-4	0.0010887675481284745	42	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	1	3	4	6	1	3	25	41	47	42	50													Vb 3	CASSLSQDAGELFF+TCRBV28-01+TCRBJ02-02	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-02*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTAGTGCAGGGGGGGAAAGAGGAAAAACTGTTTTTTGGCAGT	CASSLVQGGKEEKLFF	In	VDJ	1	68	8.882270726386875E-4	0.0011217605041323677	48	TCRBV28	TCRBV28-01	01				TCRBJ01	TCRBJ01-04	01	2	4	1	8	3	8	25	40	50	43	58				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	CASSLVQGGKEEKLFF+TCRBV28-01+TCRBJ01-04	TCRBV28-01*01		TCRBJ01-04*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTGAGACAGGGCGTTGGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	1	71	9.274135611374531E-4		41	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	5	2	3	8	2	5	25	37	46	39	51													Vb 3	X+TCRBV28-01+TCRBJ02-02	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-02*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTCAACAGGGCTACGAGCAGTACTTCGGGCCG	CASSQQGYEQYF	In	VDJ	1	89	0.001162532492130047	0.001468186542173246	36	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	3	3	3	2	0	25	37	-1	39	45													Vb 3	CASSQQGYEQYF+TCRBV28-01+TCRBJ02-07	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-07*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTTCTCCAGGGCCGTGGGCCCCAGCATTTTGGTGAT	CASSFLQGRGPQHF	In	VDJ	1	89	0.001162532492130047	0.001468186542173246	42	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	3	4	3	9	4	6	25	39	48	43	54													Vb 3	CASSFLQGRGPQHF+TCRBV28-01+TCRBJ01-05	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-05*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTATTCTCAGGTCCAAGCTCCTACGAGTAGTACTTCGGGCCG	CASSLFSGPSSYE*YF	Stop	VDJ	1	98	0.0012800919576263438		48	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	1	4	4	11	3	17	25	41	48	44	65													Vb 3	CASSLFSGPSSYE*YF+TCRBV28-01+TCRBJ02-07	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-07*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTCGACAGGGACCCGCGGGTGAAAAACTGTTTTTTGGCAGT	CASSRQGPAGEKLFF	In	VDJ	1	115	0.0015021487257860157	0.0018970949702238572	45	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	5	2	3	7	1	9	25	37	45	38	54													Vb 3	CASSRQGPAGEKLFF+TCRBV28-01+TCRBJ01-04	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-04*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGCCCGGACTTCCTAAATCAGCCCCAGCATTTTGGTGAT	CASSPDFLNQPQHF	In	VDJ	2	119	0.001554397377117703	0.0019630808822316435	42	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-05	01	6	1	10	4	3	5	25	36	44	39	49						01,02							Vb 3	CASSPDFLNQPQHF+TCRBV28-01+TCRBJ01-05	TCRBV28-01*01	TCRBD02-01	TCRBJ01-05*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCTTCTTCATCTTTTGGCACTGAAGCTTTCTTTGGACAA		Out	VDJ	2	146	0.0019070757736065938		40	TCRBV28	TCRBV28-01	01				TCRBJ01	TCRBJ01-01	01	8	0	10	4	13	0	25	34	-1	47	49				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	X+TCRBV28-01+TCRBJ01-01	TCRBV28-01*01		TCRBJ01-01*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGGCCCACTACAGGGTCCGGAAACACCATATATTTTGGAGAG	CASRPTTGSGNTIYF	In	VDJ	2	158	0.0020638217276016564	0.0026064435243075604	45	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	6	3	3	4	7	3	25	36	49	43	52													Vb 3	CASRPTTGSGNTIYF+TCRBV28-01+TCRBJ01-03	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-03*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTGGGGACTGTCTTAGGTGGTGAGCAGTTCTTCGGGCCA	CASSLGTVLGGEQFF	In	VDJ	2	161	0.002103008216100422	0.0026559329583134	45	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	3	0	10	9	1	11	25	39	46	40	57						01,02							Vb 3	CASSLGTVLGGEQFF+TCRBV28-01+TCRBJ02-01	TCRBV28-01*01	TCRBD02-01	TCRBJ02-01*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCACCCTGACAGGGTATAGCAATCAGCCCCAGCATTTTGGTGAT	CASTLTGYSNQPQHF	In	VDJ	8	622	0.008124665282077406	0.010260809317210776	45	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	7	2	3	0	4	2	25	35	46	39	48													Vb 3	CASTLTGYSNQPQHF+TCRBV28-01+TCRBJ01-05	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-05*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGGATCGGGACAGGGGGCGCTCTTGAAGCTTTCTTTGGACAA	CASRIGTGGALEAFF	In	VDJ	18	1447	0.018900949619237953	0.02387040366881671	45	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	0	0	7	4	5	25	36	52	40	57													Vb 3	CASRIGTGGALEAFF+TCRBV28-01+TCRBJ01-01	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-01*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTATTCCCAGGTCCAAGCTCCTACGAGCAGTACTTCGGGCCG	CASSLFPGPSSYEQYF	In	VDJ	44	3443	0.04497302663375002	0.05679737376070209	48	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	1	4	4	0	3	6	25	41	48	44	54													Vb 3	CASSLFPGPSSYEQYF+TCRBV28-01+TCRBJ02-07	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-07*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
GACTCGGCCGTGTATGTCTGTGCAAGTCGCATGAGCGGCTCCACACAAAGTCGGGCCAACGTCCTGACTTTCGGGGCC	CASRMSGSTQSRANVLTF	In	VDJ	1	23	3.0042974515720315E-4	3.7941899404477143E-4	54	TCRBV12	TCRBV12-02	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-06	01	5	6	5	5	3	14	18	30	38	33	52						01,02								CASRMSGSTQSRANVLTF+TCRBV12-02+TCRBJ02-06	TCRBV12-02*01	TCRBD02-01	TCRBJ02-06*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
GACTCGGCCGTGTATGTCTGTGGCACCTCCTGGGACAGCAGTTCCACTGAAGCTTTCTTTGGACAA	CGTSWDSSSTEAFF	In	VDJ	1	27	3.5267839648889064E-4	4.454049060525578E-4	42	TCRBV12	TCRBV12-02	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	13	0	5	4	9	6	18	22	38	31	44														CGTSWDSSSTEAFF+TCRBV12-02+TCRBJ01-01	TCRBV12-02*01	TCRBD01-01*01	TCRBJ01-01*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
TCGGCCGTGTATGTCTGTGCAAGTCGCTACGGACAGGGGATCCCCACATACTAGCGGGAGGGAGTGGATGAGCAGTTCTTCGGGCCA	CASRYGQGIPTY*REGVDEQFF	Stop	VDDJ	1	58	7.576054443094687E-4		66	TCRBV12	TCRBV12-02	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	4	3	0	8	10	5	15	39	62	49	67														CASRYGQGIPTY*REGVDEQFF+TCRBV12-02+TCRBJ02-01	TCRBV12-02*01	TCRBD02-01*02	TCRBJ02-01*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
CCAACCAGACCTCTCTGTACTTCTGTGCCAGCAGTCCAACCCGGACCGGCGTGGGAAACACCATATATTTTGGAGAG	CASSPTRTGVGNTIYF	In	VDJ	1	59	7.706676071423907E-4	9.732922021148485E-4	48	TCRBV27	TCRBV27-01	01				TCRBJ01	TCRBJ01-03	01	5	1	7	4	7	7	23	35	46	42	53				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 14	CASSPTRTGVGNTIYF+TCRBV27-01+TCRBJ01-03	TCRBV27-01*01		TCRBJ01-03*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
CCAACCAGACCTCTCTGTACTTCTGTGCCAGCAGCCCCGGACAGGGACGGGAGATGAAAAACTGTTTTTTGGCAGT		Out	VDJ	1	94	0.0012278433062946563		47	TCRBV27	TCRBV27-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	6	1	3	6	4	7	23	34	46	38	53													Vb 14	X+TCRBV27-01+TCRBJ01-04	TCRBV27-01*01	TCRBD01-01*01	TCRBJ01-04*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTGCGCACCGGGACTAACACCGGGGAGCTGTTTTTTGGAGAA	CSVRTGTNTGELFF	In	VDJ	1	22	2.8736758232428126E-4	3.6292251604282485E-4	42	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	6	0	10	2	7	0	25	33	-1	40	46						01,02							Vb 4	CSVRTGTNTGELFF+TCRBV29-01+TCRBJ02-02	TCRBV29-01*01	TCRBD02-01	TCRBJ02-02*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGCTTGGACAGGGGCAGATACGCAGTATTTTGGCCCA	CSAWTGADTQYF	In	VDJ	1	25	3.2655407082304687E-4	4.1241195004866464E-4	36	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	7	1	2	4	3	0	25	32	-1	35	44													Vb 4	CSAWTGADTQYF+TCRBV29-01+TCRBJ02-03	TCRBV29-01*01	TCRBD01-01*01	TCRBJ02-03*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGCCCCAGGGCGTTGGGGACTAGGGGGGGGAAATGAGCAGTTCTTCGGGCCA	CSAPGRWGLGGGNEQFF	In	VDJ	1	28	3.6574055932181253E-4	4.6190138405450437E-4	51	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	7	0	8	7	13	8	25	32	53	45	61						01,02							Vb 4	CSAPGRWGLGGGNEQFF+TCRBV29-01+TCRBJ02-01	TCRBV29-01*01	TCRBD02-01	TCRBJ02-01*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGACATTGGTGACTATGGCTACACCTTCGGTTCG	CSVDIGDYGYTF	In	VDJ	1	30	3.9186488498765625E-4	4.948943400583975E-4	36	TCRBV29	TCRBV29-01	01				TCRBJ01	TCRBJ01-02	01	3	0	10	3	4	2	25	36	42	40	44				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 4	CSVDIGDYGYTF+TCRBV29-01+TCRBJ01-02	TCRBV29-01*01		TCRBJ01-02*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTAAGGACAGTAACCTACGAGCAGTACTTCGGGCCG	CSVRTVTYEQYF	In	VDJ	1	32	4.179892106535E-4	5.278872960622907E-4	36	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	1	5	2	2	3	25	33	41	35	44													Vb 4	CSVRTVTYEQYF+TCRBV29-01+TCRBJ02-07	TCRBV29-01*01	TCRBD01-01*01	TCRBJ02-07*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCACTCGGACAGGCCCATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	35	4.5717569915226564E-4		37	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	8	1	4	5	4	3	25	31	42	35	45													Vb 4	X+TCRBV29-01+TCRBJ01-05	TCRBV29-01*01	TCRBD01-01*01	TCRBJ01-05*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGAAGGTGGCACTGAGGGAACCTATGGCTACACCTTCGGTTCG	CSVEGGTEGTYGYTF	In	VDJ	1	39	5.094243504839531E-4	6.433626420759168E-4	45	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	1	11	0	4	8	3	25	38	51	46	54													Vb 4	CSVEGGTEGTYGYTF+TCRBV29-01+TCRBJ01-02	TCRBV29-01*01	TCRBD02-01*02	TCRBJ01-02*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTTTGGTGGACATGAACACTGAAGCTTTCTTTGGACAA	CSVLVDMNTEAFF	In	VDJ	1	45	5.877973274814844E-4	7.423415100875963E-4	39	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	1	6	0	5	0	25	34	-1	39	44													Vb 4	CSVLVDMNTEAFF+TCRBV29-01+TCRBJ01-01	TCRBV29-01*01	TCRBD01-01*01	TCRBJ01-01*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTGGTGACAGTAACCTACACTGAAGCTTTCTTTGGACAA	CSVVTVTYTEAFF	In	VDJ	1	46	6.008594903144063E-4	7.588379880895429E-4	39	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	2	5	3	3	6	25	33	41	36	47													Vb 4	CSVVTVTYTEAFF+TCRBV29-01+TCRBJ01-01	TCRBV29-01*01	TCRBD01-01*01	TCRBJ01-01*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTACCGGGAGTGGGTTATGGCTACACCTTCGGTTCG	CSVPGVGYGYTF	In	VDJ	1	47	6.139216531473281E-4	7.753344660914894E-4	36	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	6	8	2	5	2	5	25	33	41	35	46													Vb 4	CSVPGVGYGYTF+TCRBV29-01+TCRBJ01-02	TCRBV29-01*01	TCRBD02-01*02	TCRBJ01-02*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTAGGACTAGCGGGACGTTCAGATACGCAGTATTTTGGCCCA	CSVGLAGRSDTQYF	In	VDJ	1	54	7.053567929777813E-4	8.908098121051156E-4	42	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	6	1	3	4	1	4	25	33	46	34	50													Vb 4	CSVGLAGRSDTQYF+TCRBV29-01+TCRBJ02-03	TCRBV29-01*01	TCRBD02-01*02	TCRBJ02-03*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGGGTCCCTTTCCTACAATGAGCAGTTCTTCGGGCCA	CSGSLSYNEQFF	In	VDJ	1	64	8.35978421307E-4	0.0010557745921245813	36	TCRBV29	TCRBV29-01	01				TCRBJ02	TCRBJ02-01	01	7	0	10	1	0	6	25	-1	34	32	40				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 4	CSGSLSYNEQFF+TCRBV29-01+TCRBJ02-01	TCRBV29-01*01		TCRBJ02-01*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGACAAGGACTACTCCTATAATGAGCAGTTCTTCGGGCCA	CSVDKDYSYNEQFF	In	VDJ	1	68	8.882270726386875E-4	0.0011217605041323677	42	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	3	1	9	7	3	7	25	36	45	39	52						01,02							Vb 4	CSVDKDYSYNEQFF+TCRBV29-01+TCRBJ02-01	TCRBV29-01*01	TCRBD02-01	TCRBJ02-01*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTCACGGACTAGCGGGGTCGAATGAGCAGTTCTTCGGGCCA	CSVHGLAGSNEQFF	In	VDJ	1	69	9.012892354716094E-4	0.0011382569821343142	42	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	5	1	3	7	3	3	25	34	49	37	52													Vb 4	CSVHGLAGSNEQFF+TCRBV29-01+TCRBJ02-01	TCRBV29-01*01	TCRBD02-01*01	TCRBJ02-01*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGAATGGGACAGGGATAATGAGCAGTTCTTCGGGCCA	CSVEWDRDNEQFF	In	VDJ	1	71	9.274135611374531E-4	0.0011712499381382076	39	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	2	0	3	7	1	2	25	37	47	38	49													Vb 4	CSVEWDRDNEQFF+TCRBV29-01+TCRBJ02-01	TCRBV29-01*01	TCRBD01-01*01	TCRBJ02-01*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTAACGGATGGACAGTCTGGGCACTTGGCTTTCTTTGGACAA	CSVTDGQSGHLAFF	In	VDJ	1	88	0.001149470329297125	0.0014516900641712994	42	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	1	5	11	7	12	25	33	46	40	58													Vb 4	CSVTDGQSGHLAFF+TCRBV29-01+TCRBJ01-01	TCRBV29-01*01	TCRBD01-01*01	TCRBJ01-01*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGTACACAGTGTGAACACTGAAGCTTTCTTTGGACAA	CSVVHSVNTEAFF	In	VDJ	1	96	0.0012539676319605	0.001583661888186872	39	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	3	5	0	3	2	25	35	42	38	44													Vb 4	CSVVHSVNTEAFF+TCRBV29-01+TCRBJ01-01	TCRBV29-01*01	TCRBD01-01*01	TCRBJ01-01*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGAAGGTAACAGGGAGGGCGRCTACGAGCAGTACTTCGGGCCG	CSVEGNREGXYEQYF	In	VDJ	1	103	0.001345402771790953	0.0016991372342004983	45	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	1	9	0	3	6	3	25	38	51	44	54													Vb 4	CSVEGNREGXYEQYF+TCRBV29-01+TCRBJ02-07	TCRBV29-01*01	TCRBD02-01*02	TCRBJ02-07*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGGCACTAGCGGGAGTGAATTCTTGGCCCAGTACTTCGGGCCA	CSVGTSGSEFLAQYF	In	VDJ	1	103	0.001345402771790953	0.0016991372342004983	45	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	4	3	2	9	2	11	25	35	48	37	59													Vb 4	CSVGTSGSEFLAQYF+TCRBV29-01+TCRBJ02-05	TCRBV29-01*01	TCRBD02-01*02	TCRBJ02-05*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTGGACAGTTCCTCTGGAAACACCATATATTTTGGAGAG	CSVDSSSGNTIYF	In	VDJ	2	128	0.001671956842614	0.0021115491842491627	39	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	6	1	5	0	0	3	25	-1	39	33	42													Vb 4	CSVDSSSGNTIYF+TCRBV29-01+TCRBJ01-03	TCRBV29-01*01	TCRBD01-01*01	TCRBJ01-03*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTAGGAGGGAAGTCGGGGAGCTGTTTTTTGGAGAA	CSVRREVGELFF	In	VDJ	2	148	0.0019332000992724374	0.0024414787442880947	36	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	5	10	0	7	1	4	25	34	41	35	45													Vb 4	CSVRREVGELFF+TCRBV29-01+TCRBJ02-02	TCRBV29-01*01	TCRBD02-01*02	TCRBJ02-02*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGCCGGGACAGGTCCCTACGAGCAGTACTTCGGGCCG	CSVAGTGPYEQYF	In	VDJ	2	155	0.0020246352391028906	0.0025569540903017207	39	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	4	0	4	2	2	2	25	35	45	37	47													Vb 4	CSVAGTGPYEQYF+TCRBV29-01+TCRBJ02-07	TCRBV29-01*01	TCRBD01-01*01	TCRBJ02-07*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGCCGGATCGGCAGGGACAGGGTCAGGCTACACCTTCGGTTCG	CSAGSAGTGSGYTF	In	VDJ	3	270	0.003526783964888906	0.0044540490605255775	42	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	7	0	3	8	11	3	25	32	52	43	55													Vb 4	CSAGSAGTGSGYTF+TCRBV29-01+TCRBJ01-02	TCRBV29-01*01	TCRBD01-01*01	TCRBJ01-02*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGCGAAAAGGACTACTCAAGAGACCCAGTACTTCGGGCCA	CSAKRTTQETQYF	In	VDJ	5	418	0.005459984064161344	0.0068955278048136726	39	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	7	1	9	2	6	2	25	32	44	38	46						01,02							Vb 4	CSAKRTTQETQYF+TCRBV29-01+TCRBJ02-05	TCRBV29-01*01	TCRBD02-01	TCRBJ02-05*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCAGCAGTTCCGCTACTGATTCAATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	23	3.0042974515720315E-4		44	TCRBV06	unresolved		TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-05	01	4	3	10	3	5	4	23	36	44	41	48		TCRBV06-05,TCRBV06-06,TCRBV06-08				01,02								X+TCRBV06-X+TCRBJ01-05	unresolved	TCRBD02-01	TCRBJ01-05*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
CTCCCTCYCAGACWTCTGTKTACTTSTGTGCCAGCAAAACCCTCCGGGGATACGCAGTATTTTGGCCCA		Out	VDJ	1	28	3.6574055932181253E-4		37	TCRBV06	unresolved		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	7	8	4	6	8	0	23	33	-1	41	45		TCRBV06-07,TCRBV06-08				01,02								X+TCRBV06-X+TCRBJ02-03	unresolved	TCRBD02-01	TCRBJ02-03*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
CGACTCGGCYGTGTATCTCTGTGCCAGCAGCTTAAATAGTGAACAGTGGGGGGTCGGCTACACCTTCGGTTCG	CASSLNSEQWGVGYTF	In	VDJ	1	30	3.9186488498765625E-4	4.948943400583975E-4	48	TCRBV07	unresolved		TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-02	01	1	9	1	8	13	2	19	34	53	47	55		TCRBV07-02,TCRBV07-05												CASSLNSEQWGVGYTF+TCRBV07-X+TCRBJ01-02	unresolved	TCRBD02-01*01	TCRBJ01-02*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
CTCCCTCYCAGACWTCTGTKTACTTSTGTGCCAGCAGTTCCGGGACAGGGGTCTTTGTGCATGAGCAGTTCTTCGGGCCA	CASSSGTGVFVHEQFF	In	VDJ	1	32	4.179892106535E-4	5.278872960622907E-4	48	TCRBV06	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	4	0	2	8	2	9	26	39	51	41	60		TCRBV06-07,TCRBV06-08												CASSSGTGVFVHEQFF+TCRBV06-X+TCRBJ02-01	unresolved	TCRBD01-01*01	TCRBJ02-01*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
SGACTCRGCYRTGTATCKCTGTGCCAGCAGCCCGCGCTTAAACCGGGACAGGGCCGGAGAGACCCAGTACTTCGGGCCA	CASSPRLNRDRAGETQYF	In	VDJ	1	33	4.3105137348642186E-4	5.443837740642373E-4	54	TCRBV07	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	5	0	3	4	13	4	19	31	53	44	57		TCRBV07-05,TCRBV07-07												CASSPRLNRDRAGETQYF+TCRBV07-X+TCRBJ02-05	unresolved	TCRBD01-01*01	TCRBJ02-05*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
CTSCTCCCAGACATCTGTRTATTTCTGCGCCAGCAGTTTTCCCAGCGGGAGAACCCAAACCCCTACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	35	4.5717569915226564E-4		56	TCRBV10	unresolved		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	5	6	2	2	6	10	23	35	49	41	59		TCRBV10-01,TCRBV10-02												X+TCRBV10-X+TCRBJ02-01	unresolved	TCRBD02-01*02	TCRBJ02-01*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
CCTSCTCCCAGACATCTGTRTATTTCTGCGCCTCCAGAAGGAGTACTAGCCCCAAATCCACAGATACGCAGTATTTTGGCCCA	CASRRSTSPKSTDTQYF	In	VDJ	1	35	4.5717569915226564E-4	5.773767300681304E-4	51	TCRBV10	unresolved		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	11	3	7	2	12	8	23	29	47	41	55		TCRBV10-01,TCRBV10-02				01,02								CASRRSTSPKSTDTQYF+TCRBV10-X+TCRBJ02-03	unresolved	TCRBD02-01	TCRBJ02-03*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
CCTSCTCCCAGACATCTGTRTATTTCTGCGCCAGCAGTGACCTGGTACGGACACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	40	5.22486513316875E-4		41	TCRBV10	unresolved		TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	3	8	5	3	7	0	26	40	-1	47	50		TCRBV10-01,TCRBV10-02				01,02								X+TCRBV10-X+TCRBJ01-01	unresolved	TCRBD02-01	TCRBJ01-01*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
CCTSCTCCCAGACATCTGTRTATTTCTGCGCCAGCAGTGAGTCGAGATGAGAGACCCAGTACTTCGGGCCA	CASSESR*ETQYF	Stop	VDJ	1	41	5.355486761497969E-4		39	TCRBV10	unresolved		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	0	11	2	4	0	3	23	-1	43	40	46		TCRBV10-01,TCRBV10-02												CASSESR*ETQYF+TCRBV10-X+TCRBJ02-05	unresolved	TCRBD02-01*02	TCRBJ02-05*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
CCTSCTCCCAGACATCTGTRTATTTCTGCGCCAGTAGTTTTAAGGGACTCTCCTCCTACAATGAGCAGTTCTTCGGGCCA	CASSFKGLSSYNEQFF	In	VDJ	1	41	5.355486761497969E-4	6.7635559807981E-4	48	TCRBV10	unresolved		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	5	0	10	0	5	3	23	35	46	40	49		TCRBV10-01,TCRBV10-02				01,02								CASSFKGLSSYNEQFF+TCRBV10-X+TCRBJ02-01	unresolved	TCRBD02-01	TCRBJ02-01*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
TGTACCCTCYCAGACATCTGTGTACTTSTGTGCCAGCAAGTCGTCCGTGGACATTCAGTACTTCGGCGCC	CASKSSVDIQYF	In	VDJ	1	52	6.792324673119375E-4	8.578168561012224E-4	36	TCRBV06	unresolved					TCRBJ02	TCRBJ02-04	01	7	0	10	8	10	0	23	33	-1	43	45		TCRBV06-04,TCRBV06-08		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASKSSVDIQYF+TCRBV06-X+TCRBJ02-04	unresolved		TCRBJ02-04*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
CCTSCTCCCAGACATCTGTRTATTTCTGCGCCAGAGTCTAGCGTCTAGCTCCTACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	52	6.792324673119375E-4		44	TCRBV10	unresolved		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	9	4	6	0	3	5	26	34	43	37	48		TCRBV10-01,TCRBV10-02				01,02								X+TCRBV10-X+TCRBJ02-01	unresolved	TCRBD02-01	TCRBJ02-01*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
CTCCCTCYCAGACWTCTGTKTACTTSTGTGCCAGCAGTTTCCTCGGGAGCTACGAGCAGTACTTCGGGCCG	CASSFLGSYEQYF	In	VDJ	1	64	8.35978421307E-4	0.0010557745921245813	39	TCRBV06	unresolved		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	4	8	2	3	4	0	23	36	-1	40	46		TCRBV06-07,TCRBV06-08												CASSFLGSYEQYF+TCRBV06-X+TCRBJ02-07	unresolved	TCRBD02-01*02	TCRBJ02-07*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
TCTGTGTACTTSTGTGCCAGCAGTGTCGGGGACGGCGAGACTTCTAGCGGGATTGGCAGGAAGACCCAGTACTTCGGGCCA	CASSVGDGETSSGIGRKTQYF	In	VDJ	1	76	9.927243753020626E-4	0.0012537323281479405	63	TCRBV06	unresolved		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	5	4	3	6	19	9	12	24	52	43	61		TCRBV06-01,TCRBV06-04,TCRBV06-08												CASSVGDGETSSGIGRKTQYF+TCRBV06-X+TCRBJ02-05	unresolved	TCRBD02-01*02	TCRBJ02-05*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
CTCCCTCYCAGACWTCTGTKTACTTSTGTGCCAGCAGTCCGGGACACCCACTTCGAAGTCTAATGAAAAACTGTTTTTTGGCAGT		Out	VDJ	1	77	0.0010057865381349843		53	TCRBV06	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	5	0	6	3	2	13	23	35	43	37	56		TCRBV06-07,TCRBV06-08												X+TCRBV06-X+TCRBJ01-04	unresolved	TCRBD01-01*01	TCRBJ01-04*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
TGTACCCTCYCAGACATCTGTGTACTTSTGTGCCATCAGTGCCGGGACCTACGAGCAGTACTTCGGGCCG	CAISAGTYEQYF	In	VDJ	1	77	0.0010057865381349843	0.001270228806149887	36	TCRBV06	unresolved		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	5	8	3	2	2	0	23	35	-1	37	42		TCRBV06-04,TCRBV06-08												CAISAGTYEQYF+TCRBV06-X+TCRBJ02-07	unresolved	TCRBD02-01*02	TCRBJ02-07*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
CTCCCTCYCAGACWTCTGTKTACTTSTGTGCCAGCAGTGACTCGGCGGATAGCACAGATACGCAGTATTTTGGCCCA	CASSDSADSTDTQYF	In	VDJ	1	108	0.0014107135859555626	0.0017816196242102312	45	TCRBV06	unresolved		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	0	7	5	0	1	2	23	40	45	41	47		TCRBV06-07,TCRBV06-08				01,02								CASSDSADSTDTQYF+TCRBV06-X+TCRBJ02-03	unresolved	TCRBD02-01	TCRBJ02-03*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
GGACTCGGCCRTGTATSTCTGTGCCAGCAGCTTATCAGGGGACACCGGGGAGCTGTTTTTTGGAGAA	CASSLSGDTGELFF	In	VDJ	2	133	0.0017372676567786094	0.0021940315742588956	42	TCRBV11	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	2	4	2	3	1	0	18	33	-1	34	40		TCRBV11-01,TCRBV11-03												CASSLSGDTGELFF+TCRBV11-X+TCRBJ02-02	unresolved	TCRBD01-01*01	TCRBJ02-02*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCAGTGAACACGACTAGCGGGAGGGCGGGGACGGGCCA	CASSEHD*REGGD	Stop	VDJ	1	37	4.8330002481810936E-4		39	TCRBV02	TCRBV02-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02			2	2	0	21	3	6	23	38	55	41	61								TCRBJ02-01,TCRBJ02-05					Vb 22	CASSEHD*REGGD+TCRBV02-01+TCRBJ02-X	TCRBV02-01*01	TCRBD02-01*02	TCRBJ02	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
CTCCCTCTCAGACTTCTGTTTACTTCTGTGCCAGCAGTCTGGAGGGCGCAGGCAGTTACGAGCAGTACTTCGGGCCG	CASSLEGAGSYEQYF	In	VDJ	1	26	3.3961623365596876E-4	4.289084280506112E-4	45	TCRBV06	TCRBV06-07	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	5	10	0	4	2	10	26	38	46	40	56														CASSLEGAGSYEQYF+TCRBV06-07+TCRBJ02-07	TCRBV06-07*01	TCRBD02-01*02	TCRBJ02-07*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
CTCCCTCTCAGACTTCTGTTTACTTCTGTGTCAGCAGTGAAGGCGCAGGGACAGATACGCAGTATTTTGGCCCA	CVSSEGAGTDTQYF	In	VDJ	1	28	3.6574055932181253E-4	4.6190138405450437E-4	42	TCRBV06	TCRBV06-07	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	5	4	3	3	7	0	26	38	-1	45	50														CVSSEGAGTDTQYF+TCRBV06-07+TCRBJ02-03	TCRBV06-07*01	TCRBD01-01*01	TCRBJ02-03*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
CTCCCTCTCAGACTTCTGTTTACTTCTGTGCCAGCAGTGGGGTGGGTGAAGCTTTCTTTGGACAA	CASSGVGEAFF	In	VDJ	1	29	3.7880272215473436E-4	4.7839786205645094E-4	33	TCRBV06	TCRBV06-07	01				TCRBJ01	TCRBJ01-01	01	5	6	2	7	0	4	26	-1	42	38	46				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSGVGEAFF+TCRBV06-07+TCRBJ01-01	TCRBV06-07*01		TCRBJ01-01*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
CTCCCTCTCAGACTTCTGTTTACTTCTGTGCCATCAGTGAAGGCGAGACCCAGTACTTCGGGCCA	CAISEGETQYF	In	VDJ	1	29	3.7880272215473436E-4	4.7839786205645094E-4	33	TCRBV06	TCRBV06-07	01				TCRBJ02	TCRBJ02-05	01	5	5	4	5	2	1	26	38	43	40	44				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CAISEGETQYF+TCRBV06-07+TCRBJ02-05	TCRBV06-07*01		TCRBJ02-05*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
CTCCCTCTCAGACTTCTGTTTACTTCTGTGCCAGCAGTGAAGGTTCAGGGCGTCAGCCCCAGCATTTTGGTGAT	CASSEGSGRQPQHF	In	VDJ	1	51	6.661703044790157E-4	8.413203780992758E-4	42	TCRBV06	TCRBV06-07	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	5	4	3	6	7	2	26	38	50	45	52														CASSEGSGRQPQHF+TCRBV06-07+TCRBJ01-05	TCRBV06-07*01	TCRBD01-01*01	TCRBJ01-05*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
CTCCCTCTCAGACTTCTGTTTACTTCTGTGCCAGCAGTTACCGGGACAGGCCAAGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	62	8.098540956411563E-4		43	TCRBV06	TCRBV06-07	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	2	0	4	1	1	0	26	41	-1	42	50														X+TCRBV06-07+TCRBJ02-05	TCRBV06-07*01	TCRBD01-01*01	TCRBJ02-05*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
GGACTCAGCCATGTATCGCTGTGCCAGCAGCTTAGGTTTAGCGGGAGGGCGGACTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	23	3.0042974515720315E-4		50	TCRBV07	TCRBV07-07	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	1	5	0	3	3	4	19	35	49	38	53														X+TCRBV07-07+TCRBJ02-07	TCRBV07-07*01	TCRBD02-01*02	TCRBJ02-07*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
CGAAGCTTGAGGATTCAGCAGTGTATTTTTGTGCCAGCAGCCAAATTATCTAAGAGACCCAGTACTTCGGGCCA	CASSQII*ETQYF	Stop	VDJ	1	96	0.0012539676319605		39	TCRBV16	TCRBV16-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	2	4	10	3	5	0	29	44	-1	49	51			01,02			01,02								CASSQII*ETQYF+TCRBV16-01+TCRBJ02-05	TCRBV16-01	TCRBD02-01	TCRBJ02-05*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
CGAAGCTTGAGGATTCAGCAGTGTATTTTTGTGCCAGCAGCATGAAGGGTAGGTTCAGCCAAAAACATTCAGTACTTCGGCGCC		Out	VDJ	2	137	0.001789516308110297		49	TCRBV16	TCRBV16-01					TCRBJ02	TCRBJ02-04	01	5	5	3	0	4	7	29	41	49	45	56			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV16-01+TCRBJ02-04	TCRBV16-01		TCRBJ02-04*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
CTCCCAGACATCTGTGTATTTCTGCGCCAGCAGCTGCCTCAAAAAGCCCGGACAGGGATGGCAAATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	22	2.8736758232428126E-4		59	TCRBV10	TCRBV10-02	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	6	1	3	4	16	6	22	33	57	49	63													Vb 12	X+TCRBV10-02+TCRBJ01-05	TCRBV10-02*01	TCRBD01-01*01	TCRBJ01-05*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGTCTCCTCCGGGCGGGAGCTTACAATGAGCAGTTCTTCGGGCCA	CASSLLRAGAYNEQFF	In	VDJ	1	24	3.13491907990125E-4	3.95915472046718E-4	48	TCRBV10	TCRBV10-02	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	5	7	2	4	9	2	23	35	51	44	53													Vb 12	CASSLLRAGAYNEQFF+TCRBV10-02+TCRBJ02-01	TCRBV10-02*01	TCRBD02-01*02	TCRBJ02-01*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGTGATAACTCCGGGGCCCAGTACTTCGGGCCA	CASSDNSGAQYF	In	VDJ	1	31	4.0492704782057814E-4	5.113908180603441E-4	36	TCRBV10	TCRBV10-02	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	3	8	3	9	6	0	23	37	-1	43	48													Vb 12	CASSDNSGAQYF+TCRBV10-02+TCRBJ02-05	TCRBV10-02*01	TCRBD02-01*01	TCRBJ02-05*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGTGAGTCAACAGGAGAGAACACTGAAGCTTTCTTTGGACAA	CASSESTGENTEAFF	In	VDJ	1	33	4.3105137348642186E-4	5.443837740642373E-4	45	TCRBV10	TCRBV10-02	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	0	3	4	1	1	3	23	40	46	41	49													Vb 12	CASSESTGENTEAFF+TCRBV10-02+TCRBJ01-01	TCRBV10-02*01	TCRBD01-01*01	TCRBJ01-01*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
TCCCAGACATCTGTGTATTTCTGCGCCAGCAGTGACCAGAAACTTGGGATCAGCGGGAGTAACTACAATGAGCAGTTCTTCGGGCCA	CASSDQKLGISGSNYNEQFF	In	VDJ	1	69	9.012892354716094E-4	0.0011382569821343142	60	TCRBV10	TCRBV10-02	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	3	6	2	3	16	3	21	35	59	51	62													Vb 12	CASSDQKLGISGSNYNEQFF+TCRBV10-02+TCRBJ02-01	TCRBV10-02*01	TCRBD02-01*02	TCRBJ02-01*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGTGAGTCGCCGGCTCCGAACTATGGCTACACCTTCGGTTCG	CAISESPAPNYGYTF	In	VDJ	1	23	3.0042974515720315E-4	3.7941899404477143E-4	45	TCRBV10	TCRBV10-03	01				TCRBJ01	TCRBJ01-02	01	0	9	0	2	3	4	23	40	46	43	50				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 12	CAISESPAPNYGYTF+TCRBV10-03+TCRBJ01-02	TCRBV10-03*01		TCRBJ01-02*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
AGCTCCCAGACATCTGTGTACTTCTGTGCCAGCAGTGAGAGGGCAGGGGGTTTAAGTGAGCAGTTCTTCGGGCCA	CASSERAGGLSEQFF	In	VDJ	1	24	3.13491907990125E-4	3.95915472046718E-4	45	TCRBV10	TCRBV10-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	2	4	1	9	4	6	24	39	50	43	56													Vb 12	CASSERAGGLSEQFF+TCRBV10-03+TCRBJ02-01	TCRBV10-03*01	TCRBD01-01*01	TCRBJ02-01*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
AGCTCCCAGACATCTGTGTACTTCTGTGCCAGCAGTGAGGGGACTAGCGGGAATGAGCAGTTCTTCGGGCCA	CASSEGTSGNEQFF	In	VDJ	1	30	3.9186488498765625E-4	4.948943400583975E-4	42	TCRBV10	TCRBV10-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	2	0	4	7	0	0	24	-1	-1	39	51						01,02							Vb 12	CASSEGTSGNEQFF+TCRBV10-03+TCRBJ02-01	TCRBV10-03*01	TCRBD02-01	TCRBJ02-01*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
AGCTCCCAGACATCTGTGTACTTCTGTGCCAGCAGTGAGGCAGTCCGGGACTAGCGATCGAGCAGTACTTCGGGCCG		Out	VDJ	1	31	4.0492704782057814E-4		47	TCRBV10	TCRBV10-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	2	0	6	6	7	2	24	39	56	46	58						01,02							Vb 12	X+TCRBV10-03+TCRBJ02-07	TCRBV10-03*01	TCRBD02-01	TCRBJ02-07*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
AGCTCCCAGACATCTGTGTACTTCTGTGCCAGCCTTCTATTAGGGGGCCAACGTCCTGACTTTCGGGGCC		Out	VDJ	1	31	4.0492704782057814E-4		40	TCRBV10	TCRBV10-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-06	01	10	4	9	4	5	4	24	31	39	36	43						01,02							Vb 12	X+TCRBV10-03+TCRBJ02-06	TCRBV10-03*01	TCRBD02-01	TCRBJ02-06*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
AGCTCCCAGACATCTGTGTACTTCTGTGCCGGAACCCGGGCAGTCGACACCGGGGAGCTGTTTTTTGGAGAA	CAGTRAVDTGELFF	In	VDJ	1	33	4.3105137348642186E-4	5.443837740642373E-4	42	TCRBV10	TCRBV10-03	01				TCRBJ02	TCRBJ02-02	01	11	8	0	3	7	5	24	30	41	37	46				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 12	CAGTRAVDTGELFF+TCRBV10-03+TCRBJ02-02	TCRBV10-03*01		TCRBJ02-02*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
AGCTCCCAGACATCTGTGTACTTCTGTGCCATCGGACCGGGACAGGGAAACACCGGGGAGCTATTTTTTGGAGAA	CAIGPGQGNTGELFF	In	VDJ	1	59	7.706676071423907E-4	9.732922021148485E-4	45	TCRBV10	TCRBV10-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	8	0	3	17	5	16	24	33	47	38	63													Vb 12	CAIGPGQGNTGELFF+TCRBV10-03+TCRBJ02-02	TCRBV10-03*01	TCRBD01-01*01	TCRBJ02-02*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGTGAGTCGGGAGGGCATTACGAGCAGTACTTCGGGCCG	CAISESGGHYEQYF	In	VDJ	4	345	0.0045064461773580465	0.005691284910671572	42	TCRBV10	TCRBV10-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	0	9	0	4	0	3	23	-1	47	40	50													Vb 12	CAISESGGHYEQYF+TCRBV10-03+TCRBJ02-07	TCRBV10-03*01	TCRBD02-01*02	TCRBJ02-07*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAGGAGAAGGTACACCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	1	23	3.0042974515720315E-4		44	TCRBV19	TCRBV19-01					TCRBJ02	TCRBJ02-02	01	1	5	4	3	4	1	27	43	50	47	51			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	X+TCRBV19-01+TCRBJ02-02	TCRBV19-01		TCRBJ02-02*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTCTCACCCGGAGTGAGCAGTACTTCGGGCCG	CASSLTRSEQYF	In	VDJ	1	23	3.0042974515720315E-4	3.7941899404477143E-4	36	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	5	10	2	7	7	1	27	39	50	46	51			01,02										Vb 17	CASSLTRSEQYF+TCRBV19-01+TCRBJ02-07	TCRBV19-01	TCRBD02-01*02	TCRBJ02-07*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAGACTCATCCTCAGCCTACGAGCAGTACTTCGGGCCG	CASSIDSSSAYEQYF	In	VDJ	1	24	3.13491907990125E-4	3.95915472046718E-4	45	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	0	4	5	2	8	0	27	44	-1	52	55			01,02										Vb 17	CASSIDSSSAYEQYF+TCRBV19-01+TCRBJ02-07	TCRBV19-01	TCRBD01-01*01	TCRBJ02-07*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATATCTGCCACGTCGGGTGGCTACACCTTCGGTTCG	CASSISATSGGYTF	In	VDJ	1	24	3.13491907990125E-4	3.95915472046718E-4	42	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	2	8	4	7	10	0	27	42	-1	52	56			01,02			01,02							Vb 17	CASSISATSGGYTF+TCRBV19-01+TCRBJ01-02	TCRBV19-01	TCRBD02-01	TCRBJ01-02*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTCGGGGGGGGCTTTACAATGAGCAGTTCTTCGGGCCA	CASSRGGLYNEQFF	In	VDJ	1	24	3.13491907990125E-4	3.95915472046718E-4	42	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	5	8	0	4	0	4	27	-1	47	39	51			01,02										Vb 17	CASSRGGLYNEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD02-01*01	TCRBJ02-01*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTAAAGGGAGGGATCAGCCCCAGCATTTTGGTGAT	CASSKGRDQPQHF	In	VDJ	1	26	3.3961623365596876E-4	4.289084280506112E-4	39	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-05	01	4	9	0	5	2	0	27	40	-1	42	49			01,02										Vb 17	CASSKGRDQPQHF+TCRBV19-01+TCRBJ01-05	TCRBV19-01	TCRBD02-01*02	TCRBJ01-05*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGCTGGGGGACCACAGATACGCAGTATTTTGGCCCA	CASSWGTTDTQYF	In	VDJ	1	30	3.9186488498765625E-4	4.948943400583975E-4	39	TCRBV19	TCRBV19-01					TCRBJ02	TCRBJ02-03	01	6	0	7	2	4	0	27	38	-1	42	47			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSWGTTDTQYF+TCRBV19-01+TCRBJ02-03	TCRBV19-01		TCRBJ02-03*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGCACGCAGACAGGGAGCTACGAGCAGTACTTCGGGCCG	CASSTQTGSYEQYF	In	VDJ	1	31	4.0492704782057814E-4	5.113908180603441E-4	42	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	2	3	3	6	2	27	38	51	44	53			01,02										Vb 17	CASSTQTGSYEQYF+TCRBV19-01+TCRBJ02-07	TCRBV19-01	TCRBD01-01*01	TCRBJ02-07*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCATCCTGTTGGGCACCGGGGAGCTGTTTTTTGGAGAA	CAILLGTGELFF	In	VDJ	1	31	4.0492704782057814E-4	5.113908180603441E-4	36	TCRBV19	TCRBV19-01					TCRBJ02	TCRBJ02-02	01	10	0	9	4	7	0	27	34	-1	41	44			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CAILLGTGELFF+TCRBV19-01+TCRBJ02-02	TCRBV19-01		TCRBJ02-02*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAACACAGGACAGGTTTAGTAGCAATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	38	4.963621876510313E-4		46	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	10	1	4	0	5	5	27	34	46	39	51			01,02										Vb 17	X+TCRBV19-01+TCRBJ01-05	TCRBV19-01	TCRBD01-01*01	TCRBJ01-05*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTAGGGGCGGAGGGGGTATTTCCAATGAGCAGTTCTTCGGGCCA	CASSRGGGGISNEQFF	In	VDJ	1	38	4.963621876510313E-4	6.268661640739702E-4	48	TCRBV19	TCRBV19-01					TCRBJ02	TCRBJ02-01	01	4	5	1	6	7	6	27	40	53	47	59			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSRGGGGISNEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01		TCRBJ02-01*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTCTATCCGGGACTAGCGGGGGGGGCGTCTTCGGGCCA	CASSLSGTSGGGVF	In	VDJ	1	38	4.963621876510313E-4	6.268661640739702E-4	42	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	5	0	0	17	6	3	27	39	61	45	64			01,02										Vb 17	CASSLSGTSGGGVF+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD02-01*01	TCRBJ02-01*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATTACCCAGACTGGTGTGCAGTTCTTCGGGCCA	CASSITQTGVQFF	In	VDJ	1	43	5.616730018156407E-4	7.093485540837031E-4	39	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	3	2	10	12	6	5	27	41	51	47	56			01,02			01,02							Vb 17	CASSITQTGVQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD02-01	TCRBJ02-01*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTACGGGGAGTGAGCAGTACTTCGGGCCG	CASSTGSEQYF	In	VDJ	1	45	5.877973274814844E-4	7.423415100875963E-4	33	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	4	8	3	7	0	3	27	-1	45	40	48			01,02			01,02							Vb 17	CASSTGSEQYF+TCRBV19-01+TCRBJ02-07	TCRBV19-01	TCRBD02-01	TCRBJ02-07*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
TTTCTATCTCTGTGCCAGTAGTTTACAAAGGGGGACTAGCGGGTACGACTTTCCTACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	47	6.139216531473281E-4		62	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	5	0	4	1	9	8	10	22	43	31	51			01,02			01,02							Vb 17	X+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD02-01	TCRBJ02-01*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATGCTCGGATCGGGGGGTCTAGGCACTGAAGCTTTCTTTGGACAA	CASSMLGSGGLGTEAFF	In	VDJ	1	49	6.400459788131719E-4	8.083274220953826E-4	51	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	3	8	1	4	8	6	27	41	56	49	62			01,02										Vb 17	CASSMLGSGGLGTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD02-01*01	TCRBJ01-01*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTTCTCTAGCGGGAGTGTACAATGAGCAGTTCTTCGGGCCA	CASSSLAGVYNEQFF	In	VDJ	1	50	6.531081416460937E-4	8.248239000973293E-4	45	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	5	4	2	4	3	2	27	39	52	42	54			01,02										Vb 17	CASSSLAGVYNEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD02-01*02	TCRBJ02-01*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGAGAACTTAGGGCACCCGTAGACTATGGCTACACCTTCGGTTCG	CASRELRAPVDYGYTF	In	VDJ	1	53	6.922946301448593E-4	8.74313334103169E-4	48	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-02	01	6	5	3	3	7	9	27	38	49	45	58			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASRELRAPVDYGYTF+TCRBV19-01+TCRBJ01-02	TCRBV19-01		TCRBJ01-02*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTCAAACCGGAGATACGCAGTATTTTGGCCCA	CASQTGDTQYF	In	VDJ	1	55	7.184189558107031E-4	9.073062901070622E-4	33	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	8	8	5	5	5	0	27	36	-1	41	44			01,02			01,02							Vb 17	CASQTGDTQYF+TCRBV19-01+TCRBJ02-03	TCRBV19-01	TCRBD02-01	TCRBJ02-03*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
TCTATCTCTGTGCCAGTACTCAGCACCTTCGACAGGCAGAGTTGTGGTAGGCCAAAAACATTCAGTACTTCGGCGCC	CASTQHLRQAELW*AKNIQYF	Stop	VDJ	1	55	7.184189558107031E-4		63	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-04	01	7	2	4	1	12	14	8	18	36	30	50			01,02										Vb 17	CASTQHLRQAELW*AKNIQYF+TCRBV19-01+TCRBJ02-04	TCRBV19-01	TCRBD01-01*01	TCRBJ02-04*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTTCCCTTGGTGCGCTGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSLGALNTGELFF	In	VDJ	1	59	7.706676071423907E-4	9.732922021148485E-4	45	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	8	7	6	1	9	2	27	36	48	45	50			01,02			01,02							Vb 17	CASSLGALNTGELFF+TCRBV19-01+TCRBJ02-02	TCRBV19-01	TCRBD02-01	TCRBJ02-02*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTTTCCGCCGGGACAGGGGGCCAGGGAGCTATGGCTACACCTTCGGTTCG	CASFRRDRGPGSYGYTF	In	VDJ	1	59	7.706676071423907E-4	9.732922021148485E-4	51	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	8	0	0	4	7	7	27	36	55	43	62			01,02										Vb 17	CASFRRDRGPGSYGYTF+TCRBV19-01+TCRBJ01-02	TCRBV19-01	TCRBD01-01*01	TCRBJ01-02*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTACCAACCAACACCTGACAGAAGGTTACTATGGCTACACCTTCGGTTCG	CASTNQHLTEGYYGYTF	In	VDJ	1	62	8.098540956411563E-4	0.0010227816361206882	51	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	7	2	5	3	13	6	27	37	55	50	61			01,02										Vb 17	CASTNQHLTEGYYGYTF+TCRBV19-01+TCRBJ01-02	TCRBV19-01	TCRBD01-01*01	TCRBJ01-02*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGCCGACAGGGAGCGGGTACTGAAGCTTTCTTTGGACAA	CASSRQGAGTEAFF	In	VDJ	1	62	8.098540956411563E-4	0.0010227816361206882	42	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	2	3	5	2	7	27	38	47	40	54			01,02										Vb 17	CASSRQGAGTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD01-01*01	TCRBJ01-01*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTGGATCAGGGGACACAGATACGCAGTATTTTGGCCCA	CASGSGDTDTQYF	In	VDJ	1	66	8.621027469728437E-4	0.0010887675481284745	39	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	8	4	2	2	4	1	27	36	46	40	47			01,02										Vb 17	CASGSGDTDTQYF+TCRBV19-01+TCRBJ02-03	TCRBV19-01	TCRBD01-01*01	TCRBJ02-03*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTACTCAATTCAATCAGCCCCAGCATTTTGGTGAT	CASSTQFNQPQHF	In	VDJ	1	68	8.882270726386875E-4	0.0011217605041323677	39	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-05	01	4	4	6	3	2	3	27	40	44	42	47			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSTQFNQPQHF+TCRBV19-01+TCRBJ01-05	TCRBV19-01		TCRBJ01-05*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATCTAGCGGGAGGGTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	68	8.882270726386875E-4		41	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	3	4	0	4	0	0	27	-1	-1	41	53			01,02										Vb 17	X+TCRBV19-01+TCRBJ02-07	TCRBV19-01	TCRBD02-01*02	TCRBJ02-07*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGAGACCTGGGGTGGGACATTCAGTACTTCGGCGCC	CASRDLGWDIQYF	In	VDJ	1	70	9.143513983045313E-4	0.0011547534601362608	39	TCRBV19	TCRBV19-01					TCRBJ02	TCRBJ02-04	01	6	6	2	8	6	4	27	38	48	44	52			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASRDLGWDIQYF+TCRBV19-01+TCRBJ02-04	TCRBV19-01		TCRBJ02-04*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTAGAGGGGGCAGCTTCAGCACAGATACGCAGTATTTTGGCCCA	CASSRGGSFSTDTQYF	In	VDJ	1	70	9.143513983045313E-4	0.0011547534601362608	48	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	4	5	0	0	1	6	27	40	48	41	54			01,02										Vb 17	CASSRGGSFSTDTQYF+TCRBV19-01+TCRBJ02-03	TCRBV19-01	TCRBD01-01*01	TCRBJ02-03*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTGAAGGGACAGTTGCCCATACTGAAGCTTTCTTTGGACAA	CASSEGTVAHTEAFF	In	VDJ	1	77	0.0010057865381349843	0.001270228806149887	45	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	0	5	5	3	8	27	39	49	42	57			01,02										Vb 17	CASSEGTVAHTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD01-01*01	TCRBJ01-01*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCGAGATAAGGAGATCGCTGGGGACCCGATGGAGGCTACACCTTCGGTTCG		Out	VDJ	1	82	0.0010710973522995938		49	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-02	01	11	0	7	8	18	8	27	33	56	51	64			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	X+TCRBV19-01+TCRBJ01-02	TCRBV19-01		TCRBJ01-02*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTAAGCTAGCGAACAGGGGCCGTTTGAACACTGAAGCTTTCTTTGGACAA	CASSKLANRGRLNTEAFF	In	VDJ	1	85	0.0011102838407983594	0.0014022006301654597	54	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	3	2	0	9	5	27	40	56	49	61			01,02										Vb 17	CASSKLANRGRLNTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD01-01*01	TCRBJ01-01*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATCACAGTTAATGAAAAACTGTTTTTTGGCAGT	CASSITVNEKLFF	In	VDJ	1	87	0.001136408166464203	0.0014351935861693528	39	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	3	3	5	4	1	1	27	41	46	42	47			01,02										Vb 17	CASSITVNEKLFF+TCRBV19-01+TCRBJ01-04	TCRBV19-01	TCRBD01-01*01	TCRBJ01-04*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTACCCCCTCGACTAGCGGGAGGGGGAATACGCAGTATTTTGGCCCA	CASTPSTSGRGNTQYF	In	VDJ	1	89	0.001162532492130047	0.001468186542173246	48	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	7	2	0	7	7	3	27	37	58	44	61			01,02										Vb 17	CASTPSTSGRGNTQYF+TCRBV19-01+TCRBJ02-03	TCRBV19-01	TCRBD02-01*02	TCRBJ02-03*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTACGGGACTAGCGTCCTACAATGAGCAGTTCTTCGGGCCA	CASSTGLASYNEQFF	In	VDJ	1	92	0.0012017189806288126	0.0015176759761790857	45	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	4	0	6	1	1	0	27	40	-1	41	51			01,02			01,02							Vb 17	CASSTGLASYNEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD02-01	TCRBJ02-01*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTCTCAACAGGGGGCAGTACGAGCAGTACTTCGGGCCG	CASSLNRGQYEQYF	In	VDJ	1	92	0.0012017189806288126	0.0015176759761790857	42	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	3	0	4	4	2	27	39	52	43	54			01,02										Vb 17	CASSLNRGQYEQYF+TCRBV19-01+TCRBJ02-07	TCRBV19-01	TCRBD01-01*01	TCRBJ02-07*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAGAAGCGGGAGGATACAATGAGCAGTTCTTCGGGCCA	CASSIEAGGYNEQFF	In	VDJ	1	100	0.0013062162832921875	0.0016496478001946585	45	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	0	6	1	4	0	1	27	-1	53	44	54			01,02										Vb 17	CASSIEAGGYNEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD02-01*02	TCRBJ02-01*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTCGTGGGGACTAGCGGCAGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	113	0.0014760244001201718		41	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	8	0	5	4	4	1	27	36	51	40	52			01,02			01,02							Vb 17	X+TCRBV19-01+TCRBJ02-05	TCRBV19-01	TCRBD02-01	TCRBJ02-05*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATATGGGGGGGCAATCAGCCCCAGCATTTTGGTGAT	CASSIWGGNQPQHF	In	VDJ	2	120	0.001567459539950625	0.00197957736023359	42	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-05	01	2	9	1	2	1	0	27	42	-1	43	49			01,02										Vb 17	CASSIWGGNQPQHF+TCRBV19-01+TCRBJ01-05	TCRBV19-01	TCRBD02-01*01	TCRBJ01-05*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAGTTAATGAGCAGTTCTTCGGGCCA	CASSIVNEQFF	In	VJ	2	135	0.001763391982444453	0.0022270245302627887	33	TCRBV19	TCRBV19-01					TCRBJ02	TCRBJ02-01	01	1	0	0	7	0	2	27	-1	43	-1	45			01,02										Vb 17	CASSIVNEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01		TCRBJ02-01*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTACTCGCCAGGGATACAATGAGCAGTTCTTCGGGCCA	CASTRQGYNEQFF	In	VDJ	2	139	0.0018156406337761406	0.002293010442270575	39	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	7	4	3	4	5	1	27	37	47	42	48			01,02										Vb 17	CASTRQGYNEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD01-01*01	TCRBJ02-01*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGCGGGACAGGGGATAGGGAGACCCAGTACTTCGGGCCA	CASSGTGDRETQYF	In	VDJ	2	160	0.0020899460532675	0.0026394364803114536	42	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	6	0	2	5	1	5	27	38	49	39	54			01,02										Vb 17	CASSGTGDRETQYF+TCRBV19-01+TCRBJ02-05	TCRBV19-01	TCRBD01-01*01	TCRBJ02-05*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATTTGGCTAGTATTGGCAACTAATGAAAAACTGTTTTTTGGCAGT	CASSIWLVLATNEKLFF	In	VDJ	2	163	0.0021291325417662657	0.0026889259143172933	51	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-04	01	3	4	8	0	4	6	27	41	49	45	55			01,02			01,02							Vb 17	CASSIWLVLATNEKLFF+TCRBV19-01+TCRBJ01-04	TCRBV19-01	TCRBD02-01	TCRBJ01-04*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTCTTGGACAGGGGCAGGGCGGGGAGCTGTTTTTTGGAGAA	CASSLGQGQGGELFF	In	VDJ	2	168	0.002194443355930875	0.002771408304327026	45	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	5	1	2	7	3	5	27	39	51	42	56			01,02										Vb 17	CASSLGQGQGGELFF+TCRBV19-01+TCRBJ02-02	TCRBV19-01	TCRBD01-01*01	TCRBJ02-02*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAGCAGCCTTATATAGCAATCAGCCCCAGCATTTTGGTGAT	CASSIAALYSNQPQHF	In	VDJ	3	202	0.002638556892250219	0.0033322885563932102	48	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-05	01	1	4	5	0	0	7	27	-1	46	43	53			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSIAALYSNQPQHF+TCRBV19-01+TCRBJ01-05	TCRBV19-01		TCRBJ01-05*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATGTGGGCAGGGAACACTGAAGCTTTCTTTGGACAA	CASSMWAGNTEAFF	In	VDJ	3	213	0.0027822406834123593	0.0035137498144146226	42	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	4	4	1	5	0	27	41	-1	46	50			01,02										Vb 17	CASSMWAGNTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD01-01*01	TCRBJ01-01*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTAAAAAGACAGGGAACACTGAAGCTTTCTTTGGACAA	CASSKKTGNTEAFF	In	VDJ	3	217	0.002834489334744047	0.003579735726422409	42	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	2	4	1	4	0	27	40	-1	44	50			01,02										Vb 17	CASSKKTGNTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD01-01*01	TCRBJ01-01*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGACCAAGGGAGAACACTGAAGCTTTCTTTGGACAA	CASRPRENTEAFF	In	VDJ	3	229	0.0029912352887391095	0.003777693462445768	39	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-01	01	6	0	8	1	5	0	27	38	-1	43	47			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASRPRENTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01		TCRBJ01-01*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTAAAGGGGGTGAGACCCAGTACTTCGGGCCA	CASSKGGETQYF	In	VDJ	3	234	0.003056546102903719	0.0038601758524555007	36	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	4	5	1	5	1	1	27	40	47	41	48			01,02										Vb 17	CASSKGGETQYF+TCRBV19-01+TCRBJ02-05	TCRBV19-01	TCRBD01-01*01	TCRBJ02-05*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGCGGGAACGGAGCCGAGCAGTACTTCGGGCCG	CASSGNGAEQYF	In	VDJ	3	237	0.0030957325914024846	0.00390966528646134	36	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	6	8	3	6	0	7	27	-1	43	38	50			01,02										Vb 17	CASSGNGAEQYF+TCRBV19-01+TCRBJ02-07	TCRBV19-01	TCRBD02-01*02	TCRBJ02-07*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGCGGGAGGCGCTACAATGAGCAGTTCTTCGGGCCA	CASSGRRYNEQFF	In	VDJ	4	331	0.004323575897697141	0.0054603342186443195	39	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	6	8	1	3	0	2	27	-1	45	38	47			01,02										Vb 17	CASSGRRYNEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD02-01*02	TCRBJ02-01*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAGGGGGACCTCAAGGGCCTAACTATGGCTACACCTTCGGTTCG	CASSIGGPQGPNYGYTF	In	VDJ	5	393	0.005133429993338297	0.006483115854765007	51	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-02	01	1	0	7	0	1	9	27	43	49	44	58			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSIGGPQGPNYGYTF+TCRBV19-01+TCRBJ01-02	TCRBV19-01		TCRBJ01-02*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGCAGTGATTCTAGTTTTGAGCAGTTCTTCGGGCCA	CASSDSSFEQFF	In	VDJ	1	24	3.13491907990125E-4	3.95915472046718E-4	36	TCRBV25	TCRBV25-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	3	4	8	9	2	3	23	37	43	39	46						01,02							Vb 11	CASSDSSFEQFF+TCRBV25-01+TCRBJ02-01	TCRBV25-01*01	TCRBD02-01	TCRBJ02-01*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
CCTCACATACCTCTCAGTACCTCTGTGTCAGCAGTGAAAAGGCCAATAACTATGGCTACACCTTCGGTTCG	CVSSEKANNYGYTF	In	VDJ	1	29	3.7880272215473436E-4	4.7839786205645094E-4	42	TCRBV25	TCRBV25-01	01				TCRBJ01	TCRBJ01-02	01	2	5	4	1	1	4	23	38	42	39	46				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 11	CVSSEKANNYGYTF+TCRBV25-01+TCRBJ01-02	TCRBV25-01*01		TCRBJ01-02*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGCAGTGAATCGGAGACAGGGGTTTTTGGGGCCAACGTCCTGACTTTCGGGGCC	CASSESETGVFGANVLTF	In	VDJ	1	44	5.747351646485625E-4	7.258450320856497E-4	54	TCRBV25	TCRBV25-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	1	2	2	3	4	4	23	39	51	43	55													Vb 11	CASSESETGVFGANVLTF+TCRBV25-01+TCRBJ02-06	TCRBV25-01*01	TCRBD01-01*01	TCRBJ02-06*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGCAGTGAAGGGCAGAACACTGAAGCTTTCTTTGGACAA	CASSEGQNTEAFF	In	VDJ	1	53	6.922946301448593E-4	8.74313334103169E-4	39	TCRBV25	TCRBV25-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	2	8	0	1	0	1	23	-1	42	38	43													Vb 11	CASSEGQNTEAFF+TCRBV25-01+TCRBJ01-01	TCRBV25-01*01	TCRBD01-01*01	TCRBJ01-01*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGCAGCAGCAGCTCCTACGAGCAGTACTTCGGGCCG	CASSSSSYEQYF	In	VDJ	1	70	9.143513983045313E-4	0.0011547534601362608	36	TCRBV25	TCRBV25-01	01				TCRBJ02	TCRBJ02-07	01	6	4	5	0	0	3	23	-1	37	34	40				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 11	CASSSSSYEQYF+TCRBV25-01+TCRBJ02-07	TCRBV25-01*01		TCRBJ02-07*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGCAGTGACAGGATCGGGAACACTGAAGCTTTCTTTGGACAA	CASSDRIGNTEAFF	In	VDJ	1	73	9.535378868032969E-4	0.0012042428941421008	42	TCRBV25	TCRBV25-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	4	4	1	0	5	23	-1	41	37	46													Vb 11	CASSDRIGNTEAFF+TCRBV25-01+TCRBJ01-01	TCRBV25-01*01	TCRBD01-01*01	TCRBJ01-01*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGCAGTTTGGGACAGAATACTGAAGCTTTCTTTGGACAA	CASSLGQNTEAFF	In	VDJ	1	91	0.0011886568177958906	0.0015011794981771391	39	TCRBV25	TCRBV25-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	0	5	5	2	3	23	35	44	37	47													Vb 11	CASSLGQNTEAFF+TCRBV25-01+TCRBJ01-01	TCRBV25-01*01	TCRBD01-01*01	TCRBJ01-01*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
CACCAGCCAAACAGCTTTGTACTTCTGTGCCATCAGCTGGGGGGGCCCCTACGAGCAGTACTTCGGGCCG	CAISWGGPYEQYF	In	VDJ	1	23	3.0042974515720315E-4	3.7941899404477143E-4	39	TCRBV22	TCRBV22-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	13	9	0	2	10	2	25	28	45	38	47														CAISWGGPYEQYF+TCRBV22-01+TCRBJ02-07	TCRBV22-01*01	TCRBD02-01*01	TCRBJ02-07*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
GAGGGACTCAGCCGTGTATCTCTACGCCAGCAGCCAAGATACACAGGGGGGGACAGATACGCAGTATTTTGGCCCA	YASSQDTQGGTDTQYF	In	VDJ	1	22	2.8736758232428126E-4	3.6292251604282485E-4	48	TCRBV04	TCRBV04-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	0	3	1	3	3	2	22	39	50	42	52													Vb 7.1	YASSQDTQGGTDTQYF+TCRBV04-01+TCRBJ02-03	TCRBV04-01*01	TCRBD01-01*01	TCRBJ02-03*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
CAGAAGACTCAGCCCTGTATCTCTGCGCCAGCAGCCAAGATCGGGAGGATCAGCCCCAGCATTTTGGTGAT	CASSQDREDQPQHF	In	VDJ	1	41	5.355486761497969E-4	6.7635559807981E-4	42	TCRBV04	TCRBV04-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-05	01	0	8	1	5	1	0	23	40	-1	41	48													Vb 7.1	CASSQDREDQPQHF+TCRBV04-01+TCRBJ01-05	TCRBV04-01*01	TCRBD02-01*02	TCRBJ01-05*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
CAGAAGACTCAGCCCTGTATCTCTGCGCCAGCAGCCAAGTGGGGATGGGCAGATTGAGGCAGTACTTCGGGCCG	CASSQVGMGRLRQYF	In	VDJ	1	43	5.616730018156407E-4	7.093485540837031E-4	45	TCRBV04	TCRBV04-01	01				TCRBJ02	TCRBJ02-07	01	1	0	8	9	2	13	23	39	45	41	58				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 7.1	CASSQVGMGRLRQYF+TCRBV04-01+TCRBJ02-07	TCRBV04-01*01		TCRBJ02-07*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
CAGAAGACTCAGCCCTGTATCTCTGCGCCAGCAGCCAAGGTTCTAGCGGGAGGTACGAGCAGTACTTCGGGCCG	CASSQGSSGRYEQYF	In	VDJ	1	48	6.2698381598025E-4	7.91830944093436E-4	45	TCRBV04	TCRBV04-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	1	4	1	4	3	0	23	39	-1	42	53													Vb 7.1	CASSQGSSGRYEQYF+TCRBV04-01+TCRBJ02-07	TCRBV04-01*01	TCRBD02-01*02	TCRBJ02-07*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
CCTCCTCCCAGACATCTGTATATTTCTGCGCCAGCAGGCGGGCGGGACTCGAACACCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	1	44	5.747351646485625E-4		46	TCRBV10	TCRBV10-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	6	0	10	0	6	0	26	37	-1	43	49			01,02			01,02							Vb 12	X+TCRBV10-01+TCRBJ02-02	TCRBV10-01	TCRBD02-01	TCRBJ02-02*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
CCTCCTCCCAGACATCTGTATATTTCTGCGCCAGCAGTGGAGACCTTAGCACAGATACGCAGTATTTTGGCCCA	CASSGDLSTDTQYF	In	VDJ	1	107	0.0013976514231226406	0.0017651231462082846	42	TCRBV10	TCRBV10-01					TCRBJ02	TCRBJ02-03	01	4	2	7	0	2	3	26	39	44	41	47			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 12	CASSGDLSTDTQYF+TCRBV10-01+TCRBJ02-03	TCRBV10-01		TCRBJ02-03*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGAAGCAAGTACAGGAGCGGGGCACTATGGCTACACCTTCGGTTCG	CASSEASTGAGHYGYTF	In	VDJ	1	25	3.2655407082304687E-4	4.1241195004866464E-4	51	TCRBV06	TCRBV06-01	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-02	01	0	6	3	3	9	1	23	40	56	49	57														CASSEASTGAGHYGYTF+TCRBV06-01+TCRBJ01-02	TCRBV06-01*01	TCRBD02-01*01	TCRBJ01-02*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGAAGATAACGGAAGGGGCACCGGGGAGCTGTTTTTTGGAGAA	CASSEDNGRGTGELFF	In	VDJ	1	37	4.8330002481810936E-4	6.103696860720237E-4	48	TCRBV06	TCRBV06-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	1	5	2	4	8	0	23	39	-1	47	52														CASSEDNGRGTGELFF+TCRBV06-01+TCRBJ02-02	TCRBV06-01*01	TCRBD01-01*01	TCRBJ02-02*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGAAGCTGAGAATCAGCCCCAGCATTTTGGTGAT	CASSEAENQPQHF	In	VDJ	1	39	5.094243504839531E-4	6.433626420759168E-4	39	TCRBV06	TCRBV06-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-05	01	0	11	2	4	1	0	23	40	-1	41	44														CASSEAENQPQHF+TCRBV06-01+TCRBJ01-05	TCRBV06-01*01	TCRBD02-01*02	TCRBJ01-05*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGAAGCCCTTGGCCTTAGCGGGAGGCCATACGAGCAGTTCTTCGGGCCA	CASSEALGLSGRPYEQFF	In	VDJ	2	171	0.002233629844429641	0.002820897738332866	54	TCRBV06	TCRBV06-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	0	5	1	10	9	6	23	40	59	49	65														CASSEALGLSGRPYEQFF+TCRBV06-01+TCRBJ02-01	TCRBV06-01*01	TCRBD02-01*02	TCRBJ02-01*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGCCGGGACACCCAAGGGGAGCAGTACTTCGGGCCG	CAWSRDTQGEQYF	In	VDJ	1	23	3.0042974515720315E-4	3.7941899404477143E-4	39	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	3	0	6	7	2	8	26	37	45	39	53													Vb 20	CAWSRDTQGEQYF+TCRBV30-01+TCRBJ02-07	TCRBV30-01*01	TCRBD01-01*01	TCRBJ02-07*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
TCCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGACCGACCATGAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	27	3.5267839648889064E-4		37	TCRBV30	TCRBV30-01	02				TCRBJ01	TCRBJ01-01	01	4	2	7	0	2	2	26	36	41	38	43				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 20	X+TCRBV30-01+TCRBJ01-01	TCRBV30-01*02		TCRBJ01-01*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCAACAGGGGAGGGGGCGGTGAAGCCCCAGCATTTTGGTGAT	CATGEGAVKPQHF	In	VDJ	1	31	4.0492704782057814E-4	5.113908180603441E-4	39	TCRBV30	TCRBV30-01	01				TCRBJ01	TCRBJ01-05	01	9	3	2	8	1	12	26	31	39	32	51				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 20	CATGEGAVKPQHF+TCRBV30-01+TCRBJ01-05	TCRBV30-01*01		TCRBJ01-05*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
TCCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTCCCCTGGGGGCAGGGGATAGTAACACTGAAGCTTTCTTTGGACAA	CAWSPLGAGDSNTEAFF	In	VDJ	1	32	4.179892106535E-4	5.278872960622907E-4	51	TCRBV30	TCRBV30-01	02	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	2	4	2	2	10	5	26	38	54	48	59													Vb 20	CAWSPLGAGDSNTEAFF+TCRBV30-01+TCRBJ01-01	TCRBV30-01*02	TCRBD01-01*01	TCRBJ01-01*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGTACCGGGGACAGCAAATTCAAAGCAGTACTTCGGGCCG	CAWSVPGTANSKQYF	In	VDJ	1	36	4.702378619851875E-4	5.938732080700771E-4	45	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	0	0	5	8	4	9	26	40	51	44	60													Vb 20	CAWSVPGTANSKQYF+TCRBV30-01+TCRBJ02-07	TCRBV30-01*01	TCRBD01-01*01	TCRBJ02-07*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
TCCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGTACTAGCGGGAGGGTATAATGAGCAGTTCTTCGGGCCA	CAWSVLAGGYNEQFF	In	VDJ	1	43	5.616730018156407E-4	7.093485540837031E-4	45	TCRBV30	TCRBV30-01	02	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	0	3	0	7	0	3	26	-1	53	40	56													Vb 20	CAWSVLAGGYNEQFF+TCRBV30-01+TCRBJ02-01	TCRBV30-01*02	TCRBD02-01*02	TCRBJ02-01*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCGGCTCGGGGGCAGATACGCAGTATTTTGGCCCA	CAGSGADTQYF	In	VDJ	1	45	5.877973274814844E-4	7.423415100875963E-4	33	TCRBV30	TCRBV30-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	8	8	2	4	4	0	26	32	-1	36	42													Vb 20	CAGSGADTQYF+TCRBV30-01+TCRBJ02-03	TCRBV30-01*01	TCRBD02-01*01	TCRBJ02-03*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGGGCAGGTTGGAAACACCATATATTTTGGAGAG	CAWSGQVGNTIYF	In	VDJ	1	49	6.400459788131719E-4	8.083274220953826E-4	39	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	1	4	4	3	2	1	26	39	45	41	46													Vb 20	CAWSGQVGNTIYF+TCRBV30-01+TCRBJ01-03	TCRBV30-01*01	TCRBD01-01*01	TCRBJ01-03*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTACAGGGTCTAAGCCCTACGAGCAGTACTTCGGGCCG	CAWSTGSKPYEQYF	In	VDJ	1	50	6.531081416460937E-4	8.248239000973293E-4	42	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	2	3	3	2	0	7	26	-1	44	38	51													Vb 20	CAWSTGSKPYEQYF+TCRBV30-01+TCRBJ02-07	TCRBV30-01*01	TCRBD01-01*01	TCRBJ02-07*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGGACGGCCAGGGGCTCGGGATACGCAGTATTTTGGCCCA	CAWSGRPGARDTQYF	In	VDJ	1	50	6.531081416460937E-4	8.248239000973293E-4	45	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	1	4	2	6	6	5	26	39	51	45	56			unresolved										Vb 20	CAWSGRPGARDTQYF+TCRBV30-01+TCRBJ02-03	TCRBV30-01*01	TCRBD01-01*01	TCRBJ02-03*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGTCAAGGAGGCGTTATAACAAAGCGGGCCAACGTCCTGACTTTCGGGGCC		Out	VDJ	1	54	7.053567929777813E-4		52	TCRBV30	TCRBV30-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-06	01	5	10	1	5	4	14	26	35	44	39	58			unresolved										Vb 20	X+TCRBV30-01+TCRBJ02-06	TCRBV30-01*01	TCRBD02-01*02	TCRBJ02-06*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTCTAAACAGGGGGCGCAGAGTGGCTACACCTTCGGTTCG	CASKQGAQSGYTF	In	VDJ	1	58	7.576054443094687E-4	9.567957241129019E-4	39	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	7	3	0	7	4	6	26	33	46	37	52			unresolved										Vb 20	CASKQGAQSGYTF+TCRBV30-01+TCRBJ01-02	TCRBV30-01*01	TCRBD01-01*01	TCRBJ01-02*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGGGCGTACTGGTTATAACAAAGTCGGGCCAACGTCCTGACTTTCGGGGCC		Out	VDJ	1	71	9.274135611374531E-4		52	TCRBV30	TCRBV30-01	01				TCRBJ02	TCRBJ02-06	01	5	3	6	5	15	5	26	35	53	50	58				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 20	X+TCRBV30-01+TCRBJ02-06	TCRBV30-01*01		TCRBJ02-06*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
TCCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGACGACAGTCAACTAATGAAAAACTGTTTTTTGGCAGT		Out	VDJ	1	81	0.0010580351894666719		44	TCRBV30	TCRBV30-01	02	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	1	2	5	0	2	1	26	39	46	41	47													Vb 20	X+TCRBV30-01+TCRBJ01-04	TCRBV30-01*02	TCRBD01-01*01	TCRBJ01-04*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGCCCGGGGGCAGGGGTAGGAGAAAAACTGTTTTTTGGCAGT	CAWSPGAGVGEKLFF	In	VDJ	1	89	0.001162532492130047	0.001468186542173246	45	TCRBV30	TCRBV30-01	01				TCRBJ01	TCRBJ01-04	01	3	4	2	8	8	5	26	37	51	45	56				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 20	CAWSPGAGVGEKLFF+TCRBV30-01+TCRBJ01-04	TCRBV30-01*01		TCRBJ01-04*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTCGACAGGGATTGAAGCTTCGTGGCAATCAGCCCCAGCATTTTGGTGAT	CAWSRQGLKLRGNQPQHF	In	VDJ	2	181	0.0023642514727588593	0.0029858625183523317	54	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	2	2	3	2	1	14	26	38	46	39	60			unresolved										Vb 20	CAWSRQGLKLRGNQPQHF+TCRBV30-01+TCRBJ01-05	TCRBV30-01*01	TCRBD01-01*01	TCRBJ01-05*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTCGACGGGACACTCGAACACTGAAGCTTTCTTTGGACAA	CASTGHSNTEAFF	In	VDJ	3	202	0.002638556892250219	0.0033322885563932102	39	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	7	0	6	1	4	3	26	33	43	37	46													Vb 20	CASTGHSNTEAFF+TCRBV30-01+TCRBJ01-01	TCRBV30-01*01	TCRBD01-01*01	TCRBJ01-01*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGCCTCGGGACAGGGGGAAACCGGGGAGCTGTTTTTTGGAGAA	CAWSASGQGETGELFF	In	VDJ	3	213	0.0027822406834123593	0.0035137498144146226	48	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	1	0	1	5	4	2	26	39	54	43	56			unresolved										Vb 20	CAWSASGQGETGELFF+TCRBV30-01+TCRBJ02-02	TCRBV30-01*01	TCRBD01-01*01	TCRBJ02-02*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGGCAGTCGGAGGCCAACCCGAGCAGTACTTCGGGCCG	CAWAVGGQPEQYF	In	VDJ	32	2547	0.03326932873545202	0.04201652947095795	39	TCRBV30	TCRBV30-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	5	10	1	6	6	6	26	35	46	41	52			unresolved										Vb 20	CAWAVGGQPEQYF+TCRBV30-01+TCRBJ02-07	TCRBV30-01*01	TCRBD02-01*02	TCRBJ02-07*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCAACTGGGACTAGCGGACACAGATACGCAGTATTTTGGCCCA	CASSQLGLADTDTQYF	In	VDJ	1	22	2.8736758232428126E-4	3.6292251604282485E-4	48	TCRBV01	TCRBV01-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	2	0	5	2	2	1	23	38	51	40	52						01,02								CASSQLGLADTDTQYF+TCRBV01-01+TCRBJ02-03	TCRBV01-01*01	TCRBD02-01	TCRBJ02-03*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCAAGACGGGAGCTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASSQDGSSGANVLTF	In	VDJ	1	45	5.877973274814844E-4	7.423415100875963E-4	48	TCRBV01	TCRBV01-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-06	01	0	8	2	0	0	0	23	-1	-1	40	46														CASSQDGSSGANVLTF+TCRBV01-01+TCRBJ02-06	TCRBV01-01*01	TCRBD02-01*02	TCRBJ02-06*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGCTTAGCCGGACAGGGTTTAACTGAAGCTTTCTTTGGACAA	CASSLAGQGLTEAFF	In	VDJ	1	22	2.8736758232428126E-4	3.6292251604282485E-4	45	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	0	1	3	5	1	4	26	43	52	44	56		TCRBV12-03,TCRBV12-04												CASSLAGQGLTEAFF+TCRBV12-X+TCRBJ01-01	TCRBV12	TCRBD01-01*01	TCRBJ01-01*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCACTTACCGGGGGGGCAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	22	2.8736758232428126E-4		44	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	3	8	0	4	5	0	23	37	-1	42	50	TCRBV01,TCRBV04													X+X+TCRBJ02-03	unresolved	TCRBD02-01*01	TCRBJ02-03*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGCGAAGCTAGGGACAGCACGCATGGCTACACCTTCGGTTCG	CAISEARDSTHGYTF	In	VDJ	1	22	2.8736758232428126E-4	3.6292251604282485E-4	45	TCRBV06			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	0	0	5	6	2	5	23	40	49	42	54		TCRBV06-01,TCRBV06-08												CAISEARDSTHGYTF+TCRBV06-X+TCRBJ01-02	TCRBV06	TCRBD01-01*01	TCRBJ01-02*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
CTCCCWMYCAGACWKCTSTTTACTTCTGTGCCAGCAGTGAAGCACAGGGCGGGAGCACAGATACGCAGTATTTTGGCCCA	CASSEAQGGSTDTQYF	In	VDJ	1	22	2.8736758232428126E-4	3.6292251604282485E-4	48	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	5	3	3	0	5	4	26	38	49	43	53	TCRBV06,TCRBV24													CASSEAQGGSTDTQYF+X+TCRBJ02-03	unresolved	TCRBD01-01*01	TCRBJ02-03*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
GGTGCATCCTGAAGACAGCAGCTTTACATCTGCAGTGCTAGAGATCTTAGAGGACTAGCGGGAGAGGTGGAGCTGTTTTTTGGAGAA		Out	VDJ	1	22	2.8736758232428126E-4		50	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	21	1	2	10	27	4	31	24	64	51	68		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ02-02	TCRBV20	TCRBD02-01*02	TCRBJ02-02*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
AGCTCCCAGACATCTGTGTAYTTCTGYGCCAGCAGTGTTAAGGGAGGAGAGGATGAGCAGTTCTTCGGGCCA	CASSVKGGEDEQFF	In	VDJ	1	23	3.0042974515720315E-4	3.7941899404477143E-4	42	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	4	9	1	8	4	5	24	37	47	41	52	TCRBV06,TCRBV10													CASSVKGGEDEQFF+X+TCRBJ02-01	unresolved	TCRBD02-01*02	TCRBJ02-01*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTCCACGCGAGGGGACAGGGGAAAACATTCAGTACTTCGGCGCC	CSAPREGTGENIQYF	In	VDJ	1	23	3.0042974515720315E-4	3.7941899404477143E-4	45	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-04	01	5	0	2	5	9	0	26	35	-1	44	54		TCRBV20-01,TCRBV20-or09_02												CSAPREGTGENIQYF+TCRBV20-X+TCRBJ02-04	TCRBV20	TCRBD01-01*01	TCRBJ02-04*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
CCCWMCCAGACAKCTSTKTACTTSTGTGCCAGCAGTACAGGGCCACGGGGGACCCAGTACTTCGGGCCA	CASSTGPRGTQYF	In	VDJ	1	23	3.0042974515720315E-4	3.7941899404477143E-4	39	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	5	3	3	7	0	8	23	-1	41	35	49	TCRBV06,TCRBV24													CASSTGPRGTQYF+X+TCRBJ02-05	unresolved	TCRBD01-01*01	TCRBJ02-05*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
CGACTCGGCTGTGTATCTCTGTGCCAGCAGCCAAGAGGGGGCAACTAGGGTCACAGATACGCAGTATTTTGGCCCA	CASSQEGATRVTDTQYF	In	VDJ	1	23	3.0042974515720315E-4	3.7941899404477143E-4	51				TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	0	6	0	2	0	9	19	-1	42	36	51	TCRBV03,TCRBV07	TCRBV03-01,TCRBV03-02,TCRBV07-05												CASSQEGATRVTDTQYF+X+TCRBJ02-03		TCRBD01-01*01	TCRBJ02-03*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
CGACTCGGCYGTGTATSTCTGTGCCAGCAGCTTAGGGGTGGTCGCAAACACCATATATTTTGGAGAG	CASSLGVVANTIYF	In	VDJ	1	23	3.0042974515720315E-4	3.7941899404477143E-4	42	unresolved						TCRBJ01	TCRBJ01-03	01	0	0	9	6	0	7	19	-1	38	35	45	TCRBV07,TCRBV11			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLGVVANTIYF+X+TCRBJ01-03	unresolved		TCRBJ01-03*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
GGGGGACTYGGCYGTGTATSTCTGTGCCAGCAGAACAGCCTCGTCTAACAATGAGCAGTTCTTTGGGCCA	CASRTASSNNEQFF	In	VDJ	1	23	3.0042974515720315E-4	3.7941899404477143E-4	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02			6	3	5	22	1	26	18	29	34	30	60	TCRBV07,TCRBV11							TCRBJ02-01,TCRBJ02-05						CASRTASSNNEQFF+X+TCRBJ02-X	unresolved	TCRBD01-01*01	TCRBJ02	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
GGACTCGGCCSTSTATSTCTGTGCCAGCAGCAACCGGGACAGGGTCAATGAGCAGTTCTTTGGGCCA	CASSNRDRVNEQFF	In	VDJ	1	23	3.0042974515720315E-4	3.7941899404477143E-4	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02			4	0	3	22	4	17	19	31	44	35	61	TCRBV05,TCRBV11							TCRBJ02-01,TCRBJ02-05						CASSNRDRVNEQFF+X+TCRBJ02-X	unresolved	TCRBD01-01*01	TCRBJ02	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
GGACTCGGCCCTCTATCTCTGTGCCAGCAGCTCGGTCGGGAGCACAGATACGCAGTATTTTGGCCCA	CASSSVGSTDTQYF	In	VDJ	1	23	3.0042974515720315E-4	3.7941899404477143E-4	42	TCRBV05			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	3	8	4	0	4	0	19	32	-1	36	40		TCRBV05-06,TCRBV05-07				01,02								CASSSVGSTDTQYF+TCRBV05-X+TCRBJ02-03	TCRBV05	TCRBD02-01	TCRBJ02-03*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
AAYCMRGRGACWCAGCWSKGTATTTYTGTGCCAGCAGTGAGGGGTCACCTTGGGCCCAGCCCCAGCATTTTGGTGAT	CASSEGSPWAQPQHF	In	VDJ	1	23	3.0042974515720315E-4	3.7941899404477143E-4	45	unresolved						TCRBJ01	TCRBJ01-05	01	6	5	2	7	2	12	24	35	42	37	54	TCRBV12,TCRBV21			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSEGSPWAQPQHF+X+TCRBJ01-05	unresolved		TCRBJ01-05*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTTGGGATGATTGAAGCTTTCTTTGGACAA	CASSFGMIEAFF	In	VDJ	1	24	3.13491907990125E-4	3.95915472046718E-4	36	TCRBV12						TCRBJ01	TCRBJ01-01	01	3	0	8	7	1	4	26	40	45	41	49		TCRBV12-03,TCRBV12-04		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSFGMIEAFF+TCRBV12-X+TCRBJ01-01	TCRBV12		TCRBJ01-01*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGTTTAAAAGAGACCCAGTACTTCGGGCCA	CSASLKETQYF	In	VDJ	1	24	3.13491907990125E-4	3.95915472046718E-4	33	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	3	5	9	3	2	1	26	37	41	39	42		TCRBV20-01,TCRBV20-or09_02				01,02								CSASLKETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD02-01	TCRBJ02-05*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTATACTAGCGGGGTATTCCTACGAGCAGTACTTCGGGCCG	CSAILAGYSYEQYF	In	VDJ	1	24	3.13491907990125E-4	3.95915472046718E-4	42	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	4	3	3	1	1	3	26	36	47	37	50		TCRBV20-01,TCRBV20-or09_02												CSAILAGYSYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01*01	TCRBJ02-07*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTCCAGGGGCTACAGGGCCTCCTGAAAAACTGTTTTTTGGCAGT	CSAPGATGPPEKLFF	In	VDJ	1	24	3.13491907990125E-4	3.95915472046718E-4	45	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	5	3	3	7	9	5	26	35	50	44	55		TCRBV20-01,TCRBV20-or09_02												CSAPGATGPPEKLFF+TCRBV20-X+TCRBJ01-04	TCRBV20	TCRBD01-01*01	TCRBJ01-04*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTCCGAGGGGGGGGGAGAACACTGAAGCTTTCTTTGGACAA	CSAPRGGENTEAFF	In	VDJ	1	24	3.13491907990125E-4	3.95915472046718E-4	42	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	5	9	0	1	4	3	26	35	46	39	49		TCRBV20-01,TCRBV20-or09_02												CSAPRGGENTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD02-01*01	TCRBJ01-01*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
CCCAACCAGACAGCTCTTTACTTCTGTGTCAGCAGGACTAGTGGAGGGGGCTCCTACAATGAGCAGTTCTTCGGGCCA	CVSRTSGGGSYNEQFF	In	VDJ	1	24	3.13491907990125E-4	3.95915472046718E-4	48	TCRBV24						TCRBJ02	TCRBJ02-01	01	7	5	1	0	9	0	24	35	-1	44	50		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CVSRTSGGGSYNEQFF+TCRBV24-X+TCRBJ02-01	TCRBV24		TCRBJ02-01*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCAAGAACTAGCGGGAGGGGACGAGCAGTACTTCGGGCCG	CASSQELAGGDEQYF	In	VDJ	1	24	3.13491907990125E-4	3.95915472046718E-4	45				TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	0	3	0	5	0	1	18	-1	48	35	49	TCRBV04,TCRBV11	TCRBV04-02,TCRBV11-03												CASSQELAGGDEQYF+X+TCRBJ02-07		TCRBD02-01*02	TCRBJ02-07*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCAAGAGTACAGAATGAATCAGCCCCAGCATTTTGGTGAT	CASSQEYRMNQPQHF	In	VDJ	1	24	3.13491907990125E-4	3.95915472046718E-4	45				TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	0	3	5	4	2	4	18	35	41	37	45	TCRBV04,TCRBV11	TCRBV04-02,TCRBV11-03												CASSQEYRMNQPQHF+X+TCRBJ01-05		TCRBD01-01*01	TCRBJ01-05*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTCCGCAGCAGGGCAGTCAGCCCCAGCATTTTGGTGAT	CASSPQQGSQPQHF	In	VDJ	1	25	3.2655407082304687E-4	4.1241195004866464E-4	42	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	5	4	3	6	6	3	26	38	49	44	52		TCRBV12-03,TCRBV12-04												CASSPQQGSQPQHF+TCRBV12-X+TCRBJ01-05	TCRBV12	TCRBD01-01*01	TCRBJ01-05*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCACACAAGGTCAGGACTAGCACATGAGCAGTTCTTCGGGCCA	CASSHTRSGLAHEQFF	In	VDJ	1	25	3.2655407082304687E-4	4.1241195004866464E-4	48	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	3	1	7	8	10	2	26	40	58	50	60		TCRBV03-01,TCRBV03-02				01,02								CASSHTRSGLAHEQFF+TCRBV03-X+TCRBJ02-01	TCRBV03	TCRBD02-01	TCRBJ02-01*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAACGGGCCATCCTACGAGCAGTACTTCGGGCCG	CSANGPSYEQYF	In	VDJ	1	25	3.2655407082304687E-4	4.1241195004866464E-4	36	TCRBV20						TCRBJ02	TCRBJ02-07	01	4	8	0	1	2	2	26	36	42	38	44		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSANGPSYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20		TCRBJ02-07*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGACCGGGACTACGAGCAGTACTTCGGGCCG	CSARDRDYEQYF	In	VDJ	1	25	3.2655407082304687E-4	4.1241195004866464E-4	36	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	0	8	3	3	1	0	26	40	-1	41	46		TCRBV20-01,TCRBV20-or09_02												CSARDRDYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01*02	TCRBJ02-07*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGGGGGGGGCAGGTAGACTACGAGCAGTACTTCGGGCCG	CSARGGQVDYEQYF	In	VDJ	1	25	3.2655407082304687E-4	4.1241195004866464E-4	42	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	3	9	0	3	0	8	26	-1	44	37	52		TCRBV20-01,TCRBV20-or09_02												CSARGGQVDYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01*01	TCRBJ02-07*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
CAGGGACTCAGCTGTGTACTTCTGTGCCAGCAGCGTAGGTGGCGGGGGGCTAGCCAAAAACATTCAGTACTTCGGCGCC	CASSVGGGGLAKNIQYF	In	VDJ	1	25	3.2655407082304687E-4	4.1241195004866464E-4	51	TCRBV12			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-04	01	6	7	1	0	8	2	22	33	49	41	51		TCRBV12-03,TCRBV12-04												CASSVGGGGLAKNIQYF+TCRBV12-X+TCRBJ02-04	TCRBV12	TCRBD02-01*01	TCRBJ02-04*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
TCAGGAGACWCRGCMSKGTATKTCTGTGCCAGCAGCCAAGCGGAGGGAGAGGGGGCTGAGCAGTTCTTCGGGCCA	CASSQAEGEGAEQFF	In	VDJ	1	25	3.2655407082304687E-4	4.1241195004866464E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	5	5	0	9	13	0	18	30	-1	43	50	TCRBV11,TCRBV21													CASSQAEGEGAEQFF+X+TCRBJ02-01	unresolved	TCRBD01-01*01	TCRBJ02-01*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
GGACTCGGCCCTCTATCTCTGTGCCACTCGGCGGGAGGCGATCAACTAGCACAGATACGTAGTATTTTGGCCCA		Out	VDJ	1	25	3.2655407082304687E-4		49	TCRBV05			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	9	7	1	13	4	22	19	26	38	30	60		TCRBV05-06,TCRBV05-07												X+TCRBV05-X+TCRBJ02-03	TCRBV05	TCRBD02-01*02	TCRBJ02-03*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
TGGRGGACTCAGCYWTGTAYTTCTGTGCCAGCAGCCCGGACAGCCCAAATCAGCCCCAGCATTTTGGTGAT	CASSPDSPNQPQHF	In	VDJ	1	25	3.2655407082304687E-4	4.1241195004866464E-4	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	4	1	5	4	2	4	23	35	43	37	47	TCRBV02,TCRBV09													CASSPDSPNQPQHF+X+TCRBJ01-05	unresolved	TCRBD01-01*01	TCRBJ01-05*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGCCACTGGGGACACTACGAGCAGTACTTCGGGCCG	CASSHWGHYEQYF	In	VDJ	1	26	3.3961623365596876E-4	4.289084280506112E-4	39	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	0	6	3	6	0	26	37	-1	43	49		TCRBV12-03,TCRBV12-04,TCRBV12-05												CASSHWGHYEQYF+TCRBV12-X+TCRBJ02-07	TCRBV12	TCRBD01-01*01	TCRBJ02-07*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
MCCWMYCAGACWTCTRTKTACYTCTGTGCCAGCAGTCCACTCCCTCCACGGGAGAGGGGCACAGCAGATACGCAGTATTTTGGCCCA	CASSPLPPRERGTADTQYF	In	VDJ	1	26	3.3961623365596876E-4	4.289084280506112E-4	57	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	5	8	2	4	12	10	24	36	54	48	64	TCRBV06,TCRBV28													CASSPLPPRERGTADTQYF+X+TCRBJ02-03	unresolved	TCRBD02-01*02	TCRBJ02-03*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGATGGCAGCGGGAGATGGGAGACCCAGTACTTCGGGCCA	CASSQDGSGRWETQYF	In	VDJ	1	26	3.3961623365596876E-4	4.289084280506112E-4	48	TCRBV03			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	0	6	2	5	4	4	26	43	55	47	59		TCRBV03-01,TCRBV03-02												CASSQDGSGRWETQYF+TCRBV03-X+TCRBJ02-05	TCRBV03	TCRBD02-01*02	TCRBJ02-05*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTATCCTATACAGGGGCGGTTATCTCCTTCGGTTCG	CASSLSYTGAVISF	In	VDJ	1	26	3.3961623365596876E-4	4.289084280506112E-4	42				TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	3	2	15	9	9	24	36	52	45	61	TCRBV24,TCRBV27	TCRBV24-01,TCRBV24-or09_02,TCRBV27-01												CASSLSYTGAVISF+X+TCRBJ01-02		TCRBD01-01*01	TCRBJ01-02*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
TCMRGRGACWCAGCWSKGTAYTTCTGTGCCAGCAATATATCTCACTAAGCCAAAAACATTCAGTACTTCGGCGCC	CASNISH*AKNIQYF	Stop	VDJ	1	26	3.3961623365596876E-4		45	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-04	01	10	3	9	0	12	0	24	31	-1	43	47	TCRBV12,TCRBV21					01,02								CASNISH*AKNIQYF+X+TCRBJ02-04	unresolved	TCRBD02-01	TCRBJ02-04*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
AACCCWSSSASWCAKCTGTGTAYTTKTGTGCCAGCAGCCCCGACGGGCCCTATGGCTACACCTTCGGTTCG	CASSPDGPYGYTF	In	VDJ	1	27	3.5267839648889064E-4	4.454049060525578E-4	39	unresolved						TCRBJ01	TCRBJ01-02	01	6	8	0	4	7	1	26	37	48	44	49	TCRBV06,TCRBV12			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSPDGPYGYTF+X+TCRBJ01-02	unresolved		TCRBJ01-02*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAGGGCTCCTACAATGAGCAGTTCTTCGGGCCA	CASSQGSYNEQFF	In	VDJ	1	27	3.5267839648889064E-4	4.454049060525578E-4	39	TCRBV03						TCRBJ02	TCRBJ02-01	01	3	0	9	0	0	0	26	-1	-1	40	43		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQGSYNEQFF+TCRBV03-X+TCRBJ02-01	TCRBV03		TCRBJ02-01*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAAGGGTCTTCAATGAGCAGTTCTTCGGGCCA	CSARRVFNEQFF	In	VDJ	1	27	3.5267839648889064E-4	4.454049060525578E-4	36	TCRBV20						TCRBJ02	TCRBJ02-01	01	2	5	3	6	0	4	26	-1	42	38	46		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSARRVFNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20		TCRBJ02-01*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGATTTACGGCAGGGCCTTTCTTTGGACAA		Out	VDJ	1	27	3.5267839648889064E-4		35	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	1	4	3	12	4	1	24	41	50	45	51		TCRBV24-01,TCRBV24-or09_02												X+TCRBV24-X+TCRBJ01-01	TCRBV24	TCRBD01-01*01	TCRBJ01-01*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATCAGGTCGGATTAGATGGCTACACCTTCGGTTCG	CSARDQVGLDGYTF	In	VDJ	1	28	3.6574055932181253E-4	4.6190138405450437E-4	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	0	4	4	6	1	9	26	40	45	41	54		TCRBV20-01,TCRBV20-or09_02												CSARDQVGLDGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD01-01*01	TCRBJ01-02*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTCAGACAGGTGTCGACTACGAGCAGTACTTCGGGCCG	CSAQTGVDYEQYF	In	VDJ	1	28	3.6574055932181253E-4	4.6190138405450437E-4	39	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	2	4	3	2	6	26	35	43	37	49		TCRBV20-01,TCRBV20-or09_02												CSAQTGVDYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD01-01*01	TCRBJ02-07*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
GACTCGGCCGTGTATSTCTGTGCCAGCAGCTTAACAGGGGGCAATCAGCCCCAGCATTTTGGTGAT	CASSLTGGNQPQHF	In	VDJ	1	28	3.6574055932181253E-4	4.6190138405450437E-4	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	2	3	2	2	0	0	18	-1	-1	33	40	TCRBV07,TCRBV11													CASSLTGGNQPQHF+X+TCRBJ01-05	unresolved	TCRBD01-01*01	TCRBJ01-05*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
GACTCGGCCGTGTATCTCTGTGCCAGCAGCTTAGAGGGCAGGGCCTCTGGCGGGGAGCTGTTTTTTGGAGAA	CASSLEGRASGGELFF	In	VDJ	1	28	3.6574055932181253E-4	4.6190138405450437E-4	48				TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	1	4	3	7	4	7	18	34	43	38	50	TCRBV07,TCRBV11	TCRBV07-02,TCRBV11-02												CASSLEGRASGGELFF+X+TCRBJ02-02		TCRBD01-01*01	TCRBJ02-02*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
AACYSRRGGACTCAGCYRTGTAYTTYTGTGCCAGCAGACAAGGCCCGGGACAGGGCTTTAGCAATGAGCAGTTCTTCGGGCCA	CASRQGPGQGFSNEQFF	In	VDJ	1	28	3.6574055932181253E-4	4.6190138405450437E-4	51	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	6	0	3	6	9	6	23	34	52	43	58	TCRBV02,TCRBV12													CASRQGPGQGFSNEQFF+X+TCRBJ02-01	unresolved	TCRBD01-01*01	TCRBJ02-01*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
AGCTCCCAGACATCTGTGTACTTCTGTGCCAGCAAGCCACAGGGAAATGAGCAGTTCTTCGGGCCA	CASKPQGNEQFF	In	VDJ	1	29	3.7880272215473436E-4	4.7839786205645094E-4	36				TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	7	3	3	7	4	1	24	34	44	38	45	TCRBV06,TCRBV10	TCRBV06-01,TCRBV06-05,TCRBV06-06,TCRBV10-03												CASKPQGNEQFF+X+TCRBJ02-01		TCRBD01-01*01	TCRBJ02-01*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCCCACGCTCTTGCAGCCCCAGCATTTTGGTGAT	CASSPTLLQPQHF	In	VDJ	1	29	3.7880272215473436E-4	4.7839786205645094E-4	39	TCRBV03						TCRBJ01	TCRBJ01-05	01	4	3	7	7	2	7	26	39	43	41	50		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSPTLLQPQHF+TCRBV03-X+TCRBJ01-05	TCRBV03		TCRBJ01-05*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCACCTCTAGCGGGAGGGCCGGATGAGCAGTTCTTCGGGCCA	CSAPLAGGPDEQFF	In	VDJ	1	29	3.7880272215473436E-4	4.7839786205645094E-4	42	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	6	4	0	8	4	4	26	34	50	38	54		TCRBV20-01,TCRBV20-or09_02												CSAPLAGGPDEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01*02	TCRBJ02-01*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGTGGGACTAGCGGAGATAGACGAGCAGTACTTCGGGCCG	CSARVGLAEIDEQYF	In	VDJ	1	29	3.7880272215473436E-4	4.7839786205645094E-4	45	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	1	0	5	5	1	6	26	39	51	40	57		TCRBV20-01,TCRBV20-or09_02				01,02								CSARVGLAEIDEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01	TCRBJ02-07*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
CAGGGACTCAGCTGTGTACTTCTGTGCCAGCACCAAGGGACAGCGAGAATGAAAAACTGTTTTTTGGCAGT		Out	VDJ	1	29	3.7880272215473436E-4		43	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	7	0	5	5	4	4	22	32	43	36	47		TCRBV12-03,TCRBV12-04												X+TCRBV12-X+TCRBJ01-04	TCRBV12	TCRBD01-01*01	TCRBJ01-04*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGATTCGGAGGGGGCAATAACCGGGGAGCTGTTTTTTGGAGAA	CATSDSEGAITGELFF	In	VDJ	1	29	3.7880272215473436E-4	4.7839786205645094E-4	48	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	2	5	0	5	3	4	24	40	50	43	54		TCRBV24-01,TCRBV24-or09_02												CATSDSEGAITGELFF+TCRBV24-X+TCRBJ02-02	TCRBV24	TCRBD01-01*01	TCRBJ02-02*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGAATTATCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASSELSGANVLTF	In	VDJ	1	29	3.7880272215473436E-4	4.7839786205645094E-4	42	TCRBV06			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-06	01	2	5	9	1	1	0	23	38	-1	39	41		TCRBV06-01,TCRBV06-08				01,02								CASSELSGANVLTF+TCRBV06-X+TCRBJ02-06	TCRBV06	TCRBD02-01	TCRBJ02-06*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCAGCTGTGTGGAGGACGGGGGCAATCAGCCCCAGCATTTTGGTGAT	CASCVEDGGNQPQHF	In	VDJ	1	29	3.7880272215473436E-4	4.7839786205645094E-4	45	unresolved			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-05	01	8	8	3	2	11	0	23	32	-1	43	48	TCRBV06,TCRBV10					01,02								CASCVEDGGNQPQHF+X+TCRBJ01-05	unresolved	TCRBD02-01	TCRBJ01-05*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
CGACTCGGCYGTGTATSTCTGTGCCAGCAGATTGACTAGCGGGAATAGCCACGAGCAGTACTTCGGGCCG	CASRLTSGNSHEQYF	In	VDJ	1	29	3.7880272215473436E-4	4.7839786205645094E-4	45	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	6	2	3	5	3	6	18	29	43	32	49	TCRBV07,TCRBV11													CASRLTSGNSHEQYF+X+TCRBJ02-07	unresolved	TCRBD02-01*02	TCRBJ02-07*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGCAAGTACAGAGAGATACAATGAGCAGTTCTTCGGGCCA	CASSLASTERYNEQFF	In	VDJ	1	29	3.7880272215473436E-4	4.7839786205645094E-4	48				TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	0	3	5	4	4	5	18	35	43	39	48	TCRBV07,TCRBV11	TCRBV07-02,TCRBV11-03												CASSLASTERYNEQFF+X+TCRBJ02-01		TCRBD01-01*01	TCRBJ02-01*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCGATGGAGGGGCAGATCAGCCCCAGCATTTTGGTGAT	CSADGGADQPQHF	In	VDJ	1	30	3.9186488498765625E-4	4.948943400583975E-4	39	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-05	01	6	10	0	5	4	4	26	34	44	38	48		TCRBV20-01,TCRBV20-or09_02												CSADGGADQPQHF+TCRBV20-X+TCRBJ01-05	TCRBV20	TCRBD02-01*02	TCRBJ01-05*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
CAGGGACTCAGCTGTGTACTTCTGTGCCTCTCCTTCCAGGGGGCTACCGACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	30	3.9186488498765625E-4		44	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	11	4	0	5	8	5	22	28	44	36	49		TCRBV12-03,TCRBV12-04												X+TCRBV12-X+TCRBJ02-01	TCRBV12	TCRBD01-01*01	TCRBJ02-01*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
CCWMCCAGACMTCTSTGTACTTSTGTGCCAGCAGGTGGACGGGAGCCTACGAGCAGTACTTCGGGCCG	CASRWTGAYEQYF	In	VDJ	1	30	3.9186488498765625E-4	4.948943400583975E-4	39	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	6	8	2	2	5	0	23	34	-1	39	45	TCRBV06,TCRBV27													CASRWTGAYEQYF+X+TCRBJ02-07	unresolved	TCRBD02-01*02	TCRBJ02-07*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
AGCTTGGTGACTCKGCYGTGTATKTCTGTGCCAGCAGCTTACGGCCAGGGGGAGAAGAGACCCAGTACTTCGGGCCA	CASSLRPGGEETQYF	In	VDJ	1	30	3.9186488498765625E-4	4.948943400583975E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	2	4	1	3	4	2	18	33	44	37	46	TCRBV03,TCRBV11													CASSLRPGGEETQYF+X+TCRBJ02-05	unresolved	TCRBD01-01*01	TCRBJ02-05*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTAAGACAGGGAATGAAAAACTGTTTTTTGGCAGT	CASSKTGNEKLFF	In	VDJ	1	31	4.0492704782057814E-4	5.113908180603441E-4	39	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	5	2	3	5	2	0	26	38	-1	40	47		TCRBV12-03,TCRBV12-04												CASSKTGNEKLFF+TCRBV12-X+TCRBJ01-04	TCRBV12	TCRBD01-01*01	TCRBJ01-04*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGGTCGGGAGCAGCCCCAGCATTTTGGTGAT	CASSQGREQPQHF	In	VDJ	1	31	4.0492704782057814E-4	5.113908180603441E-4	39	TCRBV03			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-05	01	1	8	2	7	2	0	26	42	-1	44	50		TCRBV03-01,TCRBV03-02												CASSQGREQPQHF+TCRBV03-X+TCRBJ01-05	TCRBV03	TCRBD02-01*02	TCRBJ01-05*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCGCTTGACAGGGGTTGGGGCCAACGTCCTGACTTTCGGGGCC	CASSRLTGVGANVLTF	In	VDJ	1	31	4.0492704782057814E-4	5.113908180603441E-4	48	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	4	2	2	3	4	1	26	39	51	43	52		TCRBV03-01,TCRBV03-02												CASSRLTGVGANVLTF+TCRBV03-X+TCRBJ02-06	TCRBV03	TCRBD01-01*01	TCRBJ02-06*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGAGGAAGGCTACGAGCAGTACTTCGGGCCG	CSAREEGYEQYF	In	VDJ	1	31	4.0492704782057814E-4	5.113908180603441E-4	36	TCRBV20						TCRBJ02	TCRBJ02-07	01	0	1	8	3	0	3	26	-1	43	40	46		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSAREEGYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20		TCRBJ02-07*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTCCTTCGGCTAGCTCCTACGAGCAGTACTTCGGGCCG	CASSPSASSYEQYF	In	VDJ	1	31	4.0492704782057814E-4	5.113908180603441E-4	42	TCRBV24			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	6	4	8	0	7	0	24	36	-1	43	47		TCRBV24-01,TCRBV24-or09_02				01,02								CASSPSASSYEQYF+TCRBV24-X+TCRBJ02-07	TCRBV24	TCRBD02-01	TCRBJ02-07*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCAGCAGTGACTAGAGGACAGGTTAGCCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	31	4.0492704782057814E-4		47	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	1	1	4	2	3	4	23	39	49	42	53	TCRBV06,TCRBV10													X+X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGCCAATGGACAGGTTCGACTGTTTTTTGGCAGT	CASSLANGQVRLFF	In	VDJ	1	31	4.0492704782057814E-4	5.113908180603441E-4	42				TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	0	1	4	13	4	4	18	35	46	39	50	TCRBV07,TCRBV11	TCRBV07-02,TCRBV11-03												CASSLANGQVRLFF+X+TCRBJ01-04		TCRBD01-01*01	TCRBJ01-04*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
AAGCCACGTTTGGTGCCAGCCAGACCTCTGTACCTCTGTGCCAGCAGGATCGGGACAGGGGGCGCTCTTGAAGCTTTCTTTGGACAA	CASRIGTGGALEAFF	In	VDJ	1	32	4.179892106535E-4	5.278872960622907E-4	45				TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	0	0	7	4	5	36	47	63	51	68	TCRBV25,TCRBV27,TCRBV28	TCRBV25-01,TCRBV25-or09_02,TCRBV27-01,TCRBV28-01												CASRIGTGGALEAFF+X+TCRBJ01-01		TCRBD01-01*01	TCRBJ01-01*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCGGCACTCTCGAGCAGTACTTCGGGCCG	CASSGTLEQYF	In	VDJ	1	32	4.179892106535E-4	5.278872960622907E-4	33	TCRBV03						TCRBJ02	TCRBJ02-07	01	5	9	0	6	0	5	26	-1	41	38	46		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSGTLEQYF+TCRBV03-X+TCRBJ02-07	TCRBV03		TCRBJ02-07*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGGAAGGTCACCTTCTACGCGCAGTACTTCGGGCCG	CSARKVTFYAQYF	In	VDJ	1	32	4.179892106535E-4	5.278872960622907E-4	39	TCRBV20						TCRBJ02	TCRBJ02-07	01	3	5	4	9	2	13	26	37	42	39	55		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSARKVTFYAQYF+TCRBV20-X+TCRBJ02-07	TCRBV20		TCRBJ02-07*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGGGCGGGATTTGTCACAGATACGCAGTATTTTGGCCCA	CSARAGFVTDTQYF	In	VDJ	1	32	4.179892106535E-4	5.278872960622907E-4	42	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	3	7	3	2	1	5	26	37	44	38	49		TCRBV20-01,TCRBV20-or09_02												CSARAGFVTDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01*02	TCRBJ02-03*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGAAACTAGCGGGAGCACAGATACGCAGTATTTTGGCCCA	CASSETSGSTDTQYF	In	VDJ	1	32	4.179892106535E-4	5.278872960622907E-4	45	TCRBV06			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	2	3	4	0	0	0	23	-1	-1	38	47		TCRBV06-01,TCRBV06-08				01,02								CASSETSGSTDTQYF+TCRBV06-X+TCRBJ02-03	TCRBV06	TCRBD02-01	TCRBJ02-03*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
GGACTCGGCCSTSTATSTCTGTGCCAGCAGCCCCGGGACTAGCGGGAGTGGCGGCTTAAGTAAAGATACGCAGTATTTTGGCCCA	CASSPGTSGSGGLSKDTQYF	In	VDJ	1	32	4.179892106535E-4	5.278872960622907E-4	60	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	5	0	2	5	3	15	18	30	47	33	62	TCRBV05,TCRBV11													CASSPGTSGSGGLSKDTQYF+X+TCRBJ02-03	unresolved	TCRBD02-01*02	TCRBJ02-03*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
AAYCMRGRGACWCAGCWSKGTATTTYTGTGCCAGCAGCGTAGATCGGGGCTACGAGCAGTACTTCGGGCCG	CASSVDRGYEQYF	In	VDJ	1	32	4.179892106535E-4	5.278872960622907E-4	39	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	5	8	3	3	6	0	24	36	-1	42	47	TCRBV12,TCRBV21													CASSVDRGYEQYF+X+TCRBJ02-07	unresolved	TCRBD02-01*01	TCRBJ02-07*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
TYRGGRGACWCAGCWYKGTATTTCTGTGCCAGCAGCGTAGGGGCTAGCGGAAACACCGGGGAGCTGTTTTTTGGAGAA	CASSVGASGNTGELFF	In	VDJ	1	32	4.179892106535E-4	5.278872960622907E-4	48	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	5	4	5	2	7	1	24	36	50	43	51	TCRBV09,TCRBV21					01,02								CASSVGASGNTGELFF+X+TCRBJ02-02	unresolved	TCRBD02-01	TCRBJ02-02*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
TTCTGCGCCAGCAGTGAGTCGTTAGTGGCAGGGAGACCCTTTTGGAGGGAAAAGAGCTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASSESLVAGRPFWREKSSGANVLTF	In	VDJ	1	32	4.179892106535E-4	5.278872960622907E-4	78	TCRBV10			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-06	01	0	10	0	0	23	7	3	20	49	43	56		TCRBV10-01,TCRBV10-02												CASSESLVAGRPFWREKSSGANVLTF+TCRBV10-X+TCRBJ02-06	TCRBV10	TCRBD02-01*02	TCRBJ02-06*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTATATCCTAGCGAGACCTACGAGCAGTACTTCGGGCCG	CASSLYPSETYEQYF	In	VDJ	1	33	4.3105137348642186E-4	5.443837740642373E-4	45	TCRBV12			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	2	4	6	2	4	3	26	41	51	45	54		TCRBV12-03,TCRBV12-04				01,02								CASSLYPSETYEQYF+TCRBV12-X+TCRBJ02-07	TCRBV12	TCRBD02-01	TCRBJ02-07*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGCTCCTGGATCGGCTACCTACGAGCAGTACTTCGGGCCG	CASSQAPGSATYEQYF	In	VDJ	1	33	4.3105137348642186E-4	5.443837740642373E-4	48	TCRBV03						TCRBJ02	TCRBJ02-07	01	1	1	8	2	5	7	26	42	50	47	57		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQAPGSATYEQYF+TCRBV03-X+TCRBJ02-07	TCRBV03		TCRBJ02-07*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCCACGGGACATTAATGAGCAGTTCTTCGGGCCA	CASSPRDINEQFF	In	VDJ	1	33	4.3105137348642186E-4	5.443837740642373E-4	39	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	4	0	6	7	3	2	26	39	48	42	50		TCRBV03-01,TCRBV03-02												CASSPRDINEQFF+TCRBV03-X+TCRBJ02-01	TCRBV03	TCRBD01-01*01	TCRBJ02-01*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCGAGTAGTATCCATTTGAAAGACCTATGGCTACACCCTCGGTTCG		Out	VDJ	1	33	4.3105137348642186E-4		50	TCRBV03						TCRBJ01	TCRBJ01-02	01	5	2	7	18	19	14	26	38	60	57	74		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV03-X+TCRBJ01-02	TCRBV03		TCRBJ01-02*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
SRGGGACTYRGCTGTGTAYYTCTGTGCCAGCAGCTCGCAGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSSQNTGELFF	In	VDJ	1	33	4.3105137348642186E-4	5.443837740642373E-4	39	unresolved						TCRBJ02	TCRBJ02-02	01	6	4	6	1	4	0	22	33	-1	37	39	TCRBV07,TCRBV12			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSSQNTGELFF+X+TCRBJ02-02	unresolved		TCRBJ02-02*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCTCGGACAGGTCGACCGGCTACACCTTCGGTTCG	CATSDRSTGYTF	In	VDJ	1	33	4.3105137348642186E-4	5.443837740642373E-4	36	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	9	1	4	8	2	6	24	33	42	35	48		TCRBV24-01,TCRBV24-or09_02												CATSDRSTGYTF+TCRBV24-X+TCRBJ01-02	TCRBV24	TCRBD01-01*01	TCRBJ01-02*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
GGACTCGGCCCTCTATCTCTGTGCCAGCAGCTACCGGGAGCCGGGCGGGGAGCTGTTTTTTGGAGAA	CASSYREPGGELFF	In	VDJ	1	33	4.3105137348642186E-4	5.443837740642373E-4	42	TCRBV05			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	3	8	2	7	2	5	19	32	40	34	45		TCRBV05-06,TCRBV05-07												CASSYREPGGELFF+TCRBV05-X+TCRBJ02-02	TCRBV05	TCRBD02-01*02	TCRBJ02-02*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
TYRGGRGACWCAGCWYKGTATTTCTGTGCCAGCAGTGCACAGGGGGCGAGAGGGGCCAACGTCCTGACTTTCGGGGCC	CASSAQGARGANVLTF	In	VDJ	1	33	4.3105137348642186E-4	5.443837740642373E-4	48	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	6	3	0	4	3	4	24	35	47	38	51	TCRBV09,TCRBV21													CASSAQGARGANVLTF+X+TCRBJ02-06	unresolved	TCRBD01-01*01	TCRBJ02-06*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCGAGTAGTATCCATTTGAAAGACCTATGGCTACACCTTCGGTTCG		Out	VDJ	1	34	4.4411353631934375E-4		50	TCRBV03						TCRBJ01	TCRBJ01-02	01	5	2	7	4	19	0	26	38	-1	57	60		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV03-X+TCRBJ01-02	TCRBV03		TCRBJ01-02*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTGACAGGGGGTTGCCGACCGGGGAGCTGTTTTTTGGAGAA	CSADRGLPTGELFF	In	VDJ	1	34	4.4411353631934375E-4	5.608802520661838E-4	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	5	2	1	5	0	6	26	-1	44	35	50		TCRBV20-01,TCRBV20-or09_02												CSADRGLPTGELFF+TCRBV20-X+TCRBJ02-02	TCRBV20	TCRBD01-01*01	TCRBJ02-02*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGGGCCTCCAGCCCCCAAGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	34	4.4411353631934375E-4		44	TCRBV24						TCRBJ02	TCRBJ02-05	01	5	4	5	1	6	3	24	37	46	43	49		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV24-X+TCRBJ02-05	TCRBV24		TCRBJ02-05*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
SCTCCCAGACATCTGTGTAYTTSTGYGCCAGCACCATCGATAGGGCCCTCTACAATGAGCAGTTCTTCGGGCCA	CASTIDRALYNEQFF	In	VDJ	1	34	4.4411353631934375E-4	5.608802520661838E-4	45	unresolved						TCRBJ02	TCRBJ02-01	01	7	5	3	3	8	4	23	33	45	41	49	TCRBV06,TCRBV10			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASTIDRALYNEQFF+X+TCRBJ02-01	unresolved		TCRBJ02-01*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
YCMRGRGACWCAGCWSKGTATTTYTGTGCCAGCAACGTAGCGGCGACAGGTTCGAATGTATGGACAGATACGCAGTATTTTGGCCCA	CASNVAATGSNVWTDTQYF	In	VDJ	1	34	4.4411353631934375E-4	5.608802520661838E-4	57	unresolved						TCRBJ02	TCRBJ02-03	01	10	2	4	3	13	13	24	31	50	44	63	TCRBV12,TCRBV21			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASNVAATGSNVWTDTQYF+X+TCRBJ02-03	unresolved		TCRBJ02-03*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGCTTAATGGGGGGCGGCCCGGCCACCGGGGAGCTGTTTTTTGGAGAA	CASSLMGGGPATGELFF	In	VDJ	1	35	4.5717569915226564E-4	5.773767300681304E-4	51	TCRBV12						TCRBJ02	TCRBJ02-02	01	2	6	0	4	3	8	26	41	50	44	58		TCRBV12-03,TCRBV12-04		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLMGGGPATGELFF+TCRBV12-X+TCRBJ02-02	TCRBV12		TCRBJ02-02*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTCCCACCCGCTCCGGGTACGAGCAGTACTTCGGGCCG	CASSPTRSGYEQYF	In	VDJ	1	35	4.5717569915226564E-4	5.773767300681304E-4	42	TCRBV12			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	5	8	4	4	11	0	26	38	-1	49	53		TCRBV12-03,TCRBV12-04				01,02								CASSPTRSGYEQYF+TCRBV12-X+TCRBJ02-07	TCRBV12	TCRBD02-01	TCRBJ02-07*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAATGCCTCAAAGGCGGGAGGAGGCAATGAGCAGTTCTTCGGGCCA	CNASKAGGGNEQFF	In	VDJ	1	35	4.5717569915226564E-4	5.773767300681304E-4	42	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	6	7	1	6	7	3	26	34	49	41	52		TCRBV20-01,TCRBV20-or09_02												CNASKAGGGNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01*02	TCRBJ02-01*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGCGCTTTCAAAGGCCAGACGGAAACACAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	35	4.5717569915226564E-4		47	TCRBV20						TCRBJ02	TCRBJ02-03	01	5	1	8	2	14	2	26	35	52	49	54		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV20-X+TCRBJ02-03	TCRBV20		TCRBJ02-03*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
TCMRGRGACWCAGCWSKGTAYTTCTGTGCCAGCAGTGAAGCTGAGACTAGCAGCTACAATGAGCAGTTCTTCGGGCCA	CASSEAETSSYNEQFF	In	VDJ	1	35	4.5717569915226564E-4	5.773767300681304E-4	48	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	5	2	7	3	8	2	22	34	49	42	51	TCRBV12,TCRBV21					01,02								CASSEAETSSYNEQFF+X+TCRBJ02-01	unresolved	TCRBD02-01	TCRBJ02-01*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGCCCAGGACGGGCGCAACTATGGCTACACCTTCGGTTCG	CATSAQDGRNYGYTF	In	VDJ	1	35	4.5717569915226564E-4	5.773767300681304E-4	45	TCRBV24						TCRBJ01	TCRBJ01-02	01	5	1	7	2	4	6	24	37	45	41	51		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CATSAQDGRNYGYTF+TCRBV24-X+TCRBJ01-02	TCRBV24		TCRBJ01-02*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
SCTCCCAGACATCTGTGTAYTTSTGYGCCAGCAGAGCACAGGGCAGGAAAGTCCAACGTCCTGACTTTCGGGGCC		Out	VDJ	1	35	4.5717569915226564E-4		46	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	6	3	3	8	3	9	23	34	43	37	52	TCRBV06,TCRBV10													X+X+TCRBJ02-06	unresolved	TCRBD01-01*01	TCRBJ02-06*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
GACKCRGCCRTGTAYSTSTGTGCCAGCAGCACCCGTTTTGGGGCGGAAACTAATGAAAAACTGTTTTTTGGCAGT	CASSTRFGAETNEKLFF	In	VDJ	1	35	4.5717569915226564E-4	5.773767300681304E-4	51	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	5	7	0	1	9	3	18	30	44	39	47	TCRBV11,TCRBV15													CASSTRFGAETNEKLFF+X+TCRBJ01-04	unresolved	TCRBD01-01*01	TCRBJ01-04*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
TYRGRRGACWCAGCMMKGTAYTTCTGTGCCAGCAGAGGGGGGACAGCAAGCGGGGAGCTGTTTTTTGGAGAA	CASRGGTASGELFF	In	VDJ	1	35	4.5717569915226564E-4	5.773767300681304E-4	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	6	0	5	7	4	4	24	35	46	39	50	TCRBV02,TCRBV21													CASRGGTASGELFF+X+TCRBJ02-02	unresolved	TCRBD01-01*01	TCRBJ02-02*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGGGGATGCGGACTACGAGCAGTACTTCGGGCCG	CSARGDADYEQYF	In	VDJ	1	36	4.702378619851875E-4	5.938732080700771E-4	39	TCRBV20						TCRBJ02	TCRBJ02-07	01	1	0	8	3	0	6	26	-1	43	39	49		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSARGDADYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20		TCRBJ02-07*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTGGCAACGGGACAGGGCGACCTCTGGGGCCAACGTCCTGACTTTCGGGGCC		Out	VDJ	1	36	4.702378619851875E-4		53	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	5	0	3	0	6	4	26	35	50	41	54		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ02-06	TCRBV20	TCRBD01-01*01	TCRBJ02-06*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGCCAAAGCCCCTAGCGGGGACACAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	36	4.702378619851875E-4		49	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	5	4	3	2	8	1	18	30	47	38	48	TCRBV07,TCRBV11													X+X+TCRBJ02-03	unresolved	TCRBD02-01*01	TCRBJ02-03*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
GRGACWCGGCMMTGTATCTCTGYGCCAGCAGCTCAGACAGGGCTGACCCTGGAAACACCATATATTTTGGAGAG	CASSSDRADPGNTIYF	In	VDJ	1	36	4.702378619851875E-4	5.938732080700771E-4	48	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	4	2	3	2	2	6	19	32	41	34	47	TCRBV11,TCRBV23													CASSSDRADPGNTIYF+X+TCRBJ01-03	unresolved	TCRBD01-01*01	TCRBJ01-03*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
AAYCMRGRGACWCAGCWSKGTATTTYTGTGCCAGCCAGGGACTAGCGGGAGCCCCGGGCACCGGGGAGCTGTTTTTTGGAGAA	CASQGLAGAPGTGELFF	In	VDJ	1	37	4.8330002481810936E-4	6.103696860720237E-4	51	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	12	0	2	4	6	7	26	31	51	37	58	TCRBV12,TCRBV21													CASQGLAGAPGTGELFF+X+TCRBJ02-02	unresolved	TCRBD02-01*02	TCRBJ02-02*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCCCTAGCGAGGTCACCTACGAGCAGTACTTCGGGCCG	CSAPSEVTYEQYF	In	VDJ	1	37	4.8330002481810936E-4	6.103696860720237E-4	39	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	6	4	6	2	2	6	26	34	42	36	48		TCRBV20-01,TCRBV20-or09_02				01,02								CSAPSEVTYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01	TCRBJ02-07*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGCCAGCGAGAATGAGCAGTTCTTCGGGCCA	CSARASENEQFF	In	VDJ	1	37	4.8330002481810936E-4	6.103696860720237E-4	36	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	1	6	6	7	2	2	26	39	45	41	47		TCRBV20-01,TCRBV20-or09_02				01,02								CSARASENEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01	TCRBJ02-01*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
SCTCCCAGACATCTGTGTAYTTSTGYGCCAGCAGTGAAGGGCAAGACACCGGGGAGCTGTTTTTTGGAGAA	CASSEGQDTGELFF	In	VDJ	1	37	4.8330002481810936E-4	6.103696860720237E-4	42	unresolved			unresolved			TCRBJ02	TCRBJ02-02	01	1	9	0	3	0	3	23	-1	42	39	45	TCRBV06,TCRBV10			TCRBD01,TCRBD02										CASSEGQDTGELFF+X+TCRBJ02-02	unresolved	unresolved	TCRBJ02-02*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGCCTCATCTGGGGAGATAATGAAAAACTGTTTTTTGGCAGT	CASSLIWGDNEKLFF	In	VDJ	1	37	4.8330002481810936E-4	6.103696860720237E-4	45	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-04	01	5	9	2	4	8	1	18	30	43	38	44	TCRBV07,TCRBV11													CASSLIWGDNEKLFF+X+TCRBJ01-04	unresolved	TCRBD02-01*02	TCRBJ01-04*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
GGACTCGGCCSTSTATSTCTGTGCCAGCAGCTTGCCGACGGGCGCCGATAGCACAGATACGCAGTATTTTGGCCCA	CASSLPTGADSTDTQYF	In	VDJ	1	37	4.8330002481810936E-4	6.103696860720237E-4	51	unresolved						TCRBJ02	TCRBJ02-03	01	3	8	0	0	6	6	18	32	42	38	48	TCRBV05,TCRBV11			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLPTGADSTDTQYF+X+TCRBJ02-03	unresolved		TCRBJ02-03*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
GGACTCRGCCMTSTATCKCTGTGCCAGCAGCTCGACCGGGACAGACTTAGCCGGGGAGCTGTTTTTTGGAGAA	CASSSTGTDLAGELFF	In	VDJ	1	37	4.8330002481810936E-4	6.103696860720237E-4	48	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	4	0	5	6	5	6	19	32	44	37	50	TCRBV05,TCRBV07													CASSSTGTDLAGELFF+X+TCRBJ02-02	unresolved	TCRBD01-01*01	TCRBJ02-02*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAAACGGCCCAAAGATACGCAGTATTTTGGCCCA	CSAKRPKDTQYF	In	VDJ	1	38	4.963621876510313E-4	6.268661640739702E-4	36	TCRBV20						TCRBJ02	TCRBJ02-03	01	4	9	0	5	3	4	26	36	42	39	46		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSAKRPKDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20		TCRBJ02-03*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
GAGACWCGGCMSTGTATSTCTGYGCCAGCAGCTTTTCACCTTGGGCCACTGAAGCTTTCTTTGGACAA	CASSFSPWATEAFF	In	VDJ	1	38	4.963621876510313E-4	6.268661640739702E-4	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	8	0	4	8	0	18	32	-1	40	44	TCRBV11,TCRBV23													CASSFSPWATEAFF+X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGGGGACCCGGAGGTAGGTGAGCAGTACTTCGGGCCG	CASSQGDPEVGEQYF	In	VDJ	1	39	5.094243504839531E-4	6.433626420759168E-4	45	TCRBV03						TCRBJ02	TCRBJ02-07	01	1	0	7	7	0	12	26	-1	47	42	59		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQGDPEVGEQYF+TCRBV03-X+TCRBJ02-07	TCRBV03		TCRBJ02-07*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCAAGGACAGGGTCTGGAAACACCATATATTTTGGAGAG		Out	VDJ	1	39	5.094243504839531E-4		40	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	6	1	3	1	3	0	26	34	-1	37	45		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ01-03	TCRBV20	TCRBD01-01*01	TCRBJ01-03*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTTACAGGGCTGGCAATCAGCCCCAGCATTTTGGTGAT	CSAYRAGNQPQHF	In	VDJ	1	39	5.094243504839531E-4	6.433626420759168E-4	39	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	5	3	3	2	1	3	26	35	42	36	45		TCRBV20-01,TCRBV20-or09_02												CSAYRAGNQPQHF+TCRBV20-X+TCRBJ01-05	TCRBV20	TCRBD01-01*01	TCRBJ01-05*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTTTGGACGAGAAAGAGACCCAGTACTTCGGGCCA	CSALDEKETQYF	In	VDJ	1	39	5.094243504839531E-4	6.433626420759168E-4	36	TCRBV20						TCRBJ02	TCRBJ02-05	01	5	1	7	3	2	4	26	35	41	37	45		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSALDEKETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20		TCRBJ02-05*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCTGGGGGGCGGGAGGGCCCGGCACCGGGGAGCTGTTTTTTGGAGAA	CASSWGAGGPGTGELFF	In	VDJ	1	40	5.22486513316875E-4	6.598591200778634E-4	51	TCRBV03			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	5	7	0	4	6	5	26	38	53	44	58		TCRBV03-01,TCRBV03-02												CASSWGAGGPGTGELFF+TCRBV03-X+TCRBJ02-02	TCRBV03	TCRBD02-01*02	TCRBJ02-02*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATAGGGGACAGGGTAATCAGCCCCAGCATTTTGGTGAT	CSARDRGQGNQPQHF	In	VDJ	1	40	5.22486513316875E-4	6.598591200778634E-4	45	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	0	0	3	4	3	1	26	40	52	43	53		TCRBV20-01,TCRBV20-or09_02												CSARDRGQGNQPQHF+TCRBV20-X+TCRBJ01-05	TCRBV20	TCRBD01-01*01	TCRBJ01-05*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGGCTTCTAGCGTTCGACAATGAGCAGTTCTTCGGGCCA	CSARLLAFDNEQFF	In	VDJ	1	40	5.22486513316875E-4	6.598591200778634E-4	42	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	3	4	6	5	4	4	26	37	47	41	51		TCRBV20-01,TCRBV20-or09_02				01,02								CSARLLAFDNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01	TCRBJ02-01*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAACGGGAGAAGGACGAGCAGTACTTCGGGCCG	CASSQREKDEQYF	In	VDJ	1	41	5.355486761497969E-4	6.7635559807981E-4	39	TCRBV03			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	2	8	2	5	0	4	26	-1	47	41	51		TCRBV03-01,TCRBV03-02												CASSQREKDEQYF+TCRBV03-X+TCRBJ02-07	TCRBV03	TCRBD02-01*02	TCRBJ02-07*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTTCCCCGGGACTAGTGGGCGGCGAGTAGTACTTCGGGCCG	CSASPGLVGGE*YF	Stop	VDJ	1	41	5.355486761497969E-4		42	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	5	0	8	11	5	12	26	35	48	40	60		TCRBV20-01,TCRBV20-or09_02				01,02								CSASPGLVGGE*YF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01	TCRBJ02-07*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGACGGACGACTAGCCATAGAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	41	5.355486761497969E-4		44	TCRBV24			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	7	2	7	7	6	5	24	35	48	41	53		TCRBV24-01,TCRBV24-or09_02				01,02								X+TCRBV24-X+TCRBJ02-01	TCRBV24	TCRBD02-01	TCRBJ02-01*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCAGCACCACCTGGGGGAACAATGAGCAGTTCTTCGGGCCA	CASTTWGNNEQFF	In	VDJ	1	41	5.355486761497969E-4	6.7635559807981E-4	39	unresolved						TCRBJ02	TCRBJ02-01	01	7	6	1	5	6	1	23	33	44	39	45	TCRBV06,TCRBV10			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASTTWGNNEQFF+X+TCRBJ02-01	unresolved		TCRBJ02-01*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGCCGGGACAGGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSRDRNTGELFF	In	VDJ	1	42	5.486108389827187E-4	6.928520760817565E-4	42	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	6	0	5	1	2	0	26	37	-1	39	46		TCRBV12-03,TCRBV12-04,TCRBV12-05												CASSRDRNTGELFF+TCRBV12-X+TCRBJ02-02	TCRBV12	TCRBD01-01*01	TCRBJ02-02*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCGAGGAGACGAAGGTGGGCAGTACTTCGGGCCG	CASSRGDEGGQYF	In	VDJ	1	42	5.486108389827187E-4	6.928520760817565E-4	39	TCRBV03			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	4	10	2	9	2	10	26	39	45	41	55		TCRBV03-01,TCRBV03-02												CASSRGDEGGQYF+TCRBV03-X+TCRBJ02-07	TCRBV03	TCRBD02-01*02	TCRBJ02-07*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCTTCTGCGTGGCACTGAAGCTTTCTTTGGACAA	CASSLLRGTEAFF	In	VDJ	1	42	5.486108389827187E-4	6.928520760817565E-4	39	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	4	7	6	4	4	3	26	39	46	43	49		TCRBV03-01,TCRBV03-02				01,02								CASSLLRGTEAFF+TCRBV03-X+TCRBJ01-01	TCRBV03	TCRBD02-01	TCRBJ01-01*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGAAAATGAAAAACTGTTTTTTGGCAGT	CSARENEKLFF	In	VJ	1	42	5.486108389827187E-4	6.928520760817565E-4	33	TCRBV20						TCRBJ01	TCRBJ01-04	01	0	0	0	5	0	1	26	-1	40	-1	41		TCRBV20-01,TCRBV20-or09_02												CSARENEKLFF+TCRBV20-X+TCRBJ01-04	TCRBV20		TCRBJ01-04*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGACCCCATAAGCGGGGGGCCTACGAGCAGTACTTCGGGCCG	CSARPHKRGAYEQYF	In	VDJ	1	43	5.616730018156407E-4	7.093485540837031E-4	45	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	2	6	1	2	7	0	26	38	-1	45	54		TCRBV20-01,TCRBV20-or09_02												CSARPHKRGAYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01*01	TCRBJ02-07*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTCATCTAGCGGGAGGAACAGATACGCAGTATTTTGGCCCA	CSAHLAGGTDTQYF	In	VDJ	1	43	5.616730018156407E-4	7.093485540837031E-4	42	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	5	4	1	3	3	1	26	35	49	38	50		TCRBV20-01,TCRBV20-or09_02												CSAHLAGGTDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01*02	TCRBJ02-03*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
AACCCAGGGACTCAGCTGTGTAYTTYTGTGCCAGCAGTGTGGCCCAAGGAGGTGAAGCTTTCTTTGGACAA	CASSVAQGGEAFF	In	VDJ	1	43	5.616730018156407E-4	7.093485540837031E-4	39	TCRBV12			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	5	10	1	7	9	0	22	34	-1	43	48		TCRBV12-03,TCRBV12-04												CASSVAQGGEAFF+TCRBV12-X+TCRBJ01-01	TCRBV12	TCRBD02-01*02	TCRBJ01-01*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTCCGACACAGGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSFRHRNTGELFF	In	VDJ	1	43	5.616730018156407E-4	7.093485540837031E-4	45	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	6	2	6	1	4	3	24	36	44	40	47		TCRBV24-01,TCRBV24-or09_02												CASSFRHRNTGELFF+TCRBV24-X+TCRBJ02-02	TCRBV24	TCRBD01-01*01	TCRBJ02-02*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
SCTCCCAGACATCTGTGTAYTTSTGYGCCAGCAGCTGTCCCGGGACAGGCCCCAGCATTTTGGTGAT		Out	VDJ	1	43	5.616730018156407E-4		38	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	6	0	5	9	7	0	23	34	-1	41	48	TCRBV06,TCRBV10													X+X+TCRBJ01-05	unresolved	TCRBD01-01*01	TCRBJ01-05*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
GACKCRGCCRTGTAYCTSTGTGCCAGCAGCTCCAATCGCGGGATCCGCCGCGATGAGCAGTTCTTCGGGCCA	CASSSNRGIRRDEQFF	In	VDJ	1	43	5.616730018156407E-4	7.093485540837031E-4	48	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	4	7	3	8	6	9	18	31	43	37	52	TCRBV07,TCRBV15													CASSSNRGIRRDEQFF+X+TCRBJ02-01	unresolved	TCRBD02-01*02	TCRBJ02-01*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAAGGGTAGAGGACTATACCTACGAGCAGTACTTCGGGCCG	CSARRVEDYTYEQYF	In	VDJ	1	45	5.877973274814844E-4	7.423415100875963E-4	45	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	2	1	9	2	8	2	26	38	52	46	54		TCRBV20-01,TCRBV20-or09_02				01,02								CSARRVEDYTYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01	TCRBJ02-07*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTCCCTGAATGGCTAGCGGGAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	45	5.877973274814844E-4		47	TCRBV24			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	6	4	4	5	11	0	24	36	-1	47	55		TCRBV24-01,TCRBV24-or09_02				01,02								X+TCRBV24-X+TCRBJ02-03	TCRBV24	TCRBD02-01	TCRBJ02-03*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
GGACTCGGCCSTSTATSTCTGTGCCAGCAGCCCCCGAACAGGGCTGAACACTGAAGCTTTCTTTGGACAA	CASSPRTGLNTEAFF	In	VDJ	1	45	5.877973274814844E-4	7.423415100875963E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	3	3	0	6	1	18	30	42	36	43	TCRBV05,TCRBV11													CASSPRTGLNTEAFF+X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
TTTCTGTGCCAGCAGCCAAGAAAACCGCCGGGACTAGCGGGGAAGGGGGCACCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	1	45	5.877973274814844E-4		64	TCRBV21			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-02	01	1	0	3	4	9	7	4	20	42	29	49		TCRBV21-or09_02,TCRBV21-01												X+TCRBV21-X+TCRBJ02-02	TCRBV21	TCRBD02-01*01	TCRBJ02-02*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGGGGGGGGAATGAGCAGTTCTTCGGGCCA	CASRGGNEQFF	In	VDJ	1	46	6.008594903144063E-4	7.588379880895429E-4	33	TCRBV03			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	6	9	0	7	0	0	26	-1	-1	37	44		TCRBV03-01,TCRBV03-02												CASRGGNEQFF+TCRBV03-X+TCRBJ02-01	TCRBV03	TCRBD02-01*01	TCRBJ02-01*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAACAGGGACCTATGGCTACACCTTCGGTTCG	CSARTGTYGYTF	In	VDJ	1	46	6.008594903144063E-4	7.588379880895429E-4	36	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	2	3	3	4	0	2	26	-1	44	38	46		TCRBV20-01,TCRBV20-or09_02												CSARTGTYGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD01-01*01	TCRBJ01-02*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGGGGACACTGGCTACACCTTCGGTTCG	CSARGDTGYTF	In	VDJ	1	46	6.008594903144063E-4	7.588379880895429E-4	33	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	1	0	6	7	0	1	26	-1	45	39	46		TCRBV20-01,TCRBV20-or09_02												CSARGDTGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD01-01*01	TCRBJ01-02*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTGGACTAGCGGGAGAGAGTGGCGAGCAGTACTTCGGGCCG	CSAGLAGESGEQYF	In	VDJ	1	46	6.008594903144063E-4	7.588379880895429E-4	42	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	5	1	2	6	0	7	26	-1	48	35	55		TCRBV20-01,TCRBV20-or09_02												CSAGLAGESGEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01*02	TCRBJ02-07*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
CCACGTTTGGTGCCAGCCAGACCTCTGTACCTCTGTGCCAGCAGTTTATTCCCAGGTCCAAGCTCCTACGAGCAGTACTTCGGGCCG	CASSLFPGPSSYEQYF	In	VDJ	1	46	6.008594903144063E-4	7.588379880895429E-4	48				TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	1	4	4	0	3	6	33	49	56	52	62	TCRBV27,TCRBV28	TCRBV27-01,TCRBV28-01												CASSLFPGPSSYEQYF+X+TCRBJ02-07		TCRBD01-01*01	TCRBJ02-07*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGACAACAAGGCAATGGGACTAATGGCCCAGCATTTTGGTGAT	CATSDNKAMGLMAQHF	In	VDJ	1	47	6.139216531473281E-4	7.753344660914894E-4	48	TCRBV24			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-05	01	4	0	9	11	12	4	24	38	57	50	61		TCRBV24-01,TCRBV24-or09_02				01,02								CATSDNKAMGLMAQHF+TCRBV24-X+TCRBJ01-05	TCRBV24	TCRBD02-01	TCRBJ01-05*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
GCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCTAAGGAGCTTCCATTTACAAAGTCGGGCCAACGTCCTGACTTTCGGGGCC		Out	VDJ	1	47	6.139216531473281E-4		56	TCRBV03						TCRBJ02	TCRBJ02-06	01	1	3	6	5	12	5	25	41	56	53	61		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV03-X+TCRBJ02-06	TCRBV03		TCRBJ02-06*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTCACGGGAGTGCCCTACAATGAGCAGTTCTTCGGGCCA	CASSFTGVPYNEQFF	In	VDJ	1	48	6.2698381598025E-4	7.91830944093436E-4	45	TCRBV12			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	3	8	2	2	2	3	26	40	48	42	51		TCRBV12-03,TCRBV12-04												CASSFTGVPYNEQFF+TCRBV12-X+TCRBJ02-01	TCRBV12	TCRBD02-01*02	TCRBJ02-01*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGYCAGCAGCCAAACACAGGGGTACAGCTATGGCTACACCTTCGGTTCG	CXSSQTQGYSYGYTF	In	VDJ	1	48	6.2698381598025E-4	7.91830944093436E-4	45	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	2	3	2	4	2	5	26	41	50	43	55		TCRBV03-01,TCRBV03-02												CXSSQTQGYSYGYTF+TCRBV03-X+TCRBJ01-02	TCRBV03	TCRBD01-01*01	TCRBJ01-02*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
CCCAACCAGACMKCTCTKTACTTCTGTGCCAGCAGCGCCGGGACTAGCGGGTTCGCATTACGACAATAAGCAGTTCTTCGGGCCA		Out	VDJ	1	48	6.2698381598025E-4		55	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	6	0	4	11	4	17	23	34	50	38	67	TCRBV24,TCRBV27					01,02								X+X+TCRBJ02-01	unresolved	TCRBD02-01	TCRBJ02-01*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
CTCCCWMYCAGACWKCTSTTTACTTCTGTGCCAGCAGTTACCGCAGCCTCAATCAGCCCCAGCATTTTGGTGAT	CASSYRSLNQPQHF	In	VDJ	1	48	6.2698381598025E-4	7.91830944093436E-4	42	unresolved						TCRBJ01	TCRBJ01-05	01	2	4	5	3	2	3	26	41	46	43	49	TCRBV06,TCRBV24			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSYRSLNQPQHF+X+TCRBJ01-05	unresolved		TCRBJ01-05*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGCTTCAGTTCAGCGCAGGCCAATGAGCAGTTCTTCGGGCCA	CASSFSSAQANEQFF	In	VDJ	1	48	6.2698381598025E-4	7.91830944093436E-4	45	unresolved						TCRBJ02	TCRBJ02-01	01	3	4	4	6	10	1	18	32	46	42	47	TCRBV07,TCRBV11			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSFSSAQANEQFF+X+TCRBJ02-01	unresolved		TCRBJ02-01*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
AACCCAGGGACTCAGCTGTGTAYTTYTGTGCCAGCAGTGGATCAGGAAGCAATCAGCCCCAGCATTTTGGTGAT	CASSGSGSNQPQHF	In	VDJ	1	49	6.400459788131719E-4	8.083274220953826E-4	42	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	5	4	4	1	4	1	26	38	46	42	47		TCRBV12-03,TCRBV12-04												CASSGSGSNQPQHF+TCRBV12-X+TCRBJ01-05	TCRBV12	TCRBD01-01*01	TCRBJ01-05*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCCGCCCCGGGACTACGGGAACCGGGGAGCTGTTTTTTGGAGAA	CSARPGTTGTGELFF	In	VDJ	1	49	6.400459788131719E-4	8.083274220953826E-4	45	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	6	0	9	5	7	5	26	34	48	41	53		TCRBV20-01,TCRBV20-or09_02				01,02								CSARPGTTGTGELFF+TCRBV20-X+TCRBJ02-02	TCRBV20	TCRBD02-01	TCRBJ02-02*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAAATAGCGAAATTGCGAGCAGTACTTCGGGCCG		Out	VDJ	1	49	6.400459788131719E-4		38	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	2	5	6	6	2	6	26	38	45	40	51		TCRBV20-01,TCRBV20-or09_02				01,02								X+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01	TCRBJ02-07*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGTGACAGGATAACGACAGGGGAGGGGCAGTTCTTCGGGCCA	CAISDRITTGEGQFF	In	VDJ	1	49	6.400459788131719E-4	8.083274220953826E-4	45				TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	5	2	2	12	11	4	23	35	54	46	58	TCRBV06,TCRBV10	TCRBV06-08,TCRBV10-03												CAISDRITTGEGQFF+X+TCRBJ02-01		TCRBD01-01*01	TCRBJ02-01*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTAAAGACTCGGGACTAGCGATGGGTACGCAGTATTTTGGCCCA	CASSKDSGLAMGTQYF	In	VDJ	1	50	6.531081416460937E-4	8.248239000973293E-4	48	TCRBV12			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	5	0	6	8	8	5	26	38	56	46	61		TCRBV12-03,TCRBV12-04				01,02								CASSKDSGLAMGTQYF+TCRBV12-X+TCRBJ02-03	TCRBV12	TCRBD02-01	TCRBJ02-03*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGGTACGGCGAACACTGAAGCTTTCTTTGGACAA	CASSQGTANTEAFF	In	VDJ	1	50	6.531081416460937E-4	8.248239000973293E-4	42	TCRBV03						TCRBJ01	TCRBJ01-01	01	1	9	0	1	4	0	26	42	-1	46	49		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQGTANTEAFF+TCRBV03-X+TCRBJ01-01	TCRBV03		TCRBJ01-01*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
CGACTCGGCYGTGTATSTCTGTGCCAGCAGCTTAGAATTCGTGTGCGGGAGTCGGATCGCGAGCAGTACTTCGGGCCG		Out	VDJ	1	50	6.531081416460937E-4		53	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	0	7	2	6	8	8	18	35	50	43	58	TCRBV07,TCRBV11													X+X+TCRBJ02-07	unresolved	TCRBD02-01*02	TCRBJ02-07*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
GAGACWCGGCMSTGTATCTCTGYGCCAGCACCACCCCCAAAATGGATACGCAGTATTTTGGCCCA	CASTTPKMDTQYF	In	VDJ	1	50	6.531081416460937E-4	8.248239000973293E-4	39	unresolved						TCRBJ02	TCRBJ02-03	01	7	3	7	6	2	10	20	30	34	32	44	TCRBV07,TCRBV23			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASTTPKMDTQYF+X+TCRBJ02-03	unresolved		TCRBJ02-03*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
AACCCWSSSASWCAKCTGTGTAYTTKTGTGCCAGCACTCTGGGCCTCCACGGGTTCACTGAAGCTTTCTTTGGACAA	CASTLGLHGFTEAFF	In	VDJ	1	51	6.661703044790157E-4	8.413203780992758E-4	45	unresolved						TCRBJ01	TCRBJ01-01	01	12	8	0	4	9	11	26	31	44	40	55	TCRBV06,TCRBV12			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASTLGLHGFTEAFF+X+TCRBJ01-01	unresolved		TCRBJ01-01*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCACAGGGGCTCCATTTCCATTCCGACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	51	6.661703044790157E-4		52	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	5	3	2	5	0	16	26	-1	45	38	61		TCRBV03-01,TCRBV03-02												X+TCRBV03-X+TCRBJ02-01	TCRBV03	TCRBD01-01*01	TCRBJ02-01*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGTTTCGGGACAGGGACACAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	51	6.661703044790157E-4		46	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	5	0	3	2	4	1	24	37	50	41	51		TCRBV24-01,TCRBV24-or09_02												X+TCRBV24-X+TCRBJ02-03	TCRBV24	TCRBD01-01*01	TCRBJ02-03*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGACGCGGGGGGCGCCCCTCTGGTTGAGCAGTACTTCGGGCCG	CSARDAGGAPLVEQYF	In	VDJ	1	52	6.792324673119375E-4	8.578168561012224E-4	48	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	0	7	1	7	1	13	26	40	49	41	62		TCRBV20-01,TCRBV20-or09_02												CSARDAGGAPLVEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01*01	TCRBJ02-07*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTCCTGGGACAGGGTCTCGACAGCCCCAGCATTTTGGTGAT	CASSPGTGSRQPQHF	In	VDJ	1	52	6.792324673119375E-4	8.578168561012224E-4	45	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	6	0	3	7	3	6	24	36	48	39	54		TCRBV24-01,TCRBV24-or09_02												CASSPGTGSRQPQHF+TCRBV24-X+TCRBJ01-05	TCRBV24	TCRBD01-01*01	TCRBJ01-05*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCARTGGGACTAGGGAGTACGAGCAGTACTTCGGGCCG	CASXGTREYEQYF	In	VDJ	1	52	6.792324673119375E-4	8.578168561012224E-4	39	TCRBV24			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	5	1	8	4	0	4	24	-1	44	37	48		TCRBV24-01,TCRBV24-or09_02				01,02								CASXGTREYEQYF+TCRBV24-X+TCRBJ02-07	TCRBV24	TCRBD02-01	TCRBJ02-07*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
GACKCRGCCRTGTAYSTSTGTGCCAGCAGCTTCGGTTTTAGTGGAAACACCATATATTTTGGAGAG	CASSFGFSGNTIYF	In	VDJ	1	52	6.792324673119375E-4	8.578168561012224E-4	42	unresolved			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-03	01	3	5	8	3	6	0	18	32	-1	38	41	TCRBV11,TCRBV15					01,02								CASSFGFSGNTIYF+X+TCRBJ01-03	unresolved	TCRBD02-01	TCRBJ01-03*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
CAGGGACTCAGCTGTGTACTTCTGTGCCAGCAGTCGCACCACACTAGCGGGAGGCAAATACGAGCAGTACTTCGGGCCG	CASSRTTLAGGKYEQYF	In	VDJ	1	53	6.922946301448593E-4	8.74313334103169E-4	51	TCRBV12			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	5	3	1	4	8	4	22	34	54	42	58		TCRBV12-03,TCRBV12-04												CASSRTTLAGGKYEQYF+TCRBV12-X+TCRBJ02-07	TCRBV12	TCRBD02-01*02	TCRBJ02-07*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
TSRGGGACTCAGCTKTGTAYTTCTGTGCCAGCAGCCTTTCGCTGAACACTGAAGTTTTCTTTGGACAA	CASSLSLNTEVFF	In	VDJ	1	53	6.922946301448593E-4	8.74313334103169E-4	39	unresolved						TCRBJ01	TCRBJ01-01	01	4	3	6	13	10	7	23	35	48	45	55	TCRBV09,TCRBV12			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLSLNTEVFF+X+TCRBJ01-01	unresolved		TCRBJ01-01*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
AAYCMRGRGACWCAGCWSKGTATTTYTGTGCCAGCAGCGTAGGGTCAGGGTGGGCAATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	54	7.053567929777813E-4		47	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	6	4	3	2	8	3	26	37	50	45	53	TCRBV12,TCRBV21													X+X+TCRBJ01-05	unresolved	TCRBD01-01*01	TCRBJ01-05*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
AGCTCCCAGACATCTGTGTACTTCTGTGCCAGCAATTCTGACAGTTATCAGCCCCAGCATTTTGGTGAT	CASNSDSYQPQHF	In	VDJ	1	54	7.053567929777813E-4	8.908098121051156E-4	39				TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	7	2	5	5	5	2	24	34	44	39	46	TCRBV06,TCRBV10	TCRBV06-01,TCRBV06-05,TCRBV06-06,TCRBV10-03												CASNSDSYQPQHF+X+TCRBJ01-05		TCRBD01-01*01	TCRBJ01-05*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGATTCCGATCAGCCCCAGCATTTTGGTGAT	CASSQDSDQPQHF	In	VDJ	1	54	7.053567929777813E-4	8.908098121051156E-4	39	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-05	01	0	8	6	5	3	0	26	43	-1	46	48		TCRBV03-01,TCRBV03-02				01,02								CASSQDSDQPQHF+TCRBV03-X+TCRBJ01-05	TCRBV03	TCRBD02-01	TCRBJ01-05*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCTTACAGGGGTGGAGACCCAGTACTTCGGGCCA	CASSLTGVETQYF	In	VDJ	1	54	7.053567929777813E-4	8.908098121051156E-4	39	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	4	3	2	5	2	2	26	39	48	41	50		TCRBV03-01,TCRBV03-02												CASSLTGVETQYF+TCRBV03-X+TCRBJ02-05	TCRBV03	TCRBD01-01*01	TCRBJ02-05*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGATCCTTCGTCCCGGATACGCAGTATTTTGGCCCA	CSARSFVPDTQYF	In	VDJ	1	54	7.053567929777813E-4	8.908098121051156E-4	39	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	2	4	10	6	2	8	26	38	42	40	50		TCRBV20-01,TCRBV20-or09_02				01,02								CSARSFVPDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01	TCRBJ02-03*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGCGGGCGGGGAGGCGGGCCGGGAGACCCAGTACTTCGGGCCA	CASSLAGGEAGRETQYF	In	VDJ	1	54	7.053567929777813E-4	8.908098121051156E-4	51				TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	0	7	3	5	2	11	18	35	43	37	54	TCRBV07,TCRBV11	TCRBV07-02,TCRBV11-03				01,02								CASSLAGGEAGRETQYF+X+TCRBJ02-05		TCRBD02-01	TCRBJ02-05*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
AAGARGACTCRGCYSYSTATCTCTGYGCCAGCAGCCAAGGCCAGGGGGGGGGCACAGATACGCAGTATTTTGGCCCA	CASSQGQGGGTDTQYF	In	VDJ	1	54	7.053567929777813E-4	8.908098121051156E-4	48	unresolved						TCRBJ02	TCRBJ02-03	01	4	4	1	1	6	3	19	31	44	37	47	TCRBV01,TCRBV05			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQGQGGGTDTQYF+X+TCRBJ02-03	unresolved		TCRBJ02-03*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTCATTTCGCCGGGACTAGCGGGAGTCGAGCAGTTCTTCGGGCCA	CASSFISPGLAGVEQFF	In	VDJ	1	55	7.184189558107031E-4	9.073062901070622E-4	51	TCRBV24			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	6	0	2	10	11	2	24	36	61	47	63		TCRBV24-01,TCRBV24-or09_02												CASSFISPGLAGVEQFF+TCRBV24-X+TCRBJ02-01	TCRBV24	TCRBD02-01*02	TCRBJ02-01*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCGGGGTGACCATCCGCGGAGTGAGCAGTTCTTCGGGCCA		Out	VDJ	1	56	7.314811186436251E-4		41	TCRBV03						TCRBJ02	TCRBJ02-01	01	8	6	2	9	0	15	26	-1	39	35	54		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV03-X+TCRBJ02-01	TCRBV03		TCRBJ02-01*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTCCAGTAGGATACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	56	7.314811186436251E-4		34	TCRBV20						TCRBJ01	TCRBJ01-01	01	5	1	8	5	6	1	26	35	44	41	45		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV20-X+TCRBJ01-01	TCRBV20		TCRBJ01-01*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGCCCAGGACCAGGGACGGGAGTAGCCAAAAACATTCAGTACTTCGGCGCC	CASSPGPGTGVAKNIQYF	In	VDJ	1	57	7.445432814765469E-4	9.402992461109553E-4	54	TCRBV12			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-04	01	6	8	2	0	14	1	26	37	57	51	58		TCRBV12-03,TCRBV12-04,TCRBV12-05												CASSPGPGTGVAKNIQYF+TCRBV12-X+TCRBJ02-04	TCRBV12	TCRBD02-01*02	TCRBJ02-04*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
AACYSRGGGACTCAGCTKTGTATTTYTGTGCCAGCAGCGGACTGACCTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASSGLTSGANVLTF	In	VDJ	1	57	7.445432814765469E-4	9.402992461109553E-4	45	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-06	01	6	1	10	0	1	3	26	37	43	38	46	TCRBV09,TCRBV12					01,02								CASSGLTSGANVLTF+X+TCRBJ02-06	unresolved	TCRBD02-01	TCRBJ02-06*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGGACGTGGGACTAGCGGGACGGGTGAGCAGTTCTTCGGGCCA	CSGRGTSGTGEQFF	In	VDJ	1	57	7.445432814765469E-4	9.402992461109553E-4	42	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	7	0	3	9	5	4	26	33	51	38	55		TCRBV20-01,TCRBV20-or09_02												CSGRGTSGTGEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01*02	TCRBJ02-01*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGTCGGGGAAGCTTTCTTTGGACAA	CASSQVGEAFF	In	VDJ	1	58	7.576054443094687E-4	9.567957241129019E-4	33	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	1	8	4	8	1	0	26	42	-1	43	47		TCRBV03-01,TCRBV03-02				01,02								CASSQVGEAFF+TCRBV03-X+TCRBJ01-01	TCRBV03	TCRBD02-01	TCRBJ01-01*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCGCGAGGCGGAGCGGCTATGGCTACACCTTCGGTTCG	CAARRSGYGYTF	In	VDJ	1	58	7.576054443094687E-4	9.567957241129019E-4	36	TCRBV24			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	12	6	5	4	9	0	24	30	-1	39	44		TCRBV24-01,TCRBV24-or09_02				01,02								CAARRSGYGYTF+TCRBV24-X+TCRBJ01-02	TCRBV24	TCRBD02-01	TCRBJ01-02*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCCCCGGGACTAGCGGGGACCTGGGGCATGAGCAGTTCTTCGGGCCA	CSAPGTSGDLGHEQFF	In	VDJ	1	59	7.706676071423907E-4	9.732922021148485E-4	48	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	6	0	3	8	4	9	26	34	51	38	60		TCRBV20-01,TCRBV20-or09_02												CSAPGTSGDLGHEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01*01	TCRBJ02-01*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
CAGGGACTCAGCTGTGTACTTCTGTGCCAGCAACGGGGGAATCATGAACACTGAAGCTTTCTTTGGACAA	CASNGGIMNTEAFF	In	VDJ	1	59	7.706676071423907E-4	9.732922021148485E-4	42	TCRBV12			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	7	8	2	0	1	5	22	32	39	33	44		TCRBV12-03,TCRBV12-04												CASNGGIMNTEAFF+TCRBV12-X+TCRBJ01-01	TCRBV12	TCRBD02-01*01	TCRBJ01-01*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
GCTTCTACATCTGCAGTGCTAGAGTAGCAGCGGGAGGGAATTCCGGGTTGAGTTTTCCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	1	59	7.706676071423907E-4		62	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	1	6	0	6	4	18	11	24	38	28	56		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ02-02	TCRBV20	TCRBD02-01*02	TCRBJ02-02*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCAGTTGCCTTCCCATCCGACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	60	7.837297699753125E-4		46	TCRBV03						TCRBJ02	TCRBJ02-01	01	5	4	6	5	11	4	26	38	51	49	55		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV03-X+TCRBJ02-01	TCRBV03		TCRBJ02-01*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCATCGGGATCTCGAACACCGGGGAGCTGTTTTTTGGAGAA	CASIGISNTGELFF	In	VDJ	1	60	7.837297699753125E-4	9.89788680116795E-4	42	TCRBV03			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	7	8	3	0	1	3	26	36	42	37	45		TCRBV03-01,TCRBV03-02												CASIGISNTGELFF+TCRBV03-X+TCRBJ02-02	TCRBV03	TCRBD02-01*02	TCRBJ02-02*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGAACTTGGACAGGGGGTTTGTTCGCGCCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	60	7.837297699753125E-4		53	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	7	1	1	2	5	10	24	35	50	40	60		TCRBV24-01,TCRBV24-or09_02												X+TCRBV24-X+TCRBJ02-07	TCRBV24	TCRBD01-01*01	TCRBJ02-07*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTCCCCCGGGACTAGCGAAACCTACGAGCAGTACTTCGGGCCG	CASSSPGTSETYEQYF	In	VDJ	1	60	7.837297699753125E-4	9.89788680116795E-4	48	TCRBV24			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	6	0	6	2	6	3	24	36	52	42	55		TCRBV24-01,TCRBV24-or09_02				01,02								CASSSPGTSETYEQYF+TCRBV24-X+TCRBJ02-07	TCRBV24	TCRBD02-01	TCRBJ02-07*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGCTTGGACAGGCAACCCACCGGGGAGCTGTTTTTTGGAGAA	CASSLDRQPTGELFF	In	VDJ	1	60	7.837297699753125E-4	9.89788680116795E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	3	1	4	4	0	5	18	-1	39	32	44	TCRBV07,TCRBV11													CASSLDRQPTGELFF+X+TCRBJ02-02	unresolved	TCRBD01-01*01	TCRBJ02-02*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCCCAGGTAGCGGAGCTCGAGCACCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	1	61	7.967919328082343E-4		47	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	6	5	5	4	6	8	26	34	46	40	54		TCRBV20-01,TCRBV20-or09_02				01,02								X+TCRBV20-X+TCRBJ02-02	TCRBV20	TCRBD02-01	TCRBJ02-02*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCAGGAAAACGCCCCGGGGACTGAAGCTTTCTTTGGACAA	CASSQENAPGTEAFF	In	VDJ	1	61	7.967919328082343E-4	0.0010062851581187416	45	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	3	8	3	5	11	0	23	37	-1	48	53	TCRBV01,TCRBV04													CASSQENAPGTEAFF+X+TCRBJ01-01	unresolved	TCRBD02-01*01	TCRBJ01-01*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAGTCGAAGGGAGGGGAGACCCAGTACTTCGGGCCA	CASSQSKGGETQYF	In	VDJ	1	62	8.098540956411563E-4	0.0010227816361206882	42	TCRBV03			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	3	9	0	5	6	0	26	40	-1	46	53		TCRBV03-01,TCRBV03-02												CASSQSKGGETQYF+TCRBV03-X+TCRBJ02-05	TCRBV03	TCRBD02-01*02	TCRBJ02-05*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTACGAATACTGGCCGTACCACTGAAGCTTTCTTTGGACAA	CSATNTGRTTEAFF	In	VDJ	1	62	8.098540956411563E-4	0.0010227816361206882	42	TCRBV20						TCRBJ01	TCRBJ01-01	01	4	9	0	4	8	5	26	36	47	44	52		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSATNTGRTTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20		TCRBJ01-01*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTCCGGGGGCGCTTCCCTATGGCTACACCTTCGGTTCG	CASSPGALPYGYTF	In	VDJ	1	62	8.098540956411563E-4	0.0010227816361206882	42	TCRBV24						TCRBJ01	TCRBJ01-02	01	6	6	0	4	2	6	24	36	44	38	50		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSPGALPYGYTF+TCRBV24-X+TCRBJ01-02	TCRBV24		TCRBJ01-02*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
TYRGGRGACWCAGCWYKGTATTTCTGTGCCAGCAGCGTAGAGACAGATACGCAGTATTTTGGCCCA	CASSVETDTQYF	In	VDJ	1	62	8.098540956411563E-4	0.0010227816361206882	36	unresolved			unresolved			TCRBJ02	TCRBJ02-03	01	5	5	8	3	1	2	24	36	40	37	42	TCRBV09,TCRBV21			TCRBD01,TCRBD02										CASSVETDTQYF+X+TCRBJ02-03	unresolved	unresolved	TCRBJ02-03*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
TYRGRRGACWCAGCMMKGTAYTTCTGTGCCAGCATTGGGACAGGGGGCGCTGAAGCTTTCTTTGGACAA	CASIGTGGAEAFF	In	VDJ	1	62	8.098540956411563E-4	0.0010227816361206882	39	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	7	0	0	6	2	1	23	33	47	35	48	TCRBV02,TCRBV21													CASIGTGGAEAFF+X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGCCTGTAGCGGAGAACACCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	1	63	8.229162584740781E-4		44	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	5	5	5	1	3	1	18	30	39	33	40	TCRBV07,TCRBV11					01,02								X+X+TCRBJ02-02	unresolved	TCRBD02-01	TCRBJ02-02*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
TATTTTTGTGCCAGCAGTTACGCTCGACTAGCGGGAGCAGTCCCCATTGGCACAGATACGCAGTATTTTGGCCCA	CASSYARLAGAVPIGTDTQYF	In	VDJ	1	63	8.229162584740781E-4	0.0010392781141226348	63	TCRBV12			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	4	2	2	1	6	12	6	19	37	25	49		TCRBV12-03,TCRBV12-04												CASSYARLAGAVPIGTDTQYF+TCRBV12-X+TCRBJ02-03	TCRBV12	TCRBD02-01*02	TCRBJ02-03*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTATCAGGGTGTTGGGGCGGGAGTATTTCAAGAGACCCAGTACTTCGGGCCA	CASSYQGVGAGVFQETQYF	In	VDJ	1	64	8.35978421307E-4	0.0010557745921245813	57	TCRBV24			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	6	7	2	2	15	5	24	36	58	51	63		TCRBV24-01,TCRBV24-or09_02												CASSYQGVGAGVFQETQYF+TCRBV24-X+TCRBJ02-05	TCRBV24	TCRBD02-01*02	TCRBJ02-05*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
AAYCMRGRGACWCAGCWSKGTATTTYTGTGCCAGCAGCGTACAGAGCCARGGAAGGAACACTGAAGCTTTCTTTGGACAA	CASSVQSQGRNTEAFF	In	VDJ	1	66	8.621027469728437E-4	0.0010887675481284745	48	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	4	3	1	10	3	26	37	52	47	55	TCRBV12,TCRBV21													CASSVQSQGRNTEAFF+X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCACAAGACAGAAGAACACTGAAGCTTTCTTTGGACAA	CSATRQKNTEAFF	In	VDJ	1	66	8.621027469728437E-4	0.0010887675481284745	39	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	2	5	1	5	2	26	34	44	39	46		TCRBV20-01,TCRBV20-or09_02												CSATRQKNTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD01-01*01	TCRBJ01-01*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGTCGATGGGAACGGGGAGCTGTTTTTTGGAGAA	CSARVDGNGELFF	In	VDJ	1	66	8.621027469728437E-4	0.0010887675481284745	39	TCRBV20						TCRBJ02	TCRBJ02-02	01	1	0	8	7	5	1	26	39	48	44	49		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSARVDGNGELFF+TCRBV20-X+TCRBJ02-02	TCRBV20		TCRBJ02-02*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGCCTTAGCGGGAGTGCCTACGAGCAGTACTTCGGGCCG	CASSLSGSAYEQYF	In	VDJ	1	68	8.882270726386875E-4	0.0011217605041323677	42	TCRBV24			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	7	5	2	2	3	2	24	35	47	38	49		TCRBV24-01,TCRBV24-or09_02												CASSLSGSAYEQYF+TCRBV24-X+TCRBJ02-07	TCRBV24	TCRBD02-01*02	TCRBJ02-07*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
GACKCRGCCRTGTAYSTSTGTGCCAGCAGCTGGAGAGGTAGGACAGAGCCATACAGTACTTCGGCGCC		Out	VDJ	1	68	8.882270726386875E-4		44	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-04	01	4	1	5	13	9	7	18	31	46	40	53	TCRBV11,TCRBV15													X+X+TCRBJ02-04	unresolved	TCRBD01-01*01	TCRBJ02-04*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGTCTGGGGCTAGCGGGAGTTAGATCTCTCTTCGGGCCA	CASSLGLAGVRSLF	In	VDJ	1	69	9.012892354716094E-4	0.0011382569821343142	42	TCRBV03			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	6	4	2	17	7	9	26	37	54	44	63		TCRBV03-01,TCRBV03-02												CASSLGLAGVRSLF+TCRBV03-X+TCRBJ02-01	TCRBV03	TCRBD02-01*02	TCRBJ02-01*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCCGGGGGCCCAGACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	70	9.143513983045313E-4		37	TCRBV20						TCRBJ02	TCRBJ02-01	01	6	6	0	5	2	4	26	34	42	36	46		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV20-X+TCRBJ02-01	TCRBV20		TCRBJ02-01*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGGTAGGGGTTTACTAGCGGAGGAGCACAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	70	9.143513983045313E-4		53	TCRBV24			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	7	3	5	0	10	3	24	35	53	45	56		TCRBV24-01,TCRBV24-or09_02				01,02								X+TCRBV24-X+TCRBJ02-03	TCRBV24	TCRBD02-01	TCRBJ02-03*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
TSRGGGACTCAGCTKTGTAYTTCTGTGCCAGCAGCGTAGGGACAGGGTGGAGTGGAGAGCAGTTCTTCGGGCCA	CASSVGTGWSGEQFF	In	VDJ	1	70	9.143513983045313E-4	0.0011547534601362608	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	0	1	3	10	0	9	23	-1	47	39	56	TCRBV09,TCRBV12													CASSVGTGWSGEQFF+X+TCRBJ02-01	unresolved	TCRBD01-01*01	TCRBJ02-01*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
TCMRGRGACWCAGCWSKGTAYTTCTGTGCCAGCATCTCGGGGACAGTGAACACTGAAGCTTTCTTTGGACAA	CASISGTVNTEAFF	In	VDJ	1	71	9.274135611374531E-4	0.0011712499381382076	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	7	0	5	0	5	0	22	32	-1	37	44	TCRBV12,TCRBV21													CASISGTVNTEAFF+X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTATCGATCCTCCGGCGTCCTGGTGCCGACCGTGAAGCTTTCTTTGGACAA	CASSLSILRRPGADREAFF	In	VDJ	1	72	9.40475723970375E-4	0.0011877464161401542	57	TCRBV24						TCRBJ01	TCRBJ01-01	01	6	2	7	7	27	2	24	36	66	63	68		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLSILRRPGADREAFF+TCRBV24-X+TCRBJ01-01	TCRBV24		TCRBJ01-01*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
AACCCAGGGACTCAGCYRTGTATYKYTGTGCCAGCAGCCAAGGYCCTAGCCTAGTTCACGAGCAGTACTTCGGGCCG	CASSQGPSLVHEQYF	In	VDJ	1	73	9.535378868032969E-4	0.0012042428941421008	45	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	6	4	7	5	8	7	26	37	50	45	57	TCRBV07,TCRBV12					01,02								CASSQGPSLVHEQYF+X+TCRBJ02-07	unresolved	TCRBD02-01	TCRBJ02-07*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAAGGGGACAGGGGTTGCTGGGGAGCTGTTTTTTGGAGAA	CATKGTGVAGELFF	In	VDJ	1	73	9.535378868032969E-4	0.0012042428941421008	42	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	8	0	2	8	2	5	24	34	46	36	51		TCRBV24-01,TCRBV24-or09_02												CATKGTGVAGELFF+TCRBV24-X+TCRBJ02-02	TCRBV24	TCRBD01-01*01	TCRBJ02-02*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGCTTAATAGCGGGAGCTGAAGAGCAGTACTTCGGGCCG	CASSLIAGAEEQYF	In	VDJ	1	74	9.666000496362187E-4	0.0012207393721440473	42	TCRBV12			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	2	5	2	7	1	5	26	41	51	42	56		TCRBV12-03,TCRBV12-04												CASSLIAGAEEQYF+TCRBV12-X+TCRBJ02-07	TCRBV12	TCRBD02-01*02	TCRBJ02-07*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGGTGGACGGGGAGGATTGAAGCTTTCTTTGGACAA	CSARWTGRIEAFF	In	VDJ	1	74	9.666000496362187E-4	0.0012207393721440473	39	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	3	9	1	7	7	2	26	37	50	44	52		TCRBV20-01,TCRBV20-or09_02												CSARWTGRIEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD02-01*02	TCRBJ01-01*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
GGACTCGGCCSTSTATSTCTGTGCCAGCAGCCAAGGAGACAGCTTCTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASSQGDSFSGANVLTF	In	VDJ	1	74	9.666000496362187E-4	0.0012207393721440473	51	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	4	2	5	0	6	3	19	31	42	37	45	TCRBV05,TCRBV11													CASSQGDSFSGANVLTF+X+TCRBJ02-06	unresolved	TCRBD01-01*01	TCRBJ02-06*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCAACGACGACAGGGGGCCTCCAAGAGACCCAGTACTTCGGGCCA	CSATTTGGLQETQYF	In	VDJ	1	75	9.796622124691407E-4	0.001237235850145994	45	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	6	2	0	1	6	2	26	34	50	40	52		TCRBV20-01,TCRBV20-or09_02												CSATTTGGLQETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD01-01*01	TCRBJ02-05*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTGATCCCGGGACTAGCGGGAGGAGAGGTGAGCAGTTCTTCGGGCCA	CSADPGTSGRRGEQFF	In	VDJ	1	76	9.927243753020626E-4	0.0012537323281479405	48	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	5	0	1	9	6	5	26	35	56	41	61		TCRBV20-01,TCRBV20-or09_02												CSADPGTSGRRGEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01*02	TCRBJ02-01*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGAACAGCTTGGCTACTACGAGCAGTACTTCGGGCCG	CASSEQLGYYEQYF	In	VDJ	1	76	9.927243753020626E-4	0.0012537323281479405	42	TCRBV06						TCRBJ02	TCRBJ02-07	01	2	4	5	3	0	8	23	-1	41	38	49		TCRBV06-01,TCRBV06-08		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSEQLGYYEQYF+TCRBV06-X+TCRBJ02-07	TCRBV06		TCRBJ02-07*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATCCTGAAAGCGGGAGGGCCATCGAAGAGACCCAGTACTTCGGGCCA	CSARDPESGRAIEETQYF	In	VDJ	1	77	0.0010057865381349843	0.001270228806149887	54	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	0	6	0	3	7	6	26	40	57	47	63		TCRBV20-01,TCRBV20-or09_02												CSARDPESGRAIEETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD02-01*02	TCRBJ02-05*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGGCCAGCTAGCGGGAGAAGGGGATACGAGCAGTACTTCGGGCCG	CSARPASGRRGYEQYF	In	VDJ	1	77	0.0010057865381349843	0.001270228806149887	48	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	3	4	2	4	5	7	26	37	52	42	59		TCRBV20-01,TCRBV20-or09_02												CSARPASGRRGYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01*02	TCRBJ02-07*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTATTAGCGGGACAGTATGAGCAGTTCTTCGGGCCA	CASSLLAGQYEQFF	In	VDJ	1	78	0.0010188487009679063	0.0012867252841518336	42	TCRBV24			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	6	5	3	8	4	4	24	36	48	40	52		TCRBV24-01,TCRBV24-or09_02												CASSLLAGQYEQFF+TCRBV24-X+TCRBJ02-01	TCRBV24	TCRBD02-01*02	TCRBJ02-01*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
GGACTCRGCCRTGTATSKCTGTGCCAGAAGCAGAAACTGAGTAGACAAAGTCGGGCCAACGTCCTGACTTTCGGGGCC		Out	VDJ	1	79	0.0010319108638008282		53	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	4	2	6	5	12	5	18	30	46	42	51	TCRBV05,TCRBV07,TCRBV11													X+X+TCRBJ02-06	unresolved	TCRBD01-01*01	TCRBJ02-06*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
GGACTCGGCCSTGTATCTCTGTGCCAGCAGCTCCTTTCGGGAGAGCTACGAGCAGTACTTCGGGCCG	CASSSFRESYEQYF	In	VDJ	1	80	0.00104497302663375	0.0013197182401557268	42	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	3	8	2	3	5	2	19	32	43	37	45	TCRBV05,TCRBV07													CASSSFRESYEQYF+X+TCRBJ02-07	unresolved	TCRBD02-01*02	TCRBJ02-07*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGAATTACCGGGACAGGGCACAGATACGCAGTATTTTGGCCCA	CASSELPGQGTDTQYF	In	VDJ	1	81	0.0010580351894666719	0.0013362147181576734	48	TCRBV06			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	2	0	4	1	5	0	23	38	-1	43	51		TCRBV06-01,TCRBV06-08												CASSELPGQGTDTQYF+TCRBV06-X+TCRBJ02-03	TCRBV06	TCRBD01-01*01	TCRBJ02-03*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGCTTAAATTTCGGGGACAGGGACACTGAAGCTTTCTTTGGACAA	CASSLNFGDRDTEAFF	In	VDJ	1	81	0.0010580351894666719	0.0013362147181576734	48	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	2	0	3	3	7	0	18	33	-1	40	49	TCRBV07,TCRBV11													CASSLNFGDRDTEAFF+X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTCGGACAGCGGGAGGGCCAGGTGAGCAGTTCTTCGGGCCA	CSARTAGGPGEQFF	In	VDJ	1	82	0.0010710973522995938	0.00135271119615962	42	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	5	6	0	9	5	5	26	35	50	40	55		TCRBV20-01,TCRBV20-or09_02												CSARTAGGPGEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01*02	TCRBJ02-01*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
TYRGGRGACWCAGCWYKGTATTTCTGTGCCAGCACCCAACTCGCGGGGAGCGGGAGGGCCGGGGAGCTGTTTTTTGGAGAA	CASTQLAGSGRAGELFF	In	VDJ	1	82	0.0010710973522995938	0.00135271119615962	51	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	10	6	0	6	17	0	24	31	-1	48	58	TCRBV09,TCRBV21													CASTQLAGSGRAGELFF+X+TCRBJ02-02	unresolved	TCRBD02-01*02	TCRBJ02-02*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
TCMRGRGACWCAGCWSKGTAYTTCTGTGCCAGCAGCGAAAATTGGGGTTACAATGAAAAACTGTTTTTTGGCAGT	CASSENWGYNEKLFF	In	VDJ	1	83	0.0010841595151325155	0.0013692076741615665	45	unresolved						TCRBJ01	TCRBJ01-04	01	5	6	2	5	7	4	24	36	47	43	51	TCRBV12,TCRBV21			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSENWGYNEKLFF+X+TCRBJ01-04	unresolved		TCRBJ01-04*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGTCCCTGCTCTCTGGAAACACCATATATTTTGGAGAG		Out	VDJ	1	84	0.0010972216779654375		41	TCRBV03						TCRBJ01	TCRBJ01-03	01	6	10	0	0	5	1	26	37	44	42	45		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV03-X+TCRBJ01-03	TCRBV03		TCRBJ01-03*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCGTCACTATAGCGGGTTCGAGACCAAGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	84	0.0010972216779654375		49	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	6	5	4	0	8	6	26	34	49	42	55		TCRBV20-01,TCRBV20-or09_02				01,02								X+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD02-01	TCRBJ02-05*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGGGCCCATACTAGCGCAGGGCAGTTCTTCGGGCCA	CSARAHTSAGQFF	In	VDJ	1	85	0.0011102838407983594	0.0014022006301654597	39	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	3	3	6	12	7	4	26	37	51	44	55		TCRBV20-01,TCRBV20-or09_02				01,02								CSARAHTSAGQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01	TCRBJ02-01*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAAGGGGGCAAGAGACCCAGTACTTCGGGCCA	CASSQRGQETQYF	In	VDJ	1	86	0.0011233460036312814	0.0014186971081674063	39	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	2	5	1	2	0	0	26	-1	-1	41	47		TCRBV03-01,TCRBV03-02												CASSQRGQETQYF+TCRBV03-X+TCRBJ02-05	TCRBV03	TCRBD01-01*01	TCRBJ02-05*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGTGGCGGCCGAGCAGTACTTCGGGCCG	CASSQVAAEQYF	In	VDJ	1	87	0.001136408166464203	0.0014351935861693528	36	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	1	7	5	6	2	1	26	42	48	44	49		TCRBV03-01,TCRBV03-02				01,02								CASSQVAAEQYF+TCRBV03-X+TCRBJ02-07	TCRBV03	TCRBD02-01	TCRBJ02-07*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
CRRRRGACTCAGCCSTGTATCTCTRCGCCAGCAGCCAGAGGGCCAAAGGGGTAGACATTCAGTACTTCGGCGCC	XASSQRAKGVDIQYF	In	VDJ	1	87	0.001136408166464203	0.0014351935861693528	45	unresolved						TCRBJ02	TCRBJ02-04	01	3	5	2	8	9	3	22	36	50	45	53	TCRBV04,TCRBV07,TCRBV17			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									XASSQRAKGVDIQYF+X+TCRBJ02-04	unresolved		TCRBJ02-04*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGGGACAGGGACACTGAAGCTTTCTTTGGACAA	CSARDRDTEAFF	In	VDJ	1	95	0.0012409054691275782	0.0015671654101849254	36	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	1	3	3	0	0	26	-1	-1	37	45		TCRBV20-01,TCRBV20-or09_02												CSARDRDTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD01-01*01	TCRBJ01-01*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGTGGGGGTGGAAACACCATATATTTTGGAGAG	CASSGGGNTIYF	In	VDJ	1	97	0.0012670297947934219	0.0016001583661888186	36	TCRBV03						TCRBJ01	TCRBJ01-03	01	6	6	1	3	1	0	26	37	-1	38	43		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSGGGNTIYF+TCRBV03-X+TCRBJ01-03	TCRBV03		TCRBJ01-03*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
CCCWMCCAGACAKCTSTKTACTTSTGTGCCAGCAGAGGAGCCGAGGTAAGGACAGCAAATCAGCCCCAGCATTTTGGTGAT	CASRGAEVRTANQPQHF	In	VDJ	1	101	0.0013192784461251094	0.0016661442781966051	51	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	6	1	5	4	14	2	23	34	54	48	56	TCRBV06,TCRBV24													CASRGAEVRTANQPQHF+X+TCRBJ01-05	unresolved	TCRBD01-01*01	TCRBJ01-05*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTGGACGACAGGGGAAGGCAGATACGCAGTATTTTGGCCCA	CSAGRQGKADTQYF	In	VDJ	1	102	0.0013323406089580314	0.0016826407561985517	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	5	2	2	4	4	4	26	35	47	39	51		TCRBV20-01,TCRBV20-or09_02												CSAGRQGKADTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD01-01*01	TCRBJ02-03*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGCCTGGGACAGCTCCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	102	0.0013323406089580314		40	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	7	0	5	0	3	0	24	35	-1	38	45		TCRBV24-01,TCRBV24-or09_02												X+TCRBV24-X+TCRBJ02-07	TCRBV24	TCRBD01-01*01	TCRBJ02-07*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
GGACTCGGCCSTSTATSTCTGTGCCAGCAGGGGGACTAGCGGGGACACCGGGGAGCTGTTTTTTGGAGAA	CASRGTSGDTGELFF	In	VDJ	1	103	0.001345402771790953	0.0016991372342004983	45	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-02	01	6	0	3	3	1	0	18	29	-1	30	43	TCRBV05,TCRBV11													CASRGTSGDTGELFF+X+TCRBJ02-02	unresolved	TCRBD02-01*01	TCRBJ02-02*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATCAACTGATGGGGGAAAATCAGCCCCAGCATTTTGGTGAT	CSARDQLMGENQPQHF	In	VDJ	1	105	0.001371527097456797	0.0017321301902043914	48	TCRBV20						TCRBJ01	TCRBJ01-05	01	0	6	1	4	9	2	26	40	54	49	56		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSARDQLMGENQPQHF+TCRBV20-X+TCRBJ01-05	TCRBV20		TCRBJ01-05*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATCCCCGTACAGGGTTTTACTACAATGAGCAGTTCTTCGGGCCA	CSARDPRTGFYYNEQFF	In	VDJ	1	106	0.0013845892602897187	0.001748626668206338	51	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	0	3	3	3	7	5	26	40	53	47	58		TCRBV20-01,TCRBV20-or09_02												CSARDPRTGFYYNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD01-01*01	TCRBJ02-01*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTCTACTACAGGGACCACCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASSLLQGPPGANVLTF	In	VDJ	1	107	0.0013976514231226406	0.0017651231462082846	51	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	5	3	3	2	5	5	26	38	49	43	54		TCRBV12-03,TCRBV12-04												CASSLLQGPPGANVLTF+TCRBV12-X+TCRBJ02-06	TCRBV12	TCRBD01-01*01	TCRBJ02-06*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTGACCAGGGTCTGGGAAACACCATATATTTTGGAGAG	CSADQGLGNTIYF	In	VDJ	1	107	0.0013976514231226406	0.0017651231462082846	39	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	5	4	3	4	3	4	26	35	43	38	47		TCRBV20-01,TCRBV20-or09_02												CSADQGLGNTIYF+TCRBV20-X+TCRBJ01-03	TCRBV20	TCRBD01-01*01	TCRBJ01-03*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCAGCAGTCTGGGCAGGGATCAGCCCCAGCATTTTGGTGAT	CASSLGRDQPQHF	In	VDJ	1	107	0.0013976514231226406	0.0017651231462082846	39	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	5	4	3	5	5	0	23	35	-1	40	45	TCRBV06,TCRBV10													CASSLGRDQPQHF+X+TCRBJ01-05	unresolved	TCRBD01-01*01	TCRBJ01-05*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTATAAAGCGGTTGAAAGGGACGTCACCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	1	109	0.0014237757487884843		50	TCRBV20						TCRBJ02	TCRBJ02-02	01	4	0	7	4	14	2	26	36	55	50	57		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV20-X+TCRBJ02-02	TCRBV20		TCRBJ02-02*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
TYRGGRGACWCAGCWYKGTATTTCTGTGCCAGCAGCGTAAGCGGGGAGGGGGAGACCCAGTACTTCGGGCCA	CASSVSGEGETQYF	In	VDJ	1	111	0.0014499000744543282	0.0018311090582160709	42	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	1	6	3	5	0	5	23	-1	45	38	50	TCRBV09,TCRBV21					01,02								CASSVSGEGETQYF+X+TCRBJ02-05	unresolved	TCRBD02-01	TCRBJ02-05*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
AACYSRGGGACTCAGCTKTGTATTTYTGTGCCAGCACCAATCTAGCGGGGTCCTACAATGAGCAGTTCTTCGGGCCA	CASTNLAGSYNEQFF	In	VDJ	1	117	0.0015282730514518594	0.0019300879262277503	45	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	12	4	3	1	10	0	26	31	-1	41	50	TCRBV09,TCRBV12													CASTNLAGSYNEQFF+X+TCRBJ02-01	unresolved	TCRBD02-01*01	TCRBJ02-01*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCGTTTGGGGCAACTAATGAAAAACTGTTTTTTGGCAGT		Out	VDJ	1	117	0.0015282730514518594		40	TCRBV03						TCRBJ01	TCRBJ01-04	01	8	6	2	0	4	0	26	35	-1	39	43		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV03-X+TCRBJ01-04	TCRBV03		TCRBJ01-04*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGACCGCGGACTAGCGGGAATGGACAATGAGCAGTTCTTCGGGCCA	CSARDRGLAGMDNEQFF	In	VDJ	2	119	0.001554397377117703	0.0019630808822316435	51	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	0	1	3	5	4	4	26	40	56	44	60		TCRBV20-01,TCRBV20-or09_02												CSARDRGLAGMDNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01*02	TCRBJ02-01*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCGCATCCATTCCGACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	2	124	0.0016197081912823126		41	TCRBV03						TCRBJ02	TCRBJ02-01	01	5	4	6	5	1	9	26	38	41	39	50		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV03-X+TCRBJ02-01	TCRBV03		TCRBJ02-01*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTCTCAAGCGGGGGGAGACCCAGTACTTCGGGCCA	CSLKRGETQYF	In	VDJ	2	125	0.0016327703541152345	0.002062059750243323	33	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	8	6	2	5	4	0	26	32	-1	36	44		TCRBV20-01,TCRBV20-or09_02												CSLKRGETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD02-01*01	TCRBJ02-05*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
TYRGGRGACWCAGCWYKGTATTTCTGTGCCAGCAGCGACTGTTTCTTGTGGGAATGAGCAGTTCTTCGGGCCA		Out	VDJ	2	125	0.0016327703541152345		43	unresolved			unresolved			TCRBJ02	TCRBJ02-01	01	5	2	10	7	0	12	24	-1	40	36	52	TCRBV09,TCRBV21			TCRBD01,TCRBD02										X+X+TCRBJ02-01	unresolved	unresolved	TCRBJ02-01*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATACGAGGGAGGCTCAGTACTTCGGCGCC	CSARDTREAQYF	In	VDJ	2	128	0.001671956842614	0.0021115491842491627	36	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-04	01	0	9	1	12	5	1	26	40	51	45	52		TCRBV20-01,TCRBV20-or09_02												CSARDTREAQYF+TCRBV20-X+TCRBJ02-04	TCRBV20	TCRBD02-01*02	TCRBJ02-04*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGTTCGAGGGGGGACAACACCTACGAGCAGTACTTCGGGCCG	CASSRGDNTYEQYF	In	VDJ	2	128	0.001671956842614	0.0021115491842491627	42	TCRBV24						TCRBJ02	TCRBJ02-07	01	11	0	6	2	9	3	24	31	46	40	49		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSRGDNTYEQYF+TCRBV24-X+TCRBJ02-07	TCRBV24		TCRBJ02-07*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCAAGAAGGGGTCGGCGGGATGAGCACAGATACGCAGTATTTTGGCCCA	CASSQEGVGGMSTDTQYF	In	VDJ	2	131	0.0017111433311127657	0.0021610386182550024	54				TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	0	7	3	0	8	2	18	35	49	43	51	TCRBV04,TCRBV11	TCRBV04-02,TCRBV11-03												CASSQEGVGGMSTDTQYF+X+TCRBJ02-03		TCRBD02-01*02	TCRBJ02-03*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCCCCCCGGGATAACTAATGAAAAACTGTTTTTTGGCAGT	CASSPPGITNEKLFF	In	VDJ	2	134	0.0017503298196115313	0.002210528052260842	45	TCRBV03			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-04	01	4	8	3	1	4	1	26	39	48	43	49		TCRBV03-01,TCRBV03-02												CASSPPGITNEKLFF+TCRBV03-X+TCRBJ01-04	TCRBV03	TCRBD02-01*02	TCRBJ01-04*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
GGACTCGGCCSTSTATSTCTGTGCCAGCAGCCTTTACTTCACTAGCGGGGAGATGCAGTTCTTCGGGCCA	CASSLYFTSGEMQFF	In	VDJ	2	141	0.0018417649594419845	0.002326003398274468	45	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	5	3	3	12	9	4	18	30	49	39	53	TCRBV05,TCRBV11													CASSLYFTSGEMQFF+X+TCRBJ02-01	unresolved	TCRBD02-01*01	TCRBJ02-01*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCAGCAGTGAGGGGGACCCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASSEGDPGANVLTF	In	VDJ	2	144	0.00188095144794075	0.0023754928322803084	45	unresolved			unresolved			TCRBJ02	TCRBJ02-06	01	5	5	1	2	1	3	23	35	42	36	45	TCRBV06,TCRBV10			TCRBD01,TCRBD02										CASSEGDPGANVLTF+X+TCRBJ02-06	unresolved	unresolved	TCRBJ02-06*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTCACCCGGACAGTTTCAGCGCGAGCAGTACTTCGGGCCG	CASSSPGQFQREQYF	In	VDJ	2	147	0.0019201379364395157	0.002424982266286148	45	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	1	5	6	6	8	24	36	48	42	56		TCRBV24-01,TCRBV24-or09_02												CASSSPGQFQREQYF+TCRBV24-X+TCRBJ02-07	TCRBV24	TCRBD01-01*01	TCRBJ02-07*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCGGACAAAGTGCCATTTCGTGTTAGACGAGCAGTACTTCGGGCCG		Out	VDJ	2	155	0.0020246352391028906		50	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	1	6	5	0	19	26	-1	43	38	62		TCRBV03-01,TCRBV03-02												X+TCRBV03-X+TCRBJ02-07	TCRBV03	TCRBD01-01*01	TCRBJ02-07*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTGAGTGGACAGGGCCCCACCCTTCCCCCTACGAGCAGTACTTCGGGCCG	CSAEWTGPHPSPYEQYF	In	VDJ	2	155	0.0020246352391028906	0.0025569540903017207	51	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	1	3	2	4	13	26	35	47	39	60		TCRBV20-01,TCRBV20-or09_02												CSAEWTGPHPSPYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD01-01*01	TCRBJ02-07*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
TYRGRRGACWCAGCMMKGTAYTTCTGTGCCAGCAACGCCCGGCGTACAGGGGAGACCCAGTACTTCGGGCCA	CASNARRTGETQYF	In	VDJ	2	166	0.002168319030265031	0.002738415348323133	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	7	3	3	5	11	0	23	33	-1	44	50	TCRBV02,TCRBV21													CASNARRTGETQYF+X+TCRBJ02-05	unresolved	TCRBD01-01*01	TCRBJ02-05*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGTAGATTATGAGCAGTTCTTCGGGCCA	CSARVDYEQFF	In	VDJ	2	167	0.002181381193097953	0.0027549118263250796	33	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	1	5	8	8	0	3	26	-1	42	39	45		TCRBV20-01,TCRBV20-or09_02				01,02								CSARVDYEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01	TCRBJ02-01*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
GACTCGGCCGTGTATGTCTGTGCCAGAAGCGCTACTAGCGGGAGGGCCTAGCACAGATACGCAGTATTTTGGCCCA		Out	VDJ	2	175	0.002285878495761328		52				TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	4	3	0	0	3	3	18	30	46	33	49	TCRBV05,TCRBV11	TCRBV05-03,TCRBV11-03												X+X+TCRBJ02-03		TCRBD02-01*02	TCRBJ02-03*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
TGGRGGACTCAGCYWTGTAYTTCTGTGCCAGCAGCCGACTAGCGGGCTTAACAGATACGCAGTATTTTGGCCCA	CASSRLAGLTDTQYF	In	VDJ	2	176	0.00229894065859425	0.002903380128342599	45	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	6	2	4	3	2	4	23	34	46	36	50	TCRBV02,TCRBV09					01,02								CASSRLAGLTDTQYF+X+TCRBJ02-03	unresolved	TCRBD02-01	TCRBJ02-03*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
AGCACCAACCAGACATCTRTGTAYCTCTRTGCCAGCAGTTGCGGACTAGCGGGAATGAGCAGTTCTTCGGGCCA		Out	VDJ	2	178	0.002325064984260094		41	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	4	1	4	7	2	0	25	38	-1	40	51	TCRBV26,TCRBV28					01,02								X+X+TCRBJ02-01	unresolved	TCRBD02-01	TCRBJ02-01*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCGTTACTAGCGGGAGGAGAGACCCAGTACTTCGGGCCA	CSALLAGGETQYF	In	VDJ	2	179	0.0023381271470930155	0.0029528695623484385	39	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	6	3	1	4	3	0	26	34	-1	37	49		TCRBV20-01,TCRBV20-or09_02												CSALLAGGETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD02-01*02	TCRBJ02-05*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
GRGACWCGGCMCTSTATCTCTGYGCCAGCAGAACGGGAAATCCCAGCCACAATGAGCAGTTCTTCGGGCCA	CASRTGNPSHNEQFF	In	VDJ	2	188	0.0024556866125893125	0.0031013378643659577	45	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	5	8	3	5	2	10	19	30	37	32	47	TCRBV05,TCRBV23													CASRTGNPSHNEQFF+X+TCRBJ02-01	unresolved	TCRBD02-01*02	TCRBJ02-01*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGATTGGAGGGCACAAGAGACCCAGTACTTCGGGCCA	CATSDWRAQETQYF	In	VDJ	2	190	0.0024818109382551564	0.003134330820369851	42	TCRBV24			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	2	10	0	2	0	2	24	-1	46	40	48		TCRBV24-01,TCRBV24-or09_02												CATSDWRAQETQYF+TCRBV24-X+TCRBJ02-05	TCRBV24	TCRBD02-01*02	TCRBJ02-05*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCCCATAGGTGGGATCCGGAGGCTAATGAAAAACTGTTTTTTGGCAGT		Out	VDJ	2	195	0.0025471217524197657		49	TCRBV24			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-04	01	11	10	1	3	17	0	24	31	-1	48	53		TCRBV24-01,TCRBV24-or09_02												X+TCRBV24-X+TCRBJ01-04	TCRBV24	TCRBD02-01*02	TCRBJ01-04*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
TYRGGRGACWCAGCWYKGTATTTCTGTGCCAGCAGTGACAGGGAGCAATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	3	202	0.002638556892250219		40	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	5	2	3	1	1	0	23	34	-1	35	42	TCRBV09,TCRBV21													X+X+TCRBJ01-05	unresolved	TCRBD01-01*01	TCRBJ01-05*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
AGCTKGGKGACTYKGCTGTGTATYTCTGTGCCAGCAGCCCGGGGGGACAGGCCTCCGGTGCGCAGTATTTTGGCCCA	CASSPGGQASGAQYF	In	VDJ	3	212	0.0027691785205794374	0.003497253336412676	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	5	0	4	10	5	9	22	34	47	39	56	TCRBV03,TCRBV07													CASSPGGQASGAQYF+X+TCRBJ02-03	unresolved	TCRBD01-01*01	TCRBJ02-03*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
GGACTCGGCCSTSTATSTCTGTGCCAGCAGCTTTTTGGGACCAATCACAGATACGCAGTATTTTGGCCCA	CASSFLGPITDTQYF	In	VDJ	3	221	0.0028867379860757344	0.003645721638430195	45	unresolved						TCRBJ02	TCRBJ02-03	01	3	0	7	2	3	4	18	32	40	35	44	TCRBV05,TCRBV11			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSFLGPITDTQYF+X+TCRBJ02-03	unresolved		TCRBJ02-03*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCAGATGGACTCCCGGTGCATAATGAAAAACTGTTTTTTGGCAGT		Out	VDJ	3	226	0.0029520488002403437		49	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-04	01	5	1	10	4	4	9	26	38	47	42	56		TCRBV03-01,TCRBV03-02				01,02								X+TCRBV03-X+TCRBJ01-04	TCRBV03	TCRBD02-01	TCRBJ01-04*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCCCTCCCCTCCACCGGGTATACGAGCAGTACTTCGGGCCG	CASPPLHRVYEQYF	In	VDJ	3	230	0.0030042974515720315	0.0037941899404477144	42	TCRBV24			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	11	8	4	4	14	2	24	31	49	45	51		TCRBV24-01,TCRBV24-or09_02				01,02								CASPPLHRVYEQYF+TCRBV24-X+TCRBJ02-07	TCRBV24	TCRBD02-01	TCRBJ02-07*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGTCCTGGACAGAGGTCCGGGGAGCTGTTTTTTGGAGAA	CASSPGQRSGELFF	In	VDJ	3	232	0.003030421777237875	0.0038271828964516075	42	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	6	1	5	6	4	4	26	37	47	41	51		TCRBV03-01,TCRBV03-02												CASSPGQRSGELFF+TCRBV03-X+TCRBJ02-02	TCRBV03	TCRBD01-01*01	TCRBJ02-02*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
CRRRRGACTCAGCCSTGTATCTCTRCGCCAGCAGCCCAAGCGGATCCCCCAAAGAGACCCAGTACTTCGGGCCA	XASSPSGSPKETQYF	In	VDJ	3	233	0.003043483940070797	0.003843679374453554	45	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	5	6	5	3	3	8	22	34	42	37	50	TCRBV04,TCRBV07,TCRBV17					01,02								XASSPSGSPKETQYF+X+TCRBJ02-05	unresolved	TCRBD02-01	TCRBJ02-05*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTGCTACTTGGGGTTCGGAAGAGACCCAGTACTTCGGGCCA	CSAATWGSEETQYF	In	VDJ	3	244	0.0031871677312329373	0.0040251406324749665	42	TCRBV20						TCRBJ02	TCRBJ02-05	01	5	6	2	3	7	5	26	35	46	42	51		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSAATWGSEETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20		TCRBJ02-05*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
AAYCMRGRGACWCAGCWSKGTATTTYTGTGCCAGCAGTGTCGGGACAGGTTATGAAAAACTGTTTTTTGGCAGT	CASSVGTGYEKLFF	In	VDJ	3	266	0.0034745353135572188	0.004388063148517791	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	6	0	4	6	4	2	24	35	47	39	49	TCRBV12,TCRBV21													CASSVGTGYEKLFF+X+TCRBJ01-04	unresolved	TCRBD01-01*01	TCRBJ01-04*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGAAATGGACCCAGGGCCAGCCAAAAACATTCAGTACTTCGGCGCC	CASSQEMDPGPAKNIQYF	In	VDJ	4	276	0.0036051569418864378	0.004553027928537257	54	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-04	01	0	4	3	0	8	2	26	43	56	51	58		TCRBV03-01,TCRBV03-02												CASSQEMDPGPAKNIQYF+TCRBV03-X+TCRBJ02-04	TCRBV03	TCRBD01-01*01	TCRBJ02-04*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
TTTCTGTGCCATGGCTCCCCTTAAGCCCGGGACGGACAACTAGCGGGAGGATGTACGAGCAGTACTTCGGGCCG		Out	VDJ	4	280	0.003657405593218125		64	TCRBV03			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	10	3	1	4	27	3	4	11	50	38	53		TCRBV03-01,TCRBV03-02												X+TCRBV03-X+TCRBJ02-07	TCRBV03	TCRBD02-01*02	TCRBJ02-07*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
CGACTCGGCYGTGTATSTCTGTGCCAGCAGCTCCGGACTAGCGGGAGAAAATCCCAACACCGGGGAGCTGTTTTTTGGAGAA	CASSSGLAGENPNTGELFF	In	VDJ	4	288	0.0037619028958815	0.004750985664560617	57	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	4	1	2	2	2	8	18	31	46	33	54	TCRBV07,TCRBV11													CASSSGLAGENPNTGELFF+X+TCRBJ02-02	unresolved	TCRBD02-01*02	TCRBJ02-02*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATATTGAGGCGGGAGAGGTCGAGCAGTACTTCGGGCCG	CSARDIEAGEVEQYF	In	VDJ	4	335	0.004375824549028828	0.005526320130652106	45	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	0	7	2	6	7	4	26	40	54	47	58		TCRBV20-01,TCRBV20-or09_02												CSARDIEAGEVEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01*02	TCRBJ02-07*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
CCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATCATGGCGGGGTAGGGGAGGTCGGGTTATATGAGCAGTTCTTCGGGCCA	CSARDHGGVGEVGLYEQFF	In	VDJ	4	345	0.0045064461773580465	0.005691284910671572	57	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	0	7	3	8	5	18	24	38	49	43	67		TCRBV20-01,TCRBV20-or09_02				01,02								CSARDHGGVGEVGLYEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01	TCRBJ02-01*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
TYRGGRGACWCAGCWYKGTATTTCTGTGCCAGCAGCGTAGACGGGAGCTACAATGAGCAGTTCTTCGGGCCA	CASSVDGSYNEQFF	In	VDJ	5	383	0.005002808365009079	0.0063181510747455415	42	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	5	8	2	3	5	0	24	36	-1	41	47	TCRBV09,TCRBV21													CASSVDGSYNEQFF+X+TCRBJ02-01	unresolved	TCRBD02-01*02	TCRBJ02-01*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTATCGAGGCCAGATACGCAGTATTTTGGCCCA	CASSLSRPDTQYF	In	VDJ	5	400	0.00522486513316875	0.006598591200778634	39				TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	6	11	1	4	5	1	24	36	45	41	46	TCRBV24,TCRBV27	TCRBV24-01,TCRBV24-or09_02,TCRBV27-01												CASSLSRPDTQYF+X+TCRBJ02-03		TCRBD02-01*02	TCRBJ02-03*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGTACCACGGGACAGTTCTCCTACGAGCAGTACTTCGGGCCG	CASSTTGQFSYEQYF	In	VDJ	6	451	0.0058910354376477654	0.00743991157887791	45	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	0	5	0	6	2	26	37	50	43	52		TCRBV03-01,TCRBV03-02												CASSTTGQFSYEQYF+TCRBV03-X+TCRBJ02-07	TCRBV03	TCRBD01-01*01	TCRBJ02-07*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCTAAATGGGGGTAATGGCTACACCTTCGGTTCG	CASSLNGGNGYTF	In	VDJ	6	461	0.006021657065976985	0.007604876358897375	39	TCRBV03						TCRBJ01	TCRBJ01-02	01	4	6	1	6	5	2	26	39	49	44	51		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLNGGNGYTF+TCRBV03-X+TCRBJ01-02	TCRBV03		TCRBJ01-02*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGTGACTAGCGGGAGTGCGGGAGAGACCCAGTACTTCGGGCCA	CSVTSGSAGETQYF	In	VDJ	7	589	0.007693613908590985	0.009716425543146539	42	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	7	2	2	4	1	6	26	33	46	34	52		TCRBV20-01,TCRBV20-or09_02												CSVTSGSAGETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD02-01*02	TCRBJ02-05*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCAGATGGGGTGGGCTCCTACGAGCAGTACTTCGGGCCG	CSADGVGSYEQYF	In	VDJ	22	1702	0.02223180114163303	0.028077005559313088	39	TCRBV20						TCRBJ02	TCRBJ02-07	01	6	6	2	0	4	4	26	34	42	38	46		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSADGVGSYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20		TCRBJ02-07*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAAATAGCGGGATTGCGAGCAGTACTTCGGGCCG		Out	VDJ	27	2098	0.027404417623470095		38	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	2	5	3	6	2	3	26	38	48	40	51		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01*02	TCRBJ02-07*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
TYRGGRGACWCAGCWYKGTATTTCTGTGCCAGCAGCAGAGCGGGGGACAGGGAACAGATACGCAGTATTTTGGCCCA		Out	VDJ	27	2107	0.02752197708896639		47	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	0	0	3	3	2	1	24	41	52	43	53	TCRBV09,TCRBV21													X+X+TCRBJ02-03	unresolved	TCRBD01-01*01	TCRBJ02-03*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
TYRGGRGACWCAGCWYKGTATTTCTGTGCCGGCGATCTGGGGGGCACAGATACGCAGTATTTTGGCCCA	CAGDLGGTDTQYF	In	VDJ	31	2421	0.03162349621850386	0.03993797324271268	39	unresolved						TCRBJ02	TCRBJ02-03	01	11	6	1	1	8	0	24	30	-1	38	43	TCRBV09,TCRBV21			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CAGDLGGTDTQYF+X+TCRBJ02-03	unresolved		TCRBJ02-03*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATCTTAGAGGACTAGCGGGAGAGGTGGAGCTGTTTTTTGGAGAA	CSARDLRGLAGEVELFF	In	VDJ	33	2618	0.03419674229658947	0.043187779409096155	51	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	0	1	2	10	7	4	26	40	60	47	64		TCRBV20-01,TCRBV20-or09_02												CSARDLRGLAGEVELFF+TCRBV20-X+TCRBJ02-02	TCRBV20	TCRBD02-01*02	TCRBJ02-02*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
CAGCCAGACCTATCTGTACCACTGTGGCAGCACATCGTAGGGCTAGTATTGACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	2	158	0.0020638217276016564		46	TCRBV08	TCRBV08-02	01				TCRBJ02	TCRBJ02-01	01	0	5	3	5	2	9	22	36	42	38	51				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV08-02+TCRBJ02-01	TCRBV08-02*01		TCRBJ02-01*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
GACGCAGCCATGTACCTGTGTGCCACAGGGACAGGGGGTGTTGGAAACACCATATATTTTGGAGAG	CATGTGGVGNTIYF	In	VDJ	1	22	2.8736758232428126E-4	3.6292251604282485E-4	42	TCRBV15	TCRBV15-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	9	0	1	3	1	3	18	26	38	27	41														CATGTGGVGNTIYF+TCRBV15-01+TCRBJ01-03	TCRBV15-01*01	TCRBD01-01*01	TCRBJ01-03*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGAGATCATTCAGGGGAAGGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	28	3.6574055932181253E-4		46	TCRBV15	TCRBV15-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	0	4	2	5	5	3	18	35	46	40	49														X+TCRBV15-01+TCRBJ02-05	TCRBV15-01*01	TCRBD01-01*01	TCRBJ02-05*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGAGATAAGGGACAAAGCTACGAGCAGTACTTCGGGCCG	CATSRDKGQSYEQYF	In	VDJ	1	30	3.9186488498765625E-4	4.948943400583975E-4	45	TCRBV15	TCRBV15-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	0	0	6	3	3	3	18	35	44	38	47														CATSRDKGQSYEQYF+TCRBV15-01+TCRBJ02-07	TCRBV15-01*01	TCRBD01-01*01	TCRBJ02-07*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGAGACGACTGGGGCTTCCTGGGGCCAACGTCCTGACTTTCGGGGCC		Out	VDJ	1	34	4.4411353631934375E-4		53	TCRBV15	TCRBV15-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	0	7	0	2	5	3	18	35	45	40	48														X+TCRBV15-01+TCRBJ02-06	TCRBV15-01*01	TCRBD01-01*01	TCRBJ02-06*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGAGCAGACAGGAACACTGAAGCTTTCTTTGGACAA	CATSRADRNTEAFF	In	VDJ	1	37	4.8330002481810936E-4	6.103696860720237E-4	42	TCRBV15	TCRBV15-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	1	2	5	1	2	0	18	34	-1	36	41														CATSRADRNTEAFF+TCRBV15-01+TCRBJ01-01	TCRBV15-01*01	TCRBD01-01*01	TCRBJ01-01*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGAGAGGGACCGGGACAGGGCCCCGGGGAGCAGTTCTTCGGGCCA	CATSREGPGQGPGEQFF	In	VDJ	1	39	5.094243504839531E-4	6.433626420759168E-4	51	TCRBV15	TCRBV15-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	0	0	3	10	6	7	18	35	50	41	57														CATSREGPGQGPGEQFF+TCRBV15-01+TCRBJ02-01	TCRBV15-01*01	TCRBD01-01*01	TCRBJ02-01*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGTGCGTCCGGGGTCCAACCCTACGAGCAGTACTTCGGGCCG	CATSSASGVQPYEQYF	In	VDJ	2	121	0.001580521702783547	0.0019960738382355367	48	TCRBV15	TCRBV15-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	3	8	3	2	6	6	18	32	43	38	49														CATSSASGVQPYEQYF+TCRBV15-01+TCRBJ02-07	TCRBV15-01*01	TCRBD02-01*01	TCRBJ02-07*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGAGTTACCAGGCGGGTTGATACGCAGTATTTTGGCCCA	CATSRVTRRVDTQYF	In	VDJ	3	223	0.0029128623117415783	0.0036787145944340884	45	TCRBV15	TCRBV15-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	1	7	4	6	7	2	18	34	46	41	48						01,02								CATSRVTRRVDTQYF+TCRBV15-01+TCRBJ02-03	TCRBV15-01*01	TCRBD02-01	TCRBJ02-03*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCCCCACTAAAGAGACTAGCGGTTACGAGCAGTACTTCGGGCCG	CATSPTKETSGYEQYF	In	VDJ	6	494	0.006452708439463406	0.008149260132961612	48	TCRBV15	TCRBV15-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	5	2	5	4	11	1	18	30	50	41	51						01,02								CATSPTKETSGYEQYF+TCRBV15-01+TCRBJ02-07	TCRBV15-01*01	TCRBD02-01	TCRBJ02-07*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCAAACTAGCCGGGACAGATATCCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	23	3.0042974515720315E-4		49	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	0	5	1	9	3	18	30	46	39	49														X+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-07*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCAACAGCTGGACAGATCGAACTATGACTACACCTTCGGTTCG	CASSQQLDRSNYDYTF	In	VDJ	1	23	3.0042974515720315E-4	3.7941899404477143E-4	48	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	1	5	10	8	12	18	30	44	38	56														CASSQQLDRSNYDYTF+TCRBV11-03+TCRBJ01-02	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-02*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTCGGGAGGGCAGGGCTGGAACGAGCAGTACTTCGGGCCG	CASSSGGQGWNEQYF	In	VDJ	1	23	3.0042974515720315E-4	3.7941899404477143E-4	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	4	8	0	5	0	10	18	-1	39	31	49														CASSSGGQGWNEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-07*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCGCACCACCCCTATAACTAGCGGGGTAAACAATGAGCAGTTCTTCGGGCCA	CASSRTTPITSGVNNEQFF	In	VDJ	1	26	3.3961623365596876E-4	4.289084280506112E-4	57	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	5	3	3	5	15	3	18	30	55	45	58														CASSRTTPITSGVNNEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD02-01*01	TCRBJ02-01*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTCAGGACTAGCGGGAGAGGGACCGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSSGLAGEGPNTGELFF	In	VDJ	1	27	3.5267839648889064E-4	4.454049060525578E-4	57	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	4	1	2	0	2	6	18	31	46	33	52														CASSSGLAGEGPNTGELFF+TCRBV11-03+TCRBJ02-02	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-02*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAAGTCTAGCGGGACCCACAGATACGCAGTATTTTGGCCCA	CASSLSLAGPTDTQYF	In	VDJ	1	27	3.5267839648889064E-4	4.454049060525578E-4	48	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	2	4	3	2	3	2	18	33	45	36	47														CASSLSLAGPTDTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-03*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCAGGAGGGATCGGGACAGATACGCAGTATTTTGGCCCA	CASSPGGIGTDTQYF	In	VDJ	1	28	3.6574055932181253E-4	4.6190138405450437E-4	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	5	10	0	3	3	6	18	30	39	33	45														CASSPGGIGTDTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-03*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGAGGGGGCGAGGACTGAAGCTTTCTTTGGACAA	CASSLEGARTEAFF	In	VDJ	1	28	3.6574055932181253E-4	4.6190138405450437E-4	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	0	6	0	5	0	4	18	-1	41	35	45														CASSLEGARTEAFF+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-01*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGGATATTGGACAGTTAAGGGCCTATGGCTACACCTTCGGTTCG		Out	VDJ	1	28	3.6574055932181253E-4		47	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	1	5	4	6	8	18	29	41	35	49														X+TCRBV11-03+TCRBJ01-02	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-02*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGGGGAGGGTTAGCAATCAGCCCCAGCATTTTGGTGAT	CASSLGRVSNQPQHF	In	VDJ	1	30	3.9186488498765625E-4	4.948943400583975E-4	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-05	01	3	9	0	0	1	1	18	32	40	33	41														CASSLGRVSNQPQHF+TCRBV11-03+TCRBJ01-05	TCRBV11-03*01	TCRBD02-01*02	TCRBJ01-05*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCATCGCTCAACGGCTTAGTGGAAGAGACCCAGTACTTCGGGCCA	CASSPSLNGLVEETQYF	In	VDJ	1	32	4.179892106535E-4	5.278872960622907E-4	51	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-05	01	5	9	0	3	12	7	18	30	45	42	52				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSPSLNGLVEETQYF+TCRBV11-03+TCRBJ02-05	TCRBV11-03*01		TCRBJ02-05*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTTTTACGAATAGCGGGAGACAATGAGCAGTTCTTCGGGCCA	CASSFLRIAGDNEQFF	In	VDJ	1	32	4.179892106535E-4	5.278872960622907E-4	48	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	3	5	2	5	8	0	18	32	-1	40	49														CASSFLRIAGDNEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-01*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCGCCGGAGGAGGGGGGCCTCCCCAGCATTTTGGTGAT	CASSAGGGGPPQHF	In	VDJ	1	35	4.5717569915226564E-4	5.773767300681304E-4	42	TCRBV11	TCRBV11-03	01				TCRBJ01	TCRBJ01-05	01	5	5	1	10	8	4	18	30	44	38	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSAGGGGPPQHF+TCRBV11-03+TCRBJ01-05	TCRBV11-03*01		TCRBJ01-05*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGGCGAGGGGGCGTTCTGACAGCCCCAGCATTTTGGTGAT	CASSLGEGAF*QPQHF	Stop	VDJ	1	37	4.8330002481810936E-4		48	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	1	5	0	7	3	7	18	34	44	37	51														CASSLGEGAF*QPQHF+TCRBV11-03+TCRBJ01-05	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-05*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTGGTCAGCCGGGCTTAGCTACGAGCAGTACTTCGGGCCG	CASSWSAGLSYEQYF	In	VDJ	1	38	4.963621876510313E-4	6.268661640739702E-4	45	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-07	01	4	8	0	3	8	4	18	31	43	39	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSWSAGLSYEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01		TCRBJ02-07*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGGCCGGGGAAGGGAGCGCCGGGGAGCTGTTTTTTGGAGAA	CASSLAGEGSAGELFF	In	VDJ	1	38	4.963621876510313E-4	6.268661640739702E-4	48	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	3	8	3	6	3	9	18	32	40	35	49						01,02								CASSLAGEGSAGELFF+TCRBV11-03+TCRBJ02-02	TCRBV11-03*01	TCRBD02-01	TCRBJ02-02*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCCAGCATGGGCCCTTGGACTGAAGCTTTCTTTGGACAA	CASSPSMGPWTEAFF	In	VDJ	1	40	5.22486513316875E-4	6.598591200778634E-4	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	8	0	5	8	6	18	30	42	38	48														CASSPSMGPWTEAFF+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-01*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGGAGCGGAGGGGACACCAAGAGACCCAGTACTTCGGGCCA	CASSLERRGHQETQYF	In	VDJ	1	42	5.486108389827187E-4	6.928520760817565E-4	48	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	3	10	0	0	5	3	18	32	43	37	46														CASSLERRGHQETQYF+TCRBV11-03+TCRBJ02-05	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-05*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGACCAGGGCGCAGATACGCAGTATTTTGGCCCA	CASSLDQGADTQYF	In	VDJ	1	43	5.616730018156407E-4	7.093485540837031E-4	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	0	4	3	4	1	2	18	35	41	36	43														CASSLDQGADTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-03*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGGCCTGGGGAGGCACAGATACGCAGTATTTTGGCCCA	CASSLAWGGTDTQYF	In	VDJ	1	46	6.008594903144063E-4	7.588379880895429E-4	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	3	9	2	1	6	0	18	32	-1	38	43														CASSLAWGGTDTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-03*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTCCCTAGCGGGAGGGCCCTCAGGAGAGACCCAGTACTTCGGGCCA	CASSSLAGGPSGETQYF	In	VDJ	1	47	6.139216531473281E-4	7.753344660914894E-4	51	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	4	4	0	4	2	8	18	31	45	33	53														CASSSLAGGPSGETQYF+TCRBV11-03+TCRBJ02-05	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-05*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTCTCCGGGACAGGTTACGAGCAGTACTTCGGGCCG	CASSFSGTGYEQYF	In	VDJ	1	49	6.400459788131719E-4	8.083274220953826E-4	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	3	0	4	4	4	1	18	32	44	36	45														CASSFSGTGYEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-07*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAATGGAGCAGGCCGGGGAGCTGTTTTTTGGAGAA	CASSLMEQAGELFF	In	VDJ	1	50	6.531081416460937E-4	8.248239000973293E-4	42	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-02	01	2	4	4	6	6	0	18	33	-1	39	43				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLMEQAGELFF+TCRBV11-03+TCRBJ02-02	TCRBV11-03*01		TCRBJ02-02*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGGATTCTCCGGGCTAGCCTACGAGCAGTACTTCGGGCCG	CASSLGFSGLAYEQYF	In	VDJ	1	51	6.661703044790157E-4	8.413203780992758E-4	48	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-07	01	1	8	0	2	8	3	18	34	46	42	49				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLGFSGLAYEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01		TCRBJ02-07*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGAGGGACAGGGCTACAATGAGCAGTTCTTCGGGCCA	CASSLEGQGYNEQFF	In	VDJ	1	58	7.576054443094687E-4	9.567957241129019E-4	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	0	0	3	3	0	0	18	-1	-1	35	44														CASSLEGQGYNEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-01*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCGACAGACAATGCGCTCCTACGAGCAGTACTTCGGGCCG	CASSRQTMRSYEQYF	In	VDJ	1	79	0.0010319108638008282	0.0013032217621537802	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	2	5	0	1	8	18	30	36	31	44														CASSRQTMRSYEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-07*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGTCGGAGGGACAGGAAGGGGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	113	0.0014760244001201718		49	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	1	0	4	5	5	5	18	34	47	39	52														X+TCRBV11-03+TCRBJ02-05	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-05*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTCCACCTTACAGGGGGCGAGCTCCTACGAGCAGTACTTCGGGCCG	CASSSTLQGASSYEQYF	In	VDJ	2	122	0.0015935838656164687	0.0020125703162374832	51	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	4	3	0	0	7	3	18	31	47	38	50														CASSSTLQGASSYEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-07*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTTGACCAGGGGACTGGAAACACCATATATTTTGGAGAG	CASSFDQGTGNTIYF	In	VDJ	2	143	0.0018678892851078282	0.0023589963542783618	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	3	4	2	2	4	1	18	32	42	36	43														CASSFDQGTGNTIYF+TCRBV11-03+TCRBJ01-03	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-03*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGAATCTACCGGGACGGCGGGGCCAACGTCCTGACTTTCGGGGCC	CASRIYRDGGANVLTF	In	VDJ	2	155	0.0020246352391028906	0.0025569540903017207	48	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-06	01	6	0	7	4	8	3	18	29	42	37	45				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASRIYRDGGANVLTF+TCRBV11-03+TCRBJ02-06	TCRBV11-03*01		TCRBJ02-06*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCGCGGCGGGTGGCAAGAGACCCAGTACTTCGGGCCA	CASSRGGWQETQYF	In	VDJ	2	168	0.002194443355930875	0.002771408304327026	42	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	5	7	4	2	4	3	18	30	39	34	42						01,02								CASSRGGWQETQYF+TCRBV11-03+TCRBJ02-05	TCRBV11-03*01	TCRBD02-01	TCRBJ02-05*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAAACGGCATGAACACTGAAGCTTTCTTTGGACAA	CASSLNGMNTEAFF	In	VDJ	2	175	0.002285878495761328	0.0028868836503406522	42	TCRBV11	TCRBV11-03	01				TCRBJ01	TCRBJ01-01	01	2	9	0	0	3	1	18	33	39	36	40				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLNGMNTEAFF+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01		TCRBJ01-01*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAATGGCTAGCGTAGATCAGCAGTACTTCGGGCCG	CASSLMASVDQQYF	In	VDJ	2	176	0.00229894065859425	0.002903380128342599	42	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	2	4	6	8	4	6	18	33	43	37	49						01,02								CASSLMASVDQQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD02-01	TCRBJ02-07*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGTATTGGGGTCCCTAAACTATGGCTACACCTTCGGTTCG	CASSLVLGSLNYGYTF	In	VDJ	3	224	0.0029259244745745002	0.003695211072436035	48	TCRBV11	TCRBV11-03	01				TCRBJ01	TCRBJ01-02	01	1	6	2	2	4	6	18	34	42	38	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLVLGSLNYGYTF+TCRBV11-03+TCRBJ01-02	TCRBV11-03*01		TCRBJ01-02*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTATCGGGCGGGGACAATGAGCAGTTCTTCGGGCCA	CASSLSGGDNEQFF	In	VDJ	3	227	0.0029651109630732656	0.0037447005064418747	42	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	2	7	3	5	4	0	18	33	-1	37	43														CASSLSGGDNEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD02-01*01	TCRBJ02-01*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGGAAAAAAGGGAGGCGAAGAAAGTATGGGTGCTCGGCTACACCTTCGGTTCG	CASSLEKREAKKVWVLGYTF	In	VDJ	3	231	0.003017359614404953	0.003810686418449661	60	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	3	9	1	8	8	20	18	32	46	40	66														CASSLEKREAKKVWVLGYTF+TCRBV11-03+TCRBJ01-02	TCRBV11-03*01	TCRBD02-01*02	TCRBJ01-02*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCGACTACGGTGGGGCAGGGCGGGGGAGCAGTACTTCGGGCCG	CASSRLRWGRAGEQYF	In	VDJ	3	267	0.0034875974763901407	0.004404559626519738	48	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	5	7	3	7	18	0	18	30	-1	48	54														CASSRLRWGRAGEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD02-01*01	TCRBJ02-07*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGGAGGGTGGGCTACTAAGAGACCCAGTACTTCGGGCCA		Out	VDJ	4	314	0.004101519129537469		46	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	3	10	0	3	0	9	18	-1	38	32	47														X+TCRBV11-03+TCRBJ02-05	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-05*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGACCACTGGACGGTACAGATACGCAGTATTTTGGCCCA	CASRPLDGTDTQYF	In	VDJ	5	369	0.004819938085348172	0.006087200382718289	42	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-03	01	6	1	7	3	6	3	18	29	39	35	42				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASRPLDGTDTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01		TCRBJ02-03*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCGACAGGGGGCGGTGAAAAACTGTTTTTTGGCAGT	CASSPTGGGEKLFF	In	VDJ	5	415	0.005420797575662578	0.006846038370807833	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	5	2	0	7	2	2	18	30	42	32	44														CASSPTGGGEKLFF+TCRBV11-03+TCRBJ01-04	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-04*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAAAGACTAGCGGGAGAGGGGGATACGCAGTATTTTGGCCCA		Out	VDJ	7	565	0.00738012200060086		49	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	2	2	2	6	2	5	18	33	47	35	52														X+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-03*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTCCGGACTAGCGGGAGATCTCCCGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSSGLAGDLPNTGELFF	In	VDJ	21	1649	0.02153950651148817	0.027202692225209917	57	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	4	1	2	0	2	6	18	31	46	33	52														CASSSGLAGDLPNTGELFF+TCRBV11-03+TCRBJ02-02	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-02*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCTCGGGAGTCAAGCTCCTACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	42	5.486108389827187E-4		43	TCRBV12	TCRBV12-05	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	12	8	2	0	5	5	26	31	42	36	47														X+TCRBV12-05+TCRBJ02-01	TCRBV12-05*01	TCRBD02-01*02	TCRBJ02-01*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCACACCCAAAGACAATGAGCAGTTCTTCGGGCCA	CATPKDNEQFF	In	VDJ	1	47	6.139216531473281E-4	7.753344660914894E-4	33	TCRBV12	TCRBV12-05	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	12	3	6	5	1	7	26	31	35	32	42														CATPKDNEQFF+TCRBV12-05+TCRBJ02-01	TCRBV12-05*01	TCRBD01-01*01	TCRBJ02-01*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
CCCAGGGACTCAGCTGTGTATTTTTGTGCTAGTGCCCTACGAGGGGGGATGAGCCATGCGAACACCGGGGAGCTGTTTTTTGGAGAA	CASALRGGMSHANTGELFF	In	VDJ	1	56	7.314811186436251E-4	9.238027681090087E-4	57	TCRBV12	TCRBV12-05	01				TCRBJ02	TCRBJ02-02	01	7	5	1	0	7	11	24	34	47	41	58				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASALRGGMSHANTGELFF+TCRBV12-05+TCRBJ02-02	TCRBV12-05*01		TCRBJ02-02*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCACCACATCAAATGGACAAGAGACCCAGTACTTCGGGCCA	CASTTSNGQETQYF	In	VDJ	1	65	8.490405841399219E-4	0.001072271070126528	42	TCRBV12	TCRBV12-05	01				TCRBJ02	TCRBJ02-05	01	12	1	8	2	16	0	26	31	-1	47	50				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASTTSNGQETQYF+TCRBV12-05+TCRBJ02-05	TCRBV12-05*01		TCRBJ02-05*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCATGACTAGCGGGAGGGCAAATGAGCAGTTCTTCGGGCCA	CASMTSGRANEQFF	In	VDJ	1	70	9.143513983045313E-4	0.0011547534601362608	42	TCRBV12	TCRBV12-05	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	12	2	0	7	6	2	26	31	51	37	53														CASMTSGRANEQFF+TCRBV12-05+TCRBJ02-01	TCRBV12-05*01	TCRBD02-01*02	TCRBJ02-01*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGTGGACAAACCGATGAAGCTTTCTTTGGACAA	CASGQTDEAFF	In	VDJ	1	99	0.0012931541204592657	0.0016331513221927118	33	TCRBV12	TCRBV12-05	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	3	6	7	0	6	26	-1	40	37	46														CASGQTDEAFF+TCRBV12-05+TCRBJ01-01	TCRBV12-05*01	TCRBD01-01*01	TCRBJ01-01*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGCTGGAGACGACGACAGGGGGACAATGAGCAGTTCTTCGGGCCA	CASSWRRRQGDNEQFF	In	VDJ	1	22	2.8736758232428126E-4	3.6292251604282485E-4	48	TCRBV23	TCRBV23-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	6	2	1	5	11	0	20	31	-1	42	51														CASSWRRRQGDNEQFF+TCRBV23-01+TCRBJ02-01	TCRBV23-01*01	TCRBD01-01*01	TCRBJ02-01*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
GAGACACGGCACTGTATCTCTGCGCCAGCACGCTCCCCGGGACAGGGTCCGACGAGCAGTACTTCGGGCCG	CASTLPGTGSDEQYF	In	VDJ	1	23	3.0042974515720315E-4	3.7941899404477143E-4	45	TCRBV23	TCRBV23-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	7	0	3	5	8	4	20	30	47	38	51														CASTLPGTGSDEQYF+TCRBV23-01+TCRBJ02-07	TCRBV23-01*01	TCRBD01-01*01	TCRBJ02-07*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGCCCACGGGGAGGGGACACTGAAGCTTTCTTTGGACAA	CASSPRGGDTEAFF	In	VDJ	1	33	4.3105137348642186E-4	5.443837740642373E-4	42	TCRBV23	TCRBV23-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	6	9	0	3	6	1	20	31	44	37	45														CASSPRGGDTEAFF+TCRBV23-01+TCRBJ01-01	TCRBV23-01*01	TCRBD02-01*02	TCRBJ01-01*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGCTTGTCTGCACAGGAGAATCAGCCCCAGCATTTTGGTGAT	CASSLSAQENQPQHF	In	VDJ	1	35	4.5717569915226564E-4	5.773767300681304E-4	45	TCRBV23	TCRBV23-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	6	3	4	4	9	2	20	31	45	40	47														CASSLSAQENQPQHF+TCRBV23-01+TCRBJ01-05	TCRBV23-01*01	TCRBD01-01*01	TCRBJ01-05*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGTCAATCAGGCCCTAGTGGGAATACGCAGTATTTTGGCCCA	CASSQSGPSGNTQYF	In	VDJ	1	45	5.877973274814844E-4	7.423415100875963E-4	45	TCRBV23	TCRBV23-01	01				TCRBJ02	TCRBJ02-03	01	0	0	8	7	10	0	20	37	-1	47	51				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQSGPSGNTQYF+TCRBV23-01+TCRBJ02-03	TCRBV23-01*01		TCRBJ02-03*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGCCAAAGACCCCCACAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	46	6.008594903144063E-4		41	TCRBV23	TCRBV23-01	01				TCRBJ02	TCRBJ02-03	01	2	2	7	2	1	3	20	35	39	36	42				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV23-01+TCRBJ02-03	TCRBV23-01*01		TCRBJ02-03*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
GAGACACGGCACTGTATCTCTGCGCCAGCATTTTTCCGGGACAGGGTAGGCCGGGGCCAACGTCCTGACTTTCGGGGCC		Out	VDJ	1	74	9.666000496362187E-4		53	TCRBV23	TCRBV23-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	7	0	3	4	7	6	20	30	46	37	52														X+TCRBV23-01+TCRBJ02-06	TCRBV23-01*01	TCRBD01-01*01	TCRBJ02-06*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
GAGACACGGCACTGTATCTCTGCGCCAGGCCAAGGAGGCAGCGCTCAGCTCTTACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	87	0.001136408166464203		50	TCRBV23	TCRBV23-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	9	10	1	4	5	14	20	28	38	33	52														X+TCRBV23-01+TCRBJ02-01	TCRBV23-01*01	TCRBD02-01*02	TCRBJ02-01*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
GAGACACGGCACTGTATCTCTGCGCCAGCGAAGACAGGAGCTCCTACGAGCAGTACTTCGGGCCG	CASEDRSSYEQYF	In	VDJ	1	98	0.0012800919576263438	0.0016166548441907652	39	TCRBV23	TCRBV23-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	8	2	4	0	3	2	20	29	38	32	40														CASEDRSSYEQYF+TCRBV23-01+TCRBJ02-07	TCRBV23-01*01	TCRBD01-01*01	TCRBJ02-07*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
TGTATCTCTGCGCCAGCAGTCAACGCGCCAAGGACAGGGAGAACCGTAAGCCGAGCAATCAGCCCCAGCATTTTGGTGAT	CASSQRAKDRENRKPSNQPQHF	In	VDJ	2	160	0.0020899460532675	0.0026394364803114536	66	TCRBV23	TCRBV23-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	2	1	3	1	8	14	8	23	39	31	53														CASSQRAKDRENRKPSNQPQHF+TCRBV23-01+TCRBJ01-05	TCRBV23-01*01	TCRBD01-01*01	TCRBJ01-05*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGTCAATATAGACTAGCTCATCGAGCAGTACTTCGGGCCG		Out	VDJ	4	335	0.004375824549028828		43	TCRBV23	TCRBV23-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	1	2	7	6	3	4	20	36	46	39	50						01,02								X+TCRBV23-01+TCRBJ02-07	TCRBV23-01*01	TCRBD02-01	TCRBJ02-07*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGACTAGGACAGGGGAGCACTGGGGCCAACGTCCTGACTTTCGGGGCC	CASRLGQGSTGANVLTF	In	VDJ	1	22	2.8736758232428126E-4	3.6292251604282485E-4	51	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	6	1	2	2	4	4	23	34	47	38	51														CASRLGQGSTGANVLTF+TCRBV06-08+TCRBJ02-06	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-06*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCAGCGGGAGCACAGATACGCAGTATTTTGGCCCA	CASSSGSTDTQYF	In	VDJ	1	22	2.8736758232428126E-4	3.6292251604282485E-4	39	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	6	6	4	0	1	0	23	34	-1	35	41						01,02								CASSSGSTDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD02-01	TCRBJ02-03*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGTGACAGAAAATCAGCCCCAGCATTTTGGTGAT	CASSVTENQPQHF	In	VDJ	1	22	2.8736758232428126E-4	3.6292251604282485E-4	39	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	5	2	5	4	2	2	23	35	42	37	44														CASSVTENQPQHF+TCRBV06-08+TCRBJ01-05	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-05*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTCAGGGGTCAATCAGCCCCAGCATTTTGGTGAT	CASSSGVNQPQHF	In	VDJ	1	22	2.8736758232428126E-4	3.6292251604282485E-4	39	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	4	4	2	3	0	1	23	-1	42	36	43														CASSSGVNQPQHF+TCRBV06-08+TCRBJ01-05	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-05*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGACGGGAGGGAAAACAATGAGCAGTTCTTCGGGCCA	CASSDGRENNEQFF	In	VDJ	1	24	3.13491907990125E-4	3.95915472046718E-4	42	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	5	8	0	5	2	3	23	35	45	37	48														CASSDGRENNEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-01*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATAGGGGGCGCCGGGACTAGGGGCGGCACCGGGGAGCTGTTTTTTGGAGAA	CAIGGAGTRGGTGELFF	In	VDJ	1	25	3.2655407082304687E-4	4.1241195004866464E-4	51	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	10	0	8	4	11	6	23	30	49	41	55						01,02								CAIGGAGTRGGTGELFF+TCRBV06-08+TCRBJ02-02	TCRBV06-08*01	TCRBD02-01	TCRBJ02-02*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGAGCGAGCGGAGCCTGCCTACGAGCAGTACTTCGGGCCG	CASSERAEPAYEQYF	In	VDJ	1	26	3.3961623365596876E-4	4.289084280506112E-4	45	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	5	6	5	2	5	6	23	35	45	40	51						01,02								CASSERAEPAYEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD02-01	TCRBJ02-07*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGCACTAGCGGGAGCTCAAGAGACCCAGTACTTCGGGCCA	CASSALAGAQETQYF	In	VDJ	1	26	3.3961623365596876E-4	4.289084280506112E-4	45	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	5	3	2	2	2	2	23	35	48	37	50														CASSALAGAQETQYF+TCRBV06-08+TCRBJ02-05	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-05*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTCAGGGGGTTCCGGTCTATGGCTACACCTTCGGTTCG	CASSQGVPVYGYTF	In	VDJ	1	27	3.5267839648889064E-4	4.454049060525578E-4	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	4	1	4	0	7	23	-1	42	35	49														CASSQGVPVYGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-02*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGACTCCAACCTAGGACTAGCGGGAGTGAGTGAGCAGTTCTTCGGGCCA	CASSDSNLGLAGVSEQFF	In	VDJ	1	28	3.6574055932181253E-4	4.6190138405450437E-4	54	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	0	1	2	9	7	4	23	40	60	47	64														CASSDSNLGLAGVSEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-01*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGATCTTCTCGGGACAGATACGCAGTATTTTGGCCCA	CASSDLLGTDTQYF	In	VDJ	1	28	3.6574055932181253E-4	4.6190138405450437E-4	42	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	5	8	4	3	8	0	23	35	-1	43	47						01,02								CASSDLLGTDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD02-01	TCRBJ02-03*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCTCACACCGGGACGGGAACACTGAAGCTTTCTTTGGACAA	CASHRDGNTEAFF	In	VDJ	1	28	3.6574055932181253E-4	4.6190138405450437E-4	39	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-01	01	11	0	7	1	7	2	23	29	41	36	43				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASHRDGNTEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01		TCRBJ01-01*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
TCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTAAGCTTACTACAGGGATGAAGCCTCCTCTAACTATAGCTACACCTTCGGTTCG	CASS*AYYRDEASSNYSYTF	Stop	VDJ	1	28	3.6574055932181253E-4		60	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	3	3	3	9	8	21	21	35	49	43	70														CASS*AYYRDEASSNYSYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-02*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGGTCAGGAGCAAGCGCAGTATTTTGGCCCA	CASSGQEQAQYF	In	VDJ	1	31	4.0492704782057814E-4	5.113908180603441E-4	36	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-03	01	5	4	4	10	3	6	23	35	42	38	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSGQEQAQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01		TCRBJ02-03*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTATGGACAGGGAGTGGATCAGCCCCAGCATTTTGGTGAT	CASSYYGQGVDQPQHF	In	VDJ	1	33	4.3105137348642186E-4	5.443837740642373E-4	48	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	1	1	3	5	2	5	23	39	49	41	54														CASSYYGQGVDQPQHF+TCRBV06-08+TCRBJ01-05	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-05*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGACTCAAGGGGCGACACAGATACGCAGTATTTTGGCCCA	CASSDSRGDTDTQYF	In	VDJ	1	34	4.4411353631934375E-4	5.608802520661838E-4	45	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	0	5	2	2	1	3	23	40	46	41	49														CASSDSRGDTDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-03*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGGGACTAGCGGGATCAACCCCGATAGCACAGATACGCAGTATTTTGGCCCA	CASSGTSGINPDSTDTQYF	In	VDJ	1	35	4.5717569915226564E-4	5.773767300681304E-4	57	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	5	0	3	0	0	11	23	-1	48	35	59														CASSGTSGINPDSTDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-03*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGACCAGGAGGATATGGCTACACCTTCGGTTCG	CASRPGGYGYTF	In	VDJ	1	36	4.702378619851875E-4	5.938732080700771E-4	36	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	6	10	1	5	4	1	23	34	43	38	44														CASRPGGYGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD02-01*02	TCRBJ01-02*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTCCTCGGACTAGCGGGAACTACGAGCAGTACTTCGGGCCG	CASSPRTSGNYEQYF	In	VDJ	1	39	5.094243504839531E-4	6.433626420759168E-4	45	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	5	1	3	3	4	1	23	35	51	39	52														CASSPRTSGNYEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-07*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCCTCGGACAGGCATGGGATACGCAGTATTTTGGCCCA	CASSLGQAWDTQYF	In	VDJ	1	42	5.486108389827187E-4	6.928520760817565E-4	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	6	1	4	6	4	5	23	34	45	38	50														CASSLGQAWDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-03*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTTCGGACTAGCGGGAGAAGAGACCCAGTACTTCGGGCCA	CASSFGLAGEETQYF	In	VDJ	1	44	5.747351646485625E-4	7.258450320856497E-4	45	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	4	1	2	3	2	0	23	36	-1	38	51														CASSFGLAGEETQYF+TCRBV06-08+TCRBJ02-05	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-05*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCGGACAGGCCAACTATGGCTACACCTTCGGTTCG	CASGQANYGYTF	In	VDJ	1	44	5.747351646485625E-4	7.258450320856497E-4	36	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	8	1	4	2	0	2	23	-1	39	32	41														CASGQANYGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-02*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACAAGCGGGAGTACAATGAGCAGTTCTTCGGGCCA	CASSYKREYNEQFF	In	VDJ	1	46	6.008594903144063E-4	7.588379880895429E-4	42	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	2	6	2	4	1	0	23	38	-1	39	47														CASSYKREYNEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-01*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGTGGGGGTGGGGCAAGCGGGAGCTACAATGAGCAGTTCTTCGGGCCA	CAISGGGASGSYNEQFF	In	VDJ	1	46	6.008594903144063E-4	7.588379880895429E-4	51	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	5	6	2	3	12	0	23	35	-1	47	55														CAISGGGASGSYNEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-01*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTCGACCCCGAACACTGAAGCTTTCTTTGGACAA	CASSYSTPNTEAFF	In	VDJ	1	47	6.139216531473281E-4	7.753344660914894E-4	42	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-01	01	0	2	7	1	0	3	23	-1	43	40	46				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSYSTPNTEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01		TCRBJ01-01*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGGAGTGGGCAGACTAACTATGGCTACACCTTCGGTTCG	CASRSGQTNYGYTF	In	VDJ	1	48	6.2698381598025E-4	7.91830944093436E-4	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	8	0	0	4	3	23	34	42	38	45														CASRSGQTNYGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-02*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATTAGGACTAGCGGGAGTGCGGGCTCAACCGGGGAGCTGTTTTTTGGAGAA	CAIRTSGSAGSTGELFF	In	VDJ	1	48	6.2698381598025E-4	7.91830944093436E-4	51	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	10	1	2	5	3	10	23	30	46	33	56														CAIRTSGSAGSTGELFF+TCRBV06-08+TCRBJ02-02	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-02*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCACAAATCAGGGTAAATTTGGCGTTGAGCAGTTCTTCGGGCCA	CASTNQGKFGVEQFF	In	VDJ	1	51	6.661703044790157E-4	8.413203780992758E-4	45	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	7	4	3	9	5	12	23	33	43	38	55														CASTNQGKFGVEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-01*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACCAAGTAGGGGGGGACACTGAAGCTTTCTTTGGACAA	CASSYQVGGDTEAFF	In	VDJ	1	51	6.661703044790157E-4	8.413203780992758E-4	45	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	2	9	0	3	6	0	23	38	-1	44	51														CASSYQVGGDTEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD02-01*01	TCRBJ01-01*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTCCGGGCAACAGAACACTGAAGCTTTTTTTGGACAA	CASSYSGQQNTEAFF	In	VDJ	1	51	6.661703044790157E-4	8.413203780992758E-4	45	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-01	01	0	3	5	17	6	15	23	40	50	46	65				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSYSGQQNTEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01		TCRBJ01-01*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTCGGGGACTAGCGACTACAATGAGCAGTTCTTCGGGCCA	CASSSGTSDYNEQFF	In	VDJ	1	51	6.661703044790157E-4	8.413203780992758E-4	45	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	4	0	6	3	2	1	23	36	48	38	49						01,02								CASSSGTSDYNEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD02-01	TCRBJ02-01*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAACCCCGGTCCTGCGGGAGGGCCCTCAGATACGCAGTATTTTGGCCCA	CASNPGPAGGPSDTQYF	In	VDJ	1	52	6.792324673119375E-4	8.578168561012224E-4	51	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	7	7	0	4	11	4	23	33	53	44	57														CASNPGPAGGPSDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-03*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGACTAGCGGGAGAGGTAGATACGCAGTATTTTGGCCCA	CASRLAGEVDTQYF	In	VDJ	1	53	6.922946301448593E-4	8.74313334103169E-4	42	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	6	3	2	5	0	4	23	-1	45	34	49														CASRLAGEVDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-03*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTCCCCCCTCGAGCAGCACAGATACGCAGTATTTTGGCCCA	CASSPPSSSTDTQYF	In	VDJ	1	53	6.922946301448593E-4	8.74313334103169E-4	45	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	5	6	7	0	9	0	23	35	-1	44	47						01,02								CASSPPSSSTDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD02-01	TCRBJ02-03*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGGGCAGAACTTAATAGCAATCAGCCCCAGCATTTTGGTGAT	CASRAELNSNQPQHF	In	VDJ	1	55	7.184189558107031E-4	9.073062901070622E-4	45	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-05	01	6	4	5	0	2	7	23	34	39	36	46				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASRAELNSNQPQHF+TCRBV06-08+TCRBJ01-05	TCRBV06-08*01		TCRBJ01-05*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGTGGCTCGACAGAAGAGACCCAGTACTTCGGGCCA	CAISGSTEETQYF	In	VDJ	1	55	7.184189558107031E-4	9.073062901070622E-4	39	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	5	2	5	3	5	0	23	35	-1	40	45														CAISGSTEETQYF+TCRBV06-08+TCRBJ02-05	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-05*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCATAACCGGGCCCGGCATCGGTACAGATACGCAGTATTTTGGCCCA	CASITGPGIGTDTQYF	In	VDJ	1	56	7.314811186436251E-4	9.238027681090087E-4	48	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-03	01	7	8	0	3	5	11	23	33	42	38	53				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASITGPGIGTDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01		TCRBJ02-03*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTCACCAGGTCTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASSHQVSGANVLTF	In	VDJ	1	57	7.445432814765469E-4	9.402992461109553E-4	45	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	5	4	4	0	3	1	23	35	42	38	43														CASSHQVSGANVLTF+TCRBV06-08+TCRBJ02-06	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-06*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAAAGGGGGGGCGACCTACGAGCAGTACTTCGGGCCG	CASKGGATYEQYF	In	VDJ	1	58	7.576054443094687E-4	9.567957241129019E-4	39	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	7	9	0	2	2	3	23	33	42	35	45														CASKGGATYEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD02-01*01	TCRBJ02-07*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGGGGACAATGGGACAGCCGGGAGGGCTACACCTTCGGTTCG	CASRGQWDSREGYTF	In	VDJ	1	58	7.576054443094687E-4	9.567957241129019E-4	45	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	0	5	8	8	7	23	34	49	42	56														CASRGQWDSREGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-02*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGACGACGATGGGGCCAACGTCCTGACTTTCGGGGCC	CASSDDDGANVLTF	In	VDJ	1	58	7.576054443094687E-4	9.567957241129019E-4	42	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-06	01	5	2	7	3	0	5	23	-1	38	35	43				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSDDDGANVLTF+TCRBV06-08+TCRBJ02-06	TCRBV06-08*01		TCRBJ02-06*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCACGGGACAGTTCAACTATGGCTACACCTTCGGTTCG	CASTGQFNYGYTF	In	VDJ	1	60	7.837297699753125E-4	9.89788680116795E-4	39	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	7	0	5	2	1	3	23	33	41	34	44														CASTGQFNYGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-02*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTAAACAGGGCACCGGGGAGCTGTTTTTTGGAGAA	CASSKQGTGELFF	In	VDJ	1	61	7.967919328082343E-4	0.0010062851581187416	39	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	5	3	3	4	2	0	23	35	-1	37	43														CASSKQGTGELFF+TCRBV06-08+TCRBJ02-02	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-02*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACGCCCAAGGGGTAAATCAGCCCCAGCATTTTGGTGAT	CASSYAQGVNQPQHF	In	VDJ	1	64	8.35978421307E-4	0.0010557745921245813	45	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	2	5	2	4	5	2	23	38	48	43	50														CASSYAQGVNQPQHF+TCRBV06-08+TCRBJ01-05	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-05*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTCCTCTAGTAGACACAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	71	9.274135611374531E-4		46	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	0	4	8	2	2	4	23	40	46	42	50						01,02								X+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD02-01	TCRBJ02-03*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
TCCCAGACATCTGTGTACTTGTGTGCCATCAGTTAACCCGGGACTAGCGGGAGGGCCGGGAACACCGGGGAGCTGTTTTTTGGAGAA	CAIS*PGTSGRAGNTGELFF	Stop	VDJ	1	71	9.274135611374531E-4		60	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	3	0	0	1	4	4	21	35	55	39	59														CAIS*PGTSGRAGNTGELFF+TCRBV06-08+TCRBJ02-02	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-02*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCCACATCCCCCCAGGGGCGGACATTCAGTACTTCGGCGCC	CASSHIPPGADIQYF	In	VDJ	1	72	9.40475723970375E-4	0.0011877464161401542	45	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-04	01	6	4	2	8	11	3	23	34	51	45	54														CASSHIPPGADIQYF+TCRBV06-08+TCRBJ02-04	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-04*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTCGACTAGCGGGAGCACCGGGGAGCTGTTTTTTGGAGAA	CASSYSTSGSTGELFF	In	VDJ	1	74	9.666000496362187E-4	0.0012207393721440473	48	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	0	2	2	4	0	0	23	-1	-1	40	52														CASSYSTSGSTGELFF+TCRBV06-08+TCRBJ02-02	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-02*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCTTTGACGTCCAATCCGTGTCGCCCCAGCATTTTGGTGAT	CASFDVQSVSPQHF	In	VDJ	1	77	0.0010057865381349843	0.001270228806149887	42	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-05	01	8	2	7	9	3	14	23	32	38	35	52				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASFDVQSVSPQHF+TCRBV06-08+TCRBJ01-05	TCRBV06-08*01		TCRBJ01-05*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAATATGGGGGGGACTAGTACAGATACGCAGTATTTTGGCCCA	CASNMGGTSTDTQYF	In	VDJ	1	79	0.0010319108638008282	0.0013032217621537802	45	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	7	0	8	3	8	1	23	33	49	41	50						01,02								CASNMGGTSTDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD02-01	TCRBJ02-03*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGAGTCCGGGACAGGGCGTGAAAAACTGTTTTTTGGCAGT	CASSESGTGREKLFF	In	VDJ	1	83	0.0010841595151325155	0.0013692076741615665	45	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	5	0	3	7	6	2	23	35	50	41	52														CASSESGTGREKLFF+TCRBV06-08+TCRBJ01-04	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-04*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCGGGGACGGACAAGAGACCCAGTACTTCGGGCCA	CASSGDGQETQYF	In	VDJ	1	85	0.0011102838407983594	0.0014022006301654597	39	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-05	01	6	0	7	2	2	3	23	34	41	36	44				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSGDGQETQYF+TCRBV06-08+TCRBJ02-05	TCRBV06-08*01		TCRBJ02-05*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCACCACAGGGGTAGGGGAAGAGACCCAGTACTTCGGGCCA	CATTGVGEETQYF	In	VDJ	1	92	0.0012017189806288126	0.0015176759761790857	39	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	10	3	2	3	2	6	23	30	39	32	45														CATTGVGEETQYF+TCRBV06-08+TCRBJ02-05	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-05*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGAACTCTGATTTCACAGGACCGAACTAATGAAAAACTGTTTTTTGGCAGT	CASRTLISQDRTNEKLFF	In	VDJ	1	93	0.0012147811434617343	0.0015341724541810323	54	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	6	3	4	1	12	4	23	34	51	46	55														CASRTLISQDRTNEKLFF+TCRBV06-08+TCRBJ01-04	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-04*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGGTACAGCAGACACCGGGGAGCTGTTTTTTGGAGAA	CASSGTADTGELFF	In	VDJ	1	93	0.0012147811434617343	0.0015341724541810323	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	5	3	5	3	3	3	23	35	42	38	45														CASSGTADTGELFF+TCRBV06-08+TCRBJ02-02	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-02*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTCCCCGGGGGCAGGGGGAATCCGCTTTCTTTGGACAA	CASSPRGQGESAFF	In	VDJ	1	94	0.0012278433062946563	0.0015506689321829789	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	4	1	11	9	5	23	35	51	44	56														CASSPRGQGESAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-01*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGTTCACAGGGAAATCAGCCCCAGCATTTTGGTGAT	CAISSQGNQPQHF	In	VDJ	1	94	0.0012278433062946563	0.0015506689321829789	39	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	4	3	3	4	1	1	23	36	43	37	44														CAISSQGNQPQHF+TCRBV06-08+TCRBJ01-05	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-05*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGGTATCTCCGGGGCCAACGTCCTGACTTTCGGGGCC	CASSGISGANVLTF	In	VDJ	1	99	0.0012931541204592657	0.0016331513221927118	42	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-06	01	5	0	10	4	0	7	23	-1	37	35	44				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSGISGANVLTF+TCRBV06-08+TCRBJ02-06	TCRBV06-08*01		TCRBJ02-06*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGAGCTTCTAGCCGTAGTACCCGGAGCTCCTACGAGCAGTACTTCGGGCCG	CARASSRSTRSSYEQYF	In	VDJ	1	103	0.001345402771790953	0.0016991372342004983	51	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	9	4	7	0	5	14	23	31	41	36	55						01,02								CARASSRSTRSSYEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD02-01	TCRBJ02-07*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAAACGGGGAAGGACACAGAACACCGGGGAGCTGTTTTTTGGAGAA	CASKRGRTQNTGELFF	In	VDJ	1	103	0.001345402771790953	0.0016991372342004983	48	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-02	01	7	1	6	1	9	2	23	33	47	42	49				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASKRGRTQNTGELFF+TCRBV06-08+TCRBJ02-02	TCRBV06-08*01		TCRBJ02-02*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTCGGGCGCCTAGCGGGACTAGCCAAAAACATTCAGTACTTCGGCGCC		Out	VDJ	1	103	0.001345402771790953		56	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-04	01	0	4	3	0	6	2	23	40	55	46	57														X+TCRBV06-08+TCRBJ02-04	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-04*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCTCTAGGGCGGTCCAAGAGACCCAGTACTTCGGGCCA	CASSRAVQETQYF	In	VDJ	1	109	0.0014237757487884843	0.0017981161022121777	39	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-05	01	8	5	3	1	3	4	23	32	39	35	43				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSRAVQETQYF+TCRBV06-08+TCRBJ02-05	TCRBV06-08*01		TCRBJ02-05*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
CCTCCCAGACATCTGTGTACTTGTGTGTCAGCAGTTCCGGGACAGGGGTCTTCGTGCATGAGCAGTTCTTCGGGCCA	CVSSSGTGVFVHEQFF	In	VDJ	1	109	0.0014237757487884843	0.0017981161022121777	48	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	4	0	2	8	2	9	23	36	48	38	57														CVSSSGTGVFVHEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-01*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGACCGACAGGGCCTGGAAACACCATATATTTTGGAGAG	CASRPTGPGNTIYF	In	VDJ	1	114	0.0014890865629530938	0.0018805984922219106	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	6	2	3	2	3	1	23	34	44	37	45														CASRPTGPGNTIYF+TCRBV06-08+TCRBJ01-03	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-03*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTCGGGACTCGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSRDSNTGELFF	In	VDJ	2	119	0.001554397377117703	0.0019630808822316435	42	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	5	0	10	0	1	0	23	35	-1	36	42						01,02								CASSRDSNTGELFF+TCRBV06-08+TCRBJ02-02	TCRBV06-08*01	TCRBD02-01	TCRBJ02-02*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTTAACAGGGGGCGGGGACACCATATATTTTGGAGAG	CASSLTGGGDTIYF	In	VDJ	2	120	0.001567459539950625	0.00197957736023359	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	4	3	0	8	2	4	23	36	47	38	51														CASSLTGGGDTIYF+TCRBV06-08+TCRBJ01-03	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-03*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGTGGACCTAGCGGGAGGACCTCCAATGAGCAGTTCTTCGGGCCA	CAISGPSGRTSNEQFF	In	VDJ	2	146	0.0019070757736065938	0.0024084857882842015	48	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	5	4	1	6	4	5	23	35	50	39	55														CAISGPSGRTSNEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-01*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTCCGTATTGGGCGTACCCCCATCCTACGAGCAGTACTTCGGGCCA		Out	VDJ	2	153	0.0019985109134370467		50	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	5	8	0	11	7	18	23	35	46	42	64														X+TCRBV06-08+TCRBJ02-05	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-05*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGTAGGGAGGGATGGGGTGACCCAGTACTTCGGGCCA	CASSVGRDGVTQYF	In	VDJ	2	159	0.0020768838904345784	0.002622940002309507	42	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	5	9	0	7	3	7	23	35	45	38	52														CASSVGRDGVTQYF+TCRBV06-08+TCRBJ02-05	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-05*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTCGGGCTAGCGGGAGGGTCGCGTCCTACGAGCAGTACTTCGGGCCG		Out	VDJ	2	159	0.0020768838904345784		55	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	0	4	0	1	3	5	23	40	55	43	60														X+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-07*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCACCCAAAACTTGCAGCGGGCACCTACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	2	181	0.0023642514727588593		50	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	7	6	4	2	12	2	23	33	51	45	53						01,02								X+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD02-01	TCRBJ02-01*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTCGAGGGGAGTGGGCAATCAGCCCCAGCATTTTGGTGAT	CASSSRGVGNQPQHF	In	VDJ	2	190	0.0024818109382551564	0.003134330820369851	45	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-05	01	4	5	2	2	2	5	23	36	43	38	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSSRGVGNQPQHF+TCRBV06-08+TCRBJ01-05	TCRBV06-08*01		TCRBJ01-05*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGACTCGGACAACACCGGGGAGCTGTTTTTTGGAGAA	CASSDSDNTGELFF	In	VDJ	3	227	0.0029651109630732656	0.0037447005064418747	42	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-02	01	0	1	7	2	0	0	23	-1	-1	40	44				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSDSDNTGELFF+TCRBV06-08+TCRBJ02-02	TCRBV06-08*01		TCRBJ02-02*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTATGGTCTAGCGGGAGAAGGGGAGCAGTACTTCGGGCCG	CASSYGLAGEGEQYF	In	VDJ	3	233	0.003043483940070797	0.003843679374453554	45	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	3	4	2	7	4	5	23	37	51	41	56														CASSYGLAGEGEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-07*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGGGACTAGCGGGAGCACAGATACGCAGTATTTTGGCCCA	CASSGTSGSTDTQYF	In	VDJ	3	242	0.003161043405567094	0.003992147676471073	45	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	5	0	4	0	0	0	23	-1	-1	35	47						01,02								CASSGTSGSTDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD02-01	TCRBJ02-03*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGTGACTCAGACAGGGGTCTGACTTACGAGCAGTACTTCGGGCCG	CAISDSDRGLTYEQYF	In	VDJ	3	243	0.003174105568400016	0.00400864415447302	48	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	0	2	2	4	1	7	23	40	49	41	56														CAISDSDRGLTYEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-07*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCCCCGGGACAGGGGCGCACACTGAAGCTTTCTTTGGACAA	CASSPGTGAHTEAFF	In	VDJ	3	260	0.0033961623365596876	0.004289084280506112	45	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	0	2	3	4	3	23	34	48	38	51														CASSPGTGAHTEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-01*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGAACCCTGATCTCACAGGACCGAACTAATGAAAAACTGTTTTTTGGCAGT	CASRTLISQDRTNEKLFF	In	VDJ	4	336	0.00438888671186175	0.005542816608654052	54	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	6	3	4	1	12	4	23	34	51	46	55														CASRTLISQDRTNEKLFF+TCRBV06-08+TCRBJ01-04	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-04*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACCTGCAGGGGGCTGGAACGGTTGACAGTCAGCCCCAGCATTTTGGTGAT	CASSYLQGAGTVDSQPQHF	In	VDJ	6	483	0.006309024648301266	0.0079677988749402	57	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	2	4	0	6	3	15	23	38	49	41	64														CASSYLQGAGTVDSQPQHF+TCRBV06-08+TCRBJ01-05	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-05*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATAAGCCAGCGGGTCTATGGAATGAAAAACTGTTTTTTGGCAGT		Out	VDJ	9	721	0.009417819402536672		44	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-04	01	10	6	4	5	6	7	23	30	42	36	49						01,02								X+TCRBV06-08+TCRBJ01-04	TCRBV06-08*01	TCRBD02-01	TCRBJ01-04*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCAATCTACGGGGCAGAGACCCAGTACTTCGGGCCA	CASSIYGAETQYF	In	VDJ	1	22	2.8736758232428126E-4	3.6292251604282485E-4	39	TCRBV18	TCRBV18-01	01				TCRBJ02	TCRBJ02-05	01	5	7	0	4	6	0	24	36	-1	42	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	CASSIYGAETQYF+TCRBV18-01+TCRBJ02-05	TCRBV18-01*01		TCRBJ02-05*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCCCTTGGGCGGGACAGGCTCCCCTACGAGCAGTACTTCGGGCCG	CASSLGRDRLPYEQYF	In	VDJ	1	22	2.8736758232428126E-4	3.6292251604282485E-4	48	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	0	4	2	8	4	24	35	51	43	55													Vb 18	CASSLGRDRLPYEQYF+TCRBV18-01+TCRBJ02-07	TCRBV18-01*01	TCRBD01-01*01	TCRBJ02-07*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCCCGTGGACAGGGGCAATGGGGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	24	3.13491907990125E-4		44	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	8	1	2	5	4	7	24	33	46	37	53													Vb 18	X+TCRBV18-01+TCRBJ02-05	TCRBV18-01*01	TCRBD01-01*01	TCRBJ02-05*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCATTGAACAATGAGCAGTTCTTCGGGCCA	CASSPLNNEQFF	In	VDJ	1	27	3.5267839648889064E-4	4.454049060525578E-4	36	TCRBV18	TCRBV18-01	01				TCRBJ02	TCRBJ02-01	01	2	2	8	5	2	0	24	39	-1	41	43				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	CASSPLNNEQFF+TCRBV18-01+TCRBJ02-01	TCRBV18-01*01		TCRBJ02-01*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCTAACAGCCCGGGACACGGCTACAATGAGCAGTTCTTCGGGCCA	CASSPNSPGHGYNEQFF	In	VDJ	1	31	4.0492704782057814E-4	5.113908180603441E-4	51	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	3	0	6	3	9	3	24	38	53	47	56													Vb 18	CASSPNSPGHGYNEQFF+TCRBV18-01+TCRBJ02-01	TCRBV18-01*01	TCRBD01-01*01	TCRBJ02-01*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCCCAGTCCCTAACAGGAGGCTACACCTTCGGTTCG	CASSPQSLTGGYTF	In	VDJ	1	34	4.4411353631934375E-4	5.608802520661838E-4	42	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	3	3	4	8	10	1	24	38	53	48	54													Vb 18	CASSPQSLTGGYTF+TCRBV18-01+TCRBJ01-02	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-02*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCGAGGTCCGCGGTGGTGGCTTTCTTTGGACAA	CASSPRSAVVAFF	In	VDJ	1	34	4.4411353631934375E-4	5.608802520661838E-4	39	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	3	7	5	11	7	5	24	38	49	45	54						01,02							Vb 18	CASSPRSAVVAFF+TCRBV18-01+TCRBJ01-01	TCRBV18-01*01	TCRBD02-01	TCRBJ01-01*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCACCGACAGGGACGGACCATGGGGGCAGTATTTTGGCCCA		Out	VDJ	1	40	5.22486513316875E-4		47	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	0	2	3	11	0	13	24	-1	48	41	61													Vb 18	X+TCRBV18-01+TCRBJ02-03	TCRBV18-01*01	TCRBD01-01*01	TCRBJ02-03*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCACCGACAGGGTATAGCACTGAAGCTTTCTTTGGACAA	CASSPPTGYSTEAFF	In	VDJ	1	42	5.486108389827187E-4	6.928520760817565E-4	45	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	0	2	3	4	0	5	24	-1	48	41	53													Vb 18	CASSPPTGYSTEAFF+TCRBV18-01+TCRBJ01-01	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-01*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCATCGAGGGCCGGGACTAGCGGCACAGATACGCAGTATTTTGGCCCA	CASSSRAGTSGTDTQYF	In	VDJ	1	49	6.400459788131719E-4	8.083274220953826E-4	51	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	5	0	6	1	9	0	24	36	-1	45	55						01,02							Vb 18	CASSSRAGTSGTDTQYF+TCRBV18-01+TCRBJ02-03	TCRBV18-01*01	TCRBD02-01	TCRBJ02-03*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCACTAGACGAGTTTCGCGGGGAGCTGTTTTTTGGAGAA	CASSPLDEFRGELFF	In	VDJ	1	51	6.661703044790157E-4	8.413203780992758E-4	45	TCRBV18	TCRBV18-01	01				TCRBJ02	TCRBJ02-02	01	1	2	7	7	2	8	24	40	45	42	53				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	CASSPLDEFRGELFF+TCRBV18-01+TCRBJ02-02	TCRBV18-01*01		TCRBJ02-02*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCAACTTACGGAGGGCGGCCCGGGGAGCTGTTTTTTGGAGAA	CASSPTYGGRPGELFF	In	VDJ	1	58	7.576054443094687E-4	9.567957241129019E-4	48	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	2	10	0	6	6	4	24	39	51	45	55													Vb 18	CASSPTYGGRPGELFF+TCRBV18-01+TCRBJ02-02	TCRBV18-01*01	TCRBD02-01*02	TCRBJ02-02*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCACCGACAGGGAAGCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	1	75	9.796622124691407E-4		43	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	0	2	3	7	0	3	24	-1	48	41	51													Vb 18	X+TCRBV18-01+TCRBJ02-02	TCRBV18-01*01	TCRBD01-01*01	TCRBJ02-02*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCGGGACAGGGGGCGAGAATAAGCTCCTACAATGAGCAGTTCTTCGGGCCA	CASSPGQGARISSYNEQFF	In	VDJ	1	76	9.927243753020626E-4	0.0012537323281479405	57	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	3	0	0	0	0	9	24	-1	50	38	59													Vb 18	CASSPGQGARISSYNEQFF+TCRBV18-01+TCRBJ02-01	TCRBV18-01*01	TCRBD01-01*01	TCRBJ02-01*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCACGAAATGTAGTCAGACATGAAAAACTGTTTTTTGGCAGT	CASSPRNVVRHEKLFF	In	VDJ	1	86	0.0011233460036312814	0.0014186971081674063	48	TCRBV18	TCRBV18-01	01				TCRBJ01	TCRBJ01-04	01	1	2	7	6	12	0	24	40	-1	52	55				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	CASSPRNVVRHEKLFF+TCRBV18-01+TCRBJ01-04	TCRBV18-01*01		TCRBJ01-04*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCTCTCAATCCGGCCTCGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSLNPASNTGELFF	In	VDJ	1	110	0.0014368379116214062	0.0018146125802141243	48	TCRBV18	TCRBV18-01	01				TCRBJ02	TCRBJ02-02	01	6	9	0	0	9	2	24	35	47	44	49				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	CASSLNPASNTGELFF+TCRBV18-01+TCRBJ02-02	TCRBV18-01*01		TCRBJ02-02*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTACCCATGAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	2	149	0.0019462622621053594		35	TCRBV18	TCRBV18-01	01				TCRBJ01	TCRBJ01-01	01	7	3	7	0	0	3	24	-1	36	34	39				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	X+TCRBV18-01+TCRBJ01-01	TCRBV18-01*01		TCRBJ01-01*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCCCAAAGCGAGTTAGTGGCAGCTCCTACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	3	206	0.002690805543581906		56	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	3	6	6	0	4	12	24	38	46	42	58						01,02							Vb 18	X+TCRBV18-01+TCRBJ02-01	TCRBV18-01*01	TCRBD02-01	TCRBJ02-01*01	3418A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1196	947	239	9	0	710	576	123	11	0	76557	60619	15350	588	0	0.136774689	7.9157114	0.132357776	8.21802521				7319	0.12851426	0.056797374	0.044973027	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:17	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.7918059984850908	MSKCC- Snyder- P01-02		941.0	
